VAERS Reports AS7148B

VAERS 2728600

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: -
Alter: 82,0
Geschlecht: F
Eingang: 29.12.2023
Impfdatum: 22.09.2022
Beginn: 25.11.2023
Tage bis Beginn: 429,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Blood gases normal Brain natriuretic peptide normal C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Dyspnoea Influenza virus test negative Leukocytosis Obstructive sleep apnoea syndrome Oxygen saturation decreased Pyrexia Red blood cell sedimentation rate normal SARS-CoV-2 test positive Sepsis Total lung capacity decreased

Symptomtext

Patient is a 83 y.o. female patient of MD with history of Parkinson's and HTN presented to Hospital with fever, cough, and shortness of breath. Workup on admission revealed evidence of COVID infection with acute hypoxic respiratory failure requiring supplemental oxygen. During her stay, she was treated with antivirals and steroids. She completed a 5-day course of Remdesivir and received 5 days of Decadron. She was ultimately weaned down to RA and home O2 evaluation did not reveal any oxygen needs with ambulation. She was discharged home with a prescription for 5 more days of PO Decadron. Home Health Care was also arranged upon discharge. She was discharged home in stable condition. Sepsis, POA, resolved Acute Hypoxic Respiratory Failure, improving COVID Pneumonia, improving Presumed Obstructive Sleep Apnea Temp. 101.5F, HR 110, RR 32, Pulse ox 83% on RA, on admission CBC shows leukocytosis with WBC count 12.69 on admission VBG, BMP unremarkable COVID positive, Flu negative CXR shows slightly low lung volumes without discrete infiltrates Remdesivir and dexamethasone initiated (11/25) BNP WNL ESR normal, CRP elevated at 78.8 Continue steroids for a total 10-day course (received 5 day course of Remdesivir, last dose11/29) IS ordered Oxygen desaturation noted during periods of sleep, recommend outpatient sleep study for evaluation of OSA Home O2 eval 11/28 revealed desaturation with ambulation below 90% Wean to RA, home O2 eval 11/29 showed no evidence of increased oxygen needs on ambulation Parkinson's Disease Dementia Follows with Neurology (Dr) On Sinemet 25-100 mg TID, Pramipexole, Memantine Continue home meds Pt's son worried about increased weakness due to acute illness, at baseline has limited mobility due to chronic R knee pain PT/OT consulted Hypertension Continue home lisinopril Anxiety On home Prozac, Imipramine nightly PRN, and diazepam PRN Continue home meds R Knee DJD Resumed home norco

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2727568

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: -
Alter: 80,0
Geschlecht: M
Eingang: 27.12.2023
Impfdatum: 22.10.2022
Beginn: 30.10.2023
Tage bis Beginn: 373,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Arthralgia Asthenia Bone scan abnormal COVID-19 Cardiac failure congestive Chronic obstructive pulmonary disease Computerised tomogram normal Condition aggravated Dyspnoea Dyspnoea exertional Fall Hypoxia Oxygen saturation decreased Physical deconditioning Post-acute COVID-19 syndrome Rales SARS-CoV-2 test positive

Symptomtext

Patient is a 81 y.o. male patient of DO with history of COPD, HFpEF, hypertension, hyperlipidemia, Parkinson disease, physical deconditioning presented to Hospital with complaints of shortness of breath with exertion, frequent falls. Acute respiratory failure with hypoxia?resolved Presented with shortness of breath Easily desats with acute to 80s, with minimal exertion Combination of post-COVID 19, CHF, COPD Was able to wean to room air this a.m. Supplemental O2 if required Covid-19 Virus Infection Date of onset of symptoms: 10/29/2023 Symptoms present on admission: Shortness of breath with exertion Date of covid positive test: Official testing positive on 10/20/2023, but was tested positive on 10/17 with home COVID-19 test. After discussion with infectious control isolation is continued, will discontinue steroids as well Vaccination status: vaccinated Imaging: CT without acute pathology Oxygen requirements on admission: 2 L Current oxygen requirements: RA Medical therapy: steroids Consultants following: N/A Anticipated special isolation end date: No need for isolation COPD Not in exacerbation Continue bronchodilators as needed and scheduled Right knee pain X-ray concerning for displacement/dislodgment radiolucent portion of the prosthesis Was ordered NM three-phase bone scan, will order while in the hospital NM triphase bone scan?concerning for healing fracture Discussed with Dr., no surgical intervention is planned Continue PT/OT after discharge, with partial weightbearing Continue ROM exercises, outpatient follow-up with orthopedic surgery Follow-up information is in AVS Chronic HFpEF Overall euvolemic appearing But has few crackles at the bases on auscultation Given x1 dose of Lasix in ED Paroxysmal atrial fibrillation Rhythm NSR Rate control Not on systemic anticoagulation Generalized weakness Physical deconditioning Recurrent falls Combination of COVID infection, physical deconditioning Obesity, COPD and CHF, and right knee pain DC to SNF Parkinson's disease Continue home Sinemet Dementia without behavioral disturbances Continue home meds Anxiety and depression Continue home Zoloft/BuSpar Chronic antibiotic use Patient on Keflex 500 mg twice daily To my knowledge presumed for suppressive therapy for knee infection? However cannot localize any documentation about this I recommend follow-up with prescribing physician To further discuss if long-term antibiotic therapy is warrante

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2661230

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: -
Alter: 83,0
Geschlecht: M
Eingang: 26.07.2023
Impfdatum: 13.09.2022
Beginn: 14.03.2023
Tage bis Beginn: 182,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Hypotension Obstructive sleep apnoea syndrome Symptom recurrence

Symptomtext

ADULT OBSTRUCTIVE SLEEP APNEA ACUTE NON ST ELEVATION MI HYPOTENSION 2/13/2023, 2/26/2023, 1/15/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2660688

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 25.07.2023
Impfdatum: 14.09.2022
Beginn: 02.03.2023
Tage bis Beginn: 169,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2658865

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: -
Alter: 42,0
Geschlecht: M
Eingang: 20.07.2023
Impfdatum: 01.10.2022
Beginn: 21.01.2023
Tage bis Beginn: 112,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Obstructive sleep apnoea syndrome

Symptomtext

OBSTRUCTIVE SLEEP APNEA ACUTE ST ELEVATION MI, INFERIOR WALL ACUTE ST ELEVATION MI, UNSPECIFIED

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2647860

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 21.06.2023
Impfdatum: 16.09.2022
Beginn: 02.11.2022
Tage bis Beginn: 47,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Angina pectoris Angina unstable

Symptomtext

UNSTABLE ANGINA ANGINA, UNSPECIFIED ACUTE NON ST ELEVATION MI

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2642224

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 07.06.2023
Impfdatum: 13.09.2022
Beginn: 08.11.2022
Tage bis Beginn: 56,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2614655

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 13.04.2023
Impfdatum: 21.09.2022
Beginn: 17.03.2023
Tage bis Beginn: 177,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal Aspiration Barium swallow abnormal Blood sodium increased Choking Computerised tomogram head abnormal Condition aggravated Dysphagia Epistaxis COVID-19 Cerebral haematoma Cerebral mass effect Cerebrospinal fluid retention Chest X-ray abnormal Fluid retention Hypernatraemia Hypoxia

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/17/2023 Discharge Date: 03/23/2023 PRESENTING PROBLEM: Hypoxia Acute respiratory failure with hypoxia Altered mental status, unspecified altered mental status type Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung COVID-19 HOSPITAL COURSE: Patient is a 76 year old man with hx of CVA with LUE and bilateral lower extremity weakness and hydrocephalus with a VP shunt since 2013. He lives in LTC. He presented with AMS. He had a + covid home test at LTC on 3/13. He had O2 sat in the 70's while at his facility. On arrival to emergency department patient was found to be hypoxic at 88 %, he is placed on 3 L of nasal cannula. Otherwise patient was hemodynamically stable. Labs were unremarkable. \Chest x-ray was done showing infiltrate in the retrocardiac left lower lobe suspicious for PNA. CTA was neg for PE, it showed bl lower lobe consolidations. Patient was given Rocephin and azithromycin in the E.D. Procal was negative. CT brain without contrast showed diffuse low-density subdural fluid collection overlying the cerebellar hemispheres and along the interhemispheric falx are larger compared to prior with mild mass effect upon the subjacent brain parenchyma. Likely due to hygromas and/or chronic hematomas. As well as hyper densities within the paranasal sinuses. He was admitted for neurosurgery eval. Nsx ordered MRI brain which was unremarkable aside from chronic cva and concern for overshunting. Neurology changed his VP shunt settings from 2.5 to 1.5. He was treated with D5W for hypernatremia due to free water deficit. He was monitored off antibiotics but treated with decadron and remdesivir x 5 days. His hypoxia resolved to room air and mental status normalized. He was made npo on 3/18 after choking on one of his meds. SLP evaluated and recommended meds in puree otherwise thin liquids and general solids. As sodium normalized, D5W was discontinued. Discharged was initially planned on 3/20 however he had nose bleed and poorly able to cough and clear the blood in his pharynx resulting in worsening respiratory status. He was changed to npo. Unasyn was started due to CXR showing left sided consolidation. SLP was consulted and video swallow was completed on 03/21/2023 showing mild to moderate oral dysphagia and moderate to severe pharyngeal dysphagia and his diet was changed to a dysphagia diet. He was weaned to room air and transitioned to oral augmentin to complete 5 total days of antibiotics for aspiration/CAP. He discharged back to LTC on 3/23. Decadron was discontinued at discharge (initially started on 3/17) as the patient had been weaned to room air.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Dysphagia Intracranial hemorrhage Hydrocephalus Acoustic neuroma Restless legs syndrome (RLS)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG capsule albuterol (PROVENTIL, VENTOLIN, PROAIR) 108 (90 Base) MCG/ACT inhaler busPIRone (BUSPAR) 5 MG tablet desonide (TRIDESILON) 0.05 % cream famotidine (PEPCID) 20 MG tablet finasteride (PROSCAR) 1 MG/ML c
Allergien: None
Vorherige Impfungen: -

VAERS 2595685

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: MI
Alter: 91,0
Geschlecht: F
Eingang: 13.03.2023
Impfdatum: 22.09.2022
Beginn: 02.03.2023
Tage bis Beginn: 161,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal Atelectasis Atrial fibrillation Bacterial test positive Blood electrolytes abnormal Bradycardia C-reactive protein increased COVID-19 Cardiac pacemaker insertion Cardiac telemetry abnormal Chest X-ray abnormal Compression garment application Computerised tomogram head normal Computerised tomogram spine Condition aggravated Contusion Culture urine positive

Symptomtext

Discharge Provider: MD Primary Care Provider: DO Admission Date: 3/2/2023 Discharge Date: 3/10/2023 PRESENTING PROBLEM: Acute respiratory failure with hypoxia Acute on chronic respiratory failure with hypoxia COVID-19 COVID-19 virus infection HOSPITAL COURSE: Patient is a 92 y.o. female with PMH significant for T2DM, HLD, breast cancer stage I s/p XRT/lumpectomy, MVP, intermittent vertigo, glaucoma, depression who presented to ED via EMS on 3/2/23 after unwitnessed fall with head injury. Pt did not recall the fall. States that she had been walking and then woke up on the floor. Pt did hit left frontal region on floor and has large contusion without laceration. Denies any past falls or syncope. In ED, pt became hypoxic in the 80s requiring 4L O2. Pt has had a runny nose the past 3 days and husband tested positive for COVID on 2/28 and has been at hospital. In ED, labs significant for mild hyponatremia and positive COVID PCR. CTH and CT spine negative for acute process. CXR and CTA showing bilateral lower lobe atelectasis. Pt admitted under general medicine for further management . Patient's acute hypoxic respiratory failure was attributed to COVID-19 infection. Patient does not use supplemental oxygen at baseline, requiring 2-4 L O2 via nasal cannula at admission. CT angiogram of chest negative for PE. LE doppler US negative for DVT. CXR showed blunting of the posterior costophrenic angles consistent with atelectasis or small pleural effusion, as well as mild linear opacity in the left mid lung consistent with atelectasis versus scar. Started remdesivir 5 day course (EOT 3/7) and dexamethasone 6 mg daily. Patient intermittently able to wean back to room air, but returned to oxygen, frequently overnight. Labs with elevated CRP and d-dimer, which were slowly down trending. Pulm rehab evaluated prior to discharge and recommended 2L NC O2 with activity. She was set up with home oxygen. She was prescribed dexamethasone to complete 10 day course. EKG at admission showing NSR with LAD, QTC 431. Pt with new onset bradycardia with HR down to high 20s/30s-40s on tele starting 3/4 with concern for some contribution from her steroids. Echo 3/4 with LVEF 65%, no effusion or wall motion abnormality, but some poor windows. Consulted EP cardiology- briefly reviewed tele 3/5 and noted sinus bradycardia with some escape beats. Given pt remained stable. Stated no current need for intervention. Once clinically improved from her COVID, could consider transfer for EP evaluation for possible pacemaker. However, patient went into new A fib with ongoing bradycardia. Cardiology consulted and recommended transfer on 3/6 for more urgent EP consultation and evaluation for pacemaker. EP evaluated the patient, ultimately placed pacemaker on 3/9. She was started on daily metoprolol XL, and recommended to follow up in EP clinic, appointment made for 3/15. Patient also had some mild hyponatremia at admission, which resolved with gentle IV fluids (NS at 100 ml/hr). Her electrolytes were monitored and supplemented as needed. She had worsening altered mental status/metabolic encephalopathy. UA ordered at admission but not obtained until 3/4: noted large LE, 55 WBC, 13 RBC, many bacteria. Urine cx 3/4 now growing >100k E coli. Patient completed 5 days of ceftriaxone and her mentation remained at baseline thereafter. PT/OT evaluated and recommended discharge back home to assisted living with assistance, HHC, PT/OT. Pt had planned discharge on 3/9 but unfortunately was orthostatic with standing/ambulation. BB was discontinued and ted hose applied. Patient felt improved and ready for discharge back to assisted living on 3/10. Home oxygen set up and family provided transport.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hyperlipidemia History of breast cancer Depression Type 2 diabetes mellitus without complication Hypercalcemia Low-tension glaucoma of right eye, moderate stage Low-tension glaucoma of left eye, severe stage Acute respiratory failure with hypoxia COVID-19 virus infection Atrial fibrillation Bradycardia Sinoatrial node dysfunction
Andere Medikamente: aspirin 162 MG EC tablet atorvastatin (LIPITOR) 10 MG tablet citalopram (CELEXA) 20 MG tablet dexamethasone (DECADRON) 6 MG tablet diclofenac sodium 1 % gel estradiol (ESTRACE) 0.1 MG/GM vaginal cream latanoprost (XALATAN) 0.005 % ophthalmi
Allergien: Norco [Hydrocodone-acetaminophen]Nausea and Vomiting Niacin Penicillins Simvastatin Statins
Vorherige Impfungen: -

VAERS 2594689

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: MI
Alter: 90,0
Geschlecht: M
Eingang: 10.03.2023
Impfdatum: 22.09.2022
Beginn: 02.03.2023
Tage bis Beginn: 161,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Anticoagulant therapy Anticoagulation drug level below therapeutic Aortic dilatation Aortic valve thickening Asthenia Blood electrolytes normal Blood glucose abnormal Bradycardia C-reactive protein increased COVID-19 COVID-19 pneumonia Cardiomegaly Chest X-ray abnormal Dyspnoea Echocardiogram abnormal Ejection fraction Electrocardiogram T wave abnormal

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/2/2023 Discharge Date: Mar 7, 2023 PRESENTING PROBLEM: Hypoxia [R09.02] Acute hypoxemic respiratory failure [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: 91 y.o. male with hx of HTN, HLD, DM2, A flutter on coumadin, chronic LE edema w/o hx of heart failure who presented to the ER secondary to shortness of breath. He resides at an assisted living facility. There has been an outbreak of COVID-19 infection among the residents the past week. The day prior to presentation, he tested positive for COVID-19. Since then, he had been feeling extremely weak and the day of diagnosis, he had a ground level fall without injury. This morning, he was noted by the staff to be extremely weak and became hypoxic with O2 sats in the mid 80s. At that point, the facility decided to send him to the hospital for evaluation. History of atrial flutter, chronically anticoagulated with Coumadin. He is hard of hearing and ambulates using a walker. No reported fever/chills, nausea/vomiting, chest or abdominal pains. Upon arrival to the ER, the patient was hypoxic with O2 sats down to 88% but afebrile. Lab workup showed stable electrolytes, complete blood count and renal function. INR was subtherapeutic at 1.4. COVID screen was positive. Chest x-ray showed bilateral airspace disease consistent with infectious etiology/pneumonia and cardiomegaly noted. In the ER, he was started on Decadron. The patient was admitted to the hospital medicine service with acute hypoxic respiratory failure secondary to COVID-19 pneumonia. Patient continued on PO decadron and started remdesivir. He required up to 2L supplemental O2 via NC, but was able to wean back to room air on 3/5 and remained stable since that time. Checked d-dimer and bilateral LE doppler US given LE edema and subtherapeutic warfarin. D-dimer not elevated (400->360->190) and elevated CRP was down trending (32.9->->10.6). LE doppler US negative for DVT (although difficult to visualize some calf pains due to edema). Patient was also noted to have mild cardiomegaly/pulmonary edema on initial CXR. No known history of heart failure, but notes worsening LE edema over the past 6 months. Last echo 11/2021 with LVEF 66%, normal diastolic function, diffuse thickening of the aortic valve w/o stenosis. NT-Pro BNP 1221 (wnl, no prior to compare). Repeat echo was obtained 3/4 and noted LVEF 55%, RA/RV severely dilated with moderately decreased RV function and mod to severe TR, no pericardial effusion. LE edema slowly improved with only leg elevation. Ordered Ted hose for compression. Given mod-severe TR could consider further work up in the outpatient setting depending on goals of care. Patient continued on home warfarin for his A flutter, but also started on Lovenox bridge as levels remained subtherapeutic. On day of DC INR was 1.7 and patient will be Dced on home warfarin dosing with INR check in 1-2 days. Pt also became bradycardic after steroids started and required holding of his home Cardizem. EKG obtained 3/4 with junctional bradycardia and non-specific t wave changes. Decadron was discontinued 3/6 given improved respiratory status and worsening hyperglycemia and bradycardia. Patient's HR and glucose levels gradually improved. Zio patch ordered on DC to monitor rate off of the cardizem to ensure rates reasonably controlled. PT/OT evaluated and recommended return to home with assist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Typical atrial flutter Hypertension associated with diabetes Hereditary sensory motor neuropathy Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin Chronic anticoagulation Lower extremity edema Acute hypoxemic respiratory failure
Andere Medikamente: atorvastatin (LIPITOR) 10 MG tablet Elastic Bandages & Supports (MEDICAL COMPRESSION SOCKS) MISC furosemide (LASIX) 20 MG tablet furosemide (LASIX) 20 MG tablet lisinopril (PRINIVIL,ZESTRIL) 5 MG tablet metFORMIN (GLUCOPHAGE) 1000 MG table
Allergien: None
Vorherige Impfungen: -

VAERS 2586343

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: KY
Alter: 56,0
Geschlecht: M
Eingang: 23.02.2023
Impfdatum: 21.10.2022
Beginn: 22.12.2022
Tage bis Beginn: 62,0
Dosis: 4
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

PATIENT EXPIRED ON 12/22/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: COPD COAL WORKER PNEUMOCONIOSIS
Andere Medikamente: UNKNOWN
Allergien: UNKNOWN
Vorherige Impfungen: -

VAERS 2584078

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: -
Alter: 65,0
Geschlecht: M
Eingang: 19.02.2023
Impfdatum: 19.09.2022
Beginn: 26.01.2023
Tage bis Beginn: 129,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Anaemia Angiogram pulmonary abnormal Aspergillus test negative Blood culture negative Blood immunoglobulin A decreased Blood immunoglobulin G decreased Blood immunoglobulin M decreased Blood pressure abnormal COVID-19 Computerised tomogram neck Computerised tomogram thorax abnormal Cough Dyspnoea Fatigue Fungal disease carrier Fungal test negative Hypogammaglobulinaemia

Symptomtext

Patient is a 66 y.o. male with history of mantle cell lymphoma (s/p chemo/XRT in remission), NICM, recent COVID infection (end of December) who presented from home on 1/25/2023 with worsening shortness of breath, fatigue, hypoxia and cough. CT Chest reveals bibasilar patchy opacities on admit. He continues to have symptoms related to COVID-19 infection and superimposed bacterial pneumonia. He is undergoing treatment with antimicrobials as well as COVID specific therapies. He had significant improvement and is discharged home in stable condition on 1/31/2023. Acute Hypoxemic Respiratory Failure Abnormal CT chest - Most likely etiology COVID; recent COVID (sx began 12/31) and cycle threshold elevated this admit still suggesting active virus - Consider also superimposed bacterial pneumonia and fungal etiologies less likely. SLP performed MBS and was negative for aspiration. - CTPA on admit with bibasilar patchy opacities, no PE. - Blood cx NGTD (though obtained after abx started) Strep and Legionella urine Ag negative. MRSA probe negative. Fungitell and Aspergillus negative. Histo and blasto pending. - Sputum Culture with heavy growth yeast; however patient without evidence of invasive fungal infection; will hold off additional fungal therapy, suspect this is colonization - Required 2 L NC on admit and has since been weaned to room air. - Pulmonology and ID followed- Cefepime completed treatment with total 5 day course of abx for CAP (stop 1/30). Dexamethasone 10 day course planned for COVID. Remdesivir started 1/27 for total 5 days. -Repeat CT chest in 4-6 weeks for resolution per pulm COVID-19 Infection - Tested positive for COVID end of Dec 2022 and received paxlovid. Previously received Evusheld in Oct 2022. - ID following, cycle threshold consistent with active viral infection so started remdesivir and dexamethasone. - The patient completed 5 days of Remdesivir. He will complete 4 more days of dexamethasone on discharge for total 10 days of treatment Laryngitis Cough - Secondary to COVID - CT soft tissue neck w/contrast negative for lymphadenopathy or soft tissue mass - Slowly improving with scheduled hycodan syrup and robitussin-DM, hypertonic saline nebs, prn magic mouthwash. Hypogammaglobulinemia - Rechecked IG levels here which were low- IgG 407, IgM 19, IgA 80. No history of frequent infections in the past. - Heme/Onc consulted for evaluation for benefit of immune globulin therapy due to refractory sinupulmonary infection. Oncologist here evaluated and patient discussed with his prior oncologist who was in favor of IVIG, confirmed with Dr and low dose 400 mg/kg x 1 administered on 1/30 History of Mantle Cell Lymphoma - Follows with Dr., treated with chemo and XRT in mid 2000s and most recently CAR-T cell therapy in 2020. - Follow up outpatient with Dr. Mild leukopenia and anemia - Likely secondary to acute infection above - no evidence of active infection - Monitor CBC Chemotherapy Induced Nonischemic Cardiomyopathy - Per history, secondary to chemotherapy. Euvolemic on exam - TTE 03/2021 with LVEF 55-60% and mild diastolic dysfunction - Restarted home Coreg at lower dose (discussed with patient and his BP is usually in 90s systolic). Continue to hold ramipril while hospitalized, okay to resume on discharge and patient instructed to monitor BP and hold if SBP under 100 Chemotherapy Induced Cognitive Impairment - Currently alert, oriented, able to discuss medical condition and history. - Continue home memantine and wellbutrin CAD - Continue ASA HLD - Continue home statin GERD - Continue home nexium BPH - alfuzosin initially held due to soft pressures, resumed on discharge

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2579741

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: WI
Alter: 93,0
Geschlecht: F
Eingang: 10.02.2023
Impfdatum: 05.10.2022
Beginn: 29.11.2022
Tage bis Beginn: 55,0
Dosis: 4
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Cardiac failure Chest X-ray normal Condition aggravated Death Hypokalaemia Hypotension Hypovolaemia Imaging procedure Lactic acidosis Mental status changes Positive airway pressure therapy Pulmonary hypertension SARS-CoV-2 test positive Tachypnoea

Symptomtext

Presented to ED on 11/29/2022 with presented with acute onset altered mental status and acute hypoxemic respiratory failure requiring BiPAP in the emergency department. Imaging studies did not have any signs of consolidation concerning for additional consolidative pneumonia. Significantly elevated BNP with a history of known diastolic dysfunction concerning for possible volume overload. Point-of-care ultrasound the emergency department was showing minimal B-lines, however chest x-ray did not show any significant volume overload. The patient was also noted to have a lactic acidosis in the setting of hypotension and presumed hypovolemia with improvement in blood pressure with fluids, pointing against significant pulmonary edema. Tachypnea and hypokalemia were noted Patient died on 12/3/2022 Immediate Cause: Acute Hypoxic Respiratory Failure Due to or as a consequence of: Covid Pneumonia, Possible Bacterial Pneumonia, HFPEF Other Significant Conditions contributing to death: pulmonary HTN, altered mental status, HX CVA Submitter does not have access to further medical records. If additional information is needed, please contact Hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: 11/29/2022 Covid-19 positive
Aktuelle Erkrankungen: unknown
Vorgeschichte: essential hypertension, pulmonary hypertension, hyperlipidemia and hypothyroidism
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2548861

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: WV
Alter: 66,0
Geschlecht: M
Eingang: 03.01.2023
Impfdatum: 29.12.2022
Beginn: 30.12.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypoxia Pulse absent Respiratory arrest Somnolence

Symptomtext

drowsy, hypoxemia 12/30/2022 1328, 12/31/22 0505 without pulse or respiration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory arrest
Hospital-Tage: -
Labordaten: No tests or laboratory results
Aktuelle Erkrankungen: condition decline
Vorgeschichte: Spinal stenosis, HTN, OA, obstructive uropathy, congenital hypertonia, BPH, hyperlipidemia
Andere Medikamente: Amitriptyline HCl Tablet 100 MG, Colace Oral Capsule 100 MG, Lactulose Oral Solution 10gm/15ml GM/15ML , Linzess Oral Capsule 290 MCG, Lipitor Oral Tablet 80 MG, Loratadine Oral Tablet 10 MG, LORazepam Oral Tablet 0.5 MG, Lyrica Oral Capsul
Allergien: NKA
Vorherige Impfungen: -

VAERS 2543600

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: OH
Alter: 78,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 23.09.2022
Beginn: 01.12.2022
Tage bis Beginn: 69,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test Hypersomnia Influenza virus test negative Intensive care Laboratory test Lethargy Malaise Pneumonia Respiratory syncytial virus test negative SARS-CoV-2 test negative Septic shock

Symptomtext

Starting in the beginning of December 2022, he continued to get sick and was getting so bad that I took him to the local clinic and they did a bunch of tests to rule out RSV, COVID-19 and the flu but all were negative. When they did his oxygen level it was in the 70s so they rushed him to a local hospital. He was admitted into the hospital in the ICU where he was being treated for heart failure (which he didn't have). After some intervention from our son who is a doctor, he was accurately treated for pneumonia and septic shock. He was kept in the hospital for 9 days. He was discharged 9 days prior to the December holiday. As of now, he is still very lethargic and sleeping all day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Septic shock
Hospital-Tage: 9,0
Labordaten: Tests at a clinic: Ruled out RSV, COVID-19 and the flu; Numerous blood tests in the hospital when admitted
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure; hx of Open Heart surgery
Andere Medikamente: Iron; vitamin C; metoprolol; ELIQUIS; allopurinol; lisinopril; diltiazem; omeprazole; pravastatin; metformin; vitamin D3; baby aspirin; magnesium; MUCINEX; vitamin B12
Allergien: None
Vorherige Impfungen: -

VAERS 2536604

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: OK
Alter: 49,0
Geschlecht: F
Eingang: 19.12.2022
Impfdatum: 09.09.2022
Beginn: 28.11.2022
Tage bis Beginn: 80,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Back pain Chest pain Coronary arterial stent insertion Myocardial infarction Troponin

Symptomtext

On 11/24/2022 I started having back and chest pain that came and went for 2 days. On 11/28/2022 I again started having chest and back pain. I went to the ER and was diagnosed with a myocardial infarction. I had a stent placed in the mid LAD.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 3,0
Labordaten: 11/28/2022 troponin 1.16
Aktuelle Erkrankungen: NA
Vorgeschichte: Hypertension, Obesity
Andere Medikamente: Diltiazem, Prempro, Trazodone, Ozempic, benadryl, buspar
Allergien: Codeine, Lortab
Vorherige Impfungen: -

VAERS 2488712

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: ID
Alter: 78,0
Geschlecht: F
Eingang: 25.10.2022
Impfdatum: 18.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram cerebral abnormal Arteriogram carotid abnormal Cerebral infarction Cerebrovascular accident Computerised tomogram abdomen Computerised tomogram thorax Cytotoxic oedema Echocardiogram Intracranial aneurysm Intracranial mass Laboratory test Magnetic resonance imaging head abnormal Spinal nerve stimulator implantation Vasogenic cerebral oedema

Symptomtext

Admit 10/24/22 with stroke. Symptoms started 10/20/22. Stopped warfarin 10/22/22 for spine stimulator placement. CTA showed large right MCA stroke and large distal ICA cavernous saccular aneurysm. Subsequent brain MRI shows a right MCA mass, concerning for malignancy. Currently on decadron. Still hospitalized.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: CTA head and neck: 1. Findings consistent with subacute right MCA territory infarct involving a large portion of the right parietal lobe and a small portion of the right posterior frontal lobe. This has associated cytotoxic edema but no hemorrhagic conversion. No midline shift. 2. Large right distal ICA cavernous portion saccular aneurysm measuring up to 1.3 x 1.2 x 1.0 cm on 3-D rendering with a 0.4 cm neck Brain MRI: Rim-enhancing lesion in the right frontal lobe with significant surrounding vasogenic edema extending into the frontal and parietal lobes. Leading differential considerations or solitary metastasis or primary brain tumor (such as astrocytoma or other glial neuronal tumor). In the appropriate clinical setting, a brain abscess would also have similar imaging characteristics. Labs Echo and CT chest, abdomen, and pelvis pending
Aktuelle Erkrankungen: -
Vorgeschichte: ? Asthma ? Atrial fibrillation ? Brain aneurysm ? CKD (chronic kidney disease) ? Colon polyp 07/2014 splenic flexure, villous adenoma multifocal HGD ? Colon polyp 10/2015 adenoma ? COPD (chronic obstructive pulmonary disease) ? Diabetes mellitus, type 2 02/2018 ? Diverticulosis ? GERD (gastroesophageal reflux disease) ? Hyperlipidemia ? Hypertension ? Hypothyroidism ? Osteoarthritis ? PONV (postoperative nausea and vomiting) ? Sleep apnea ? Stroke 2015 right leg deficit ? Type 2 diabetes mellitus with stage 3 chronic kidney disease, without long-term current use of insulin Mixed systolic and diastolic heart failure Chronic pain
Andere Medikamente: ? albuterol (PROVENTIL HFA;VENTOLIN HFA) 90 mcg/actuation inhaler Inhale 1-2 puffs into the lungs every 4 to 6 hours as needed for Wheezing ? allopurinoL (ZYLOPRIM) 100 MG tablet Take 2 tablets (200 mg total) by mouth Daily. ? baclofen (LI
Allergien: ? Peanuts [Peanut] Swelling ? Strawberry Swelling All seeded berries. ? Tree Nuts Swelling ? Trilyte With Flavor Packets [Peg-Electrolyte Soln] Nausea And Vomiting Severe reflux, nausea, vomiting, this lasts for several days after taking. ? Venom-Honey Bee Swelling ? Iodine Other (See Comments) Passes out Both IV and topical ? Shellfish Containing Products Other (See Comments) Passes out ? Hydromorphone Other (See Comments) Hallucinations ? Cephalexin Other (See Comments) Pt not sure of reaction ? Penicillin Rash
Vorherige Impfungen: -

VAERS 2477925

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: MD
Alter: 58,0
Geschlecht: F
Eingang: 13.10.2022
Impfdatum: 13.09.2022
Beginn: 07.10.2022
Tage bis Beginn: 24,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Acute myocardial infarction Alanine aminotransferase normal Aortic dilatation Arteriogram coronary normal Bed rest Blood cholesterol normal Blood magnesium normal Blood test abnormal Blood thyroid stimulating hormone decreased Blood triglycerides normal Cardiac ventriculogram left normal Catheterisation cardiac normal Chest X-ray normal Chest discomfort Chest pain Differential white blood cell count normal Echocardiogram

Symptomtext

Hospitalized on 10/7/22 for what seemed to be heart attack symptoms (chest pressure and left arm oddness; EKG and chest x-rays clear but a comprehensive metabolic panel showed a slight rise in alanine amino (34) and chest heaviness continued. At first troponin levels were less than 0.01 but another test after a couple of hours showed troponin levels had risen to 0.07. Patient was admitted for weekend observation and continued blood tests showed rising troponin levels progressing upward to a peak of 1.49 after 36 hours of bed rest. A cardiac catheterization was scheduled for Monday. Chest pains had stopped but it was assumed the patient experienced an NSTEMI. Cardiac catheterization on Monday 10/10/23 showed no blockage in the heart, and, as troponin levels had peaked and were declining, the diagnosis became myocarditis, possibly caused by a recent COVID-19 vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 3,0
Labordaten: ECG 12-lead (borderline abnormal); comprehensive metabolic panel (alanine amino 34); CBC with auto differential (normal); hemoglobin A1C (5.6); d-dimer quantitative (0.27); CBC with auto differential (normal); troponin (<0.01); lipase (62); magnesium (2.1); APTT (21.7); prothrombin time + INR (10.3); XR chest AP only (normal); COVID-19 test (no RNA detected); TSH (1.57); lipid panel (cholesterol 159 mg/dL; triglycerides 90 mg/dL; HDL 50 mg/dL; LDL 91 mg/dL; non-HDL 109 mg/dL; total Chol/HDL ratio = 3.2); troponin (0.07); troponin (0.18); ECG 12-lead (abnormal - normal sinus rhytm, non-specific ST abnormality); troponin (0.27); echo tranthoracic complete TTE (indications of myocardial infarction - left ventrical estimated EF: 60% - grade 1 left ventrical diastolic dysfunction - ascending aorta mildly dilated); troponin (1.49); troponin (0.81); CBC without differential (all categories within normal ranges); comprehensive metabolic panel (alanine amino trans 36); cardiac catheterization (angiographic results: left dominant circulation; normal coronary angiography; normal left ventriculography - estimated ejection fraction is 60%; hemodynamic results: left entricular pressure - 143/32 mmHg; aortic pressure 144/89, mean 113 mmHg)
Aktuelle Erkrankungen: cold with persistent cough
Vorgeschichte: -
Andere Medikamente: Lisinopril 5 mg; Atorvastatin 10 mg; Azithromycin 250 mg; multivitamin (2x day)
Allergien: -
Vorherige Impfungen: -

VAERS 2471918

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

kritisch

Staat: MN
Alter: 68,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 21.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 8,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic shock Blood test Influenza virus test negative Lip swelling SARS-CoV-2 test negative Urticaria

Symptomtext

One week after the vaccination, on 9/29/2022, in the morning I broke out in hives from head to toe. I had 2 urgent care visits and I ended up in the emergency room on 10/1/2022. I had anaphylaxis shock. My lips were swelling. I was given Intravenous prednisone and Benadryl. I was in the emergency room for about 4 hours. The hives were gone by Sunday night, 10/2/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic shock
Hospital-Tage: -
Labordaten: 10/1/22 blood work 10/1/22 COVID 19 test - negative 10/1/22 Flu test - negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: high blood pressure; high cholesterol
Andere Medikamente: Lisinopril; Rosuvastatin; vitamins; fish oil
Allergien: oysters
Vorherige Impfungen: -

VAERS 2456761

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge As7148B

kritisch

Staat: TX
Alter: 46,0
Geschlecht: M
Eingang: 23.09.2022
Impfdatum: 14.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chills Death Fatigue Pain

Symptomtext

Provider was contacted by third party claiming to be family member of patient stating the day after vaccination, on September 15, 2022, patient complained of fatigue, chills and body aches. Later that same day patient was found deceased in his car. Cause of death is unknown to Provider at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2673540

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: FL
Alter: 86,0
Geschlecht: F
Eingang: 18.08.2023
Impfdatum: 14.09.2022
Beginn: 14.07.2023
Tage bis Beginn: 303,0
Dosis: 3
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Syncope

Symptomtext

7/14/2023 - 7/18/2023 (4 days) presented to emergency room with syncopal episode remdesivir IV/Decadron IV 013M20A 3/3/2021 035C21A 11/3/2021 AS7148B 9/14/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2650516

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

schwer

Staat: -
Alter: 59,0
Geschlecht: F
Eingang: 28.06.2023
Impfdatum: 14.09.2022
Beginn: 27.03.2023
Tage bis Beginn: 194,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Deep vein thrombosis Diverticulum intestinal

Symptomtext

ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 4/1/2023 DIVERTICULOSIS OF SIGMOID ACUTE DVT OF BILAT LEGS, UNSPECIFIED VEINS 4/1/2023 ABDOMINAL PAIN

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2608537

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: CA
Alter: 74,0
Geschlecht: F
Eingang: 03.04.2023
Impfdatum: 21.09.2022
Beginn: 11.12.2022
Tage bis Beginn: 81,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Body temperature decreased Chest X-ray abnormal Cough Haemoptysis Influenza virus test negative Pneumonia Positive airway pressure therapy Pulmonary oedema Respiratory syncytial virus test negative SARS-CoV-2 test negative Urinary tract infection Urine analysis abnormal

Symptomtext

On December 11, 2022 started having a cough, then a cough with blood and body temperature dropped to 86 degrees. Went to the emergency room and was admitted. Given a Chest X-ray and showed she had fluid in her lungs and was diagnosed with Pneumonia. Given a UTI test and was also positive. Tested for COVID-19 test and was negative. Was given antibiotics through IV and hospitalized for 10 days. Given Bi-pap treatments and Oxygen. Still on Oxygen at night. In Hospice.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 10,0
Labordaten: 18DEC2022 Chest X-ray, UTI test, positive; 18DEC2022 Influenza, RSV, COVID-19, negative.
Aktuelle Erkrankungen: Possible UTI
Vorgeschichte: Multiple Sclerosis; Asthma; High Blood Pressure; Hyperthyroidism.
Andere Medikamente: Baclofen; hydrochlorothiazide; azathioprine; esomeprazole magnesium; latanoprost eye drops; ADVAIR inhaler; trazadone; potassium cler; aspirin; docusate sodium; sennoside laxative; atorvastatin; amlodipine; levothyroxine; sulfamethoxazole;
Allergien: Penicillin.
Vorherige Impfungen: -

VAERS 2601685

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: OH
Alter: 68,0
Geschlecht: M
Eingang: 22.03.2023
Impfdatum: 20.09.2022
Beginn: 01.03.2023
Tage bis Beginn: 162,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Flushing Heart rate irregular Laboratory test normal No adverse event Syncope

Symptomtext

I did not have an adverse reaction to the vaccine. I had an irregular heartbeat, intense flushing and I almost fainted at rest in 03/2023. I contacted my doctor, and they directed me to the emergency room for observation. I went through multiply test all in normal range. At this time, I am waiting for results from another test before seeing a cardiologist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Tamsulosin; Pravastatin; Vitamin B12; Vitamin C; Garlic; Vitamin D
Allergien: N/A
Vorherige Impfungen: -

VAERS 2536868

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: CA
Alter: 63,0
Geschlecht: M
Eingang: 19.12.2022
Impfdatum: 10.09.2022
Beginn: 11.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diplopia Dizziness Memory impairment Seizure Transient ischaemic attack

Symptomtext

TIA/Seizure 2 days later. Extreme dizziness, diplopia and memory problems still persists. Had before due to brain stem surgery in 2018, now progressively worse since the TIA.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Moyamoya
Vorgeschichte: Cavernous Angioma
Andere Medikamente: Atorvastatin, Tadalafil
Allergien: Vimpat
Vorherige Impfungen: -

VAERS 2499100

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 04.11.2022
Impfdatum: 22.09.2022
Beginn: 21.10.2022
Tage bis Beginn: 29,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary abnormal Asthenia Atrial fibrillation COVID-19 Chest X-ray abnormal Chest tube insertion Chronic obstructive pulmonary disease Claustrophobia Condition aggravated Cough Dysphagia Dyspnoea Emphysema Fatigue Intensive care Lung disorder Lung infiltration Medical diet

Symptomtext

Admission Date: 10/21/2022 Discharge Date: Nov 2, 2022 Discharge Provider: MD Primary Care Provider: MD PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) HOSPITAL COURSE: Patient is a 72 year old with COPD, tobacco / alcohol abuse, HTN, CKDIIIb, hyperparathyroidism, GERD, and distant prior partial gastrectomy due to stomach tumor. She presented 10/21 with weeks of generalized weakness, fatigue, dyspnea, and nonproductive cough, progressive despite completing 8 of 10 days of outpatient Augmentin and 7 days of Prednisone. CTA chest showed extensive RLL endobronchial debris and infiltrate, moderate-severe upper lobe predominant emphysema, no PE. She was COVID-19 (+) but imaging was more concerning for aspiration pneumonia for which SLP was consulted (bedside eval showed oropharyngeal dysphagia, VFSS was unable to be completed). Sputum from 10/22 actually grew many Serratia / PsA (antibiotics changed to Cefepime pending sensitivities). On 10/23, she was moved to ICU with respiratory distress requiring BiPAP. Precedex was needed due to claustrophobia. By 10/24, she was able to wean down to nasal cannula but AM CXR showed moderate right PTX. IR placed chest tube. Later on 10/24, she developed rapid Atrial fib for which Amio gtt / enteral Lopressor was started. Lopressor was titrated and she converted to NSR 10/25, amiodarone discontinued. VFSS 10/25 showed large CP bar versus Zenker's diverticulum with associated significant esophageal retention - dysphagia diet / swallow strategies initiated. She was transferred out of the intensive care unit and did well. Discharge was delayed while waiting for pneumothorax to resolve and her chest tube was ultimately discontinued on 11/01. Repeat chest x-ray today showed no recurrence of pneumothorax. She continued to require 4 L of oxygen and the patient was discharged home. Home oxygen was arranged. She will continue with the prednisone taper

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: 10/21/2022 Pt is a otherwise healthy 72 y.o. female presenting to the UC with difficulty breathing. HPI: Significant pulmonary history, chronic obstructive pulmonary disease. Is not immunocompromised. Is not a smoker. The patient reports: Upper respiratory infection symptoms since the 1st week of October. Has been treated by PCP with steroids and Augmentin. Chest x-ray on showing chronic signs of emphysema otherwise no consolidation or acute disease. Difficulty breathing has been progressive significantly over the past few days. 5 mg prednisone and maintenance inhalers today. No nebulizer oxygen at home. She denies any fever, myalgias, chest pain, abdominal pain, diaphoresis, or nausea vomiting. ASSESSMENT/PLAN 1.Diagnoses and all orders for this visit: COPD with acute exacerbation (HCC) - predniSONE (DELTASONE) tablet 60 mg - ipratropium-albuterol (DUO-NEB) 0.5-2.5 (3) MG/3ML nebulizer solution 3 mL 2. Chronic obstructive pulmonary disease exacerbation was discussed with the patient. Recommending ambulance, both herself and husband feel private vehicle is appropriate. She was given 60 mg prednisone as well as a DuoNeb here in the urgent care. She is placed on 2 L O2 nasal cannula, oxygen saturation 93% and resolved tachypnea. She is brought to vehicle via wheelchair and discharge in stable condition. Medical decision making: Symptomatic care provided. Likely needing admission. Electrocardiogram not obtained, clinical picture of pulmonary involvement only at this time. Due to underlying chronic obstructive pulmonary disease, acute pulmonary embolism possible became be addressed with further evaluation and management and emergency department. 3. The following items were considered and discussed with the patient at today's visit: ? Today's diagnosis ? Any medication/s prescribed ? Follow up care 4. Condition at discharge: stable and improved 5. Follow Up Instructions: Follow Up: Go to Hospital ED for Evaluation as soon as possible When: Immediately 10/11/2022 Office visit at Clinic Patient is a 72 y.o. female is here today with concern regarding 5 day history of cough with green sputum and dyspnea. She is using her albuterol more often, but states this is not helping much. States her husband had similar sx. Denies f/c. Weight is stable Assessment: 1. Lower resp. tract infection amoxicillin-clavulanate (AUGMENTIN) 875-125 mg per tablet predniSONE (DELTASONE) 20 mg tablet XR CHEST 2 VIEW IMPRESSION 1. No acute abnormalities in the chest. 2. Findings suggestive of emphysema
Vorgeschichte: Acute respiratory failure with hypoxia (HCC) Chronic obstructive pulmonary disease with acute exacerbation (HCC) Secondary spontaneous pneumothorax Essential hypertension Atrial fibrillation (HCC) Unspecified severe protein-calorie malnutrition (HCC) Infection due to Serratia marcescens AKI (acute kidney injury) (HCC) Tobacco use Alcohol abuse Peripheral edema
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amLODIPine (NORVASC) 5 MG tablet benzonatate (TESSALON) 100 MG capsule Biotin 5000 MCG TABS budesonide/formoterol (SYMBICORT) 160-4.5 MCG/ACT inhaler cit
Allergien: NKA
Vorherige Impfungen: -

VAERS 2484160

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 20.10.2022
Impfdatum: 27.09.2022
Beginn: 12.10.2022
Tage bis Beginn: 15,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Asthenia Balance disorder Blood pressure increased Blood test abnormal Computerised tomogram Computerised tomogram head Computerised tomogram neck Consciousness fluctuating Dizziness Electrocardiogram Fall Feeling abnormal Feeling hot Headache Heart rate decreased Nausea Oxygen saturation decreased

Symptomtext

She got her vaccine, the next day she had soreness in the arm when the shot was given, a little warm. She started with mild headaches, which put if off as to what it might be. On 10/8/22 she started getting reaction where she was near fainting, BP spiking. She called her daughter and then it went in waves. On 10/12/22 she woke up and felt that she was better, and fed her fish and birds and then had shaking weakness and her BP was 200's/110. She tried to get up to use the bathroom, stood up and fell backwards into the recliner. Her husband took her to the ER. They did a CT scan, EKG, blood work, urine specimen and the only thing they found was high BP which was 229/107, oxygen kept dropping off and her heart rate was very slow. She was in and out of it due to weakness. They did give her a bunch of medicines which did bring her BP down. They gave her Diphenhydramine, Metoclopramide HCI, Famotidine 20 mg, Lorazepam 1 mg all IV. Her blood work was abnormal, did a COVID test, Lohxol 100 ml, sodium chloride 10 ml, then again 100 ml. She had a CT scan of head with contrast and neck and then was discharged. At home she was put on anti-nausea Metoclopramide 4 times a day for nausea. She went to Hospital. She went to bed when she came home as she was knocked out and still felt funky the next day and it started getting worse again. She called and they told her to call and report it to us. She has anxiety and off balance/dizziness. They did not find anything to hold her or admit her, and told her to FU with her PCP. She then had an itchy skin rash that formed on her left wrist, left hip and starting on the right side of her stomach. It is a rough patch on the skin at each location, not deep red, but the skin looks different and itches worse than a mosquito bite. She monitors her BP every day, but it is still fluctuating up and down.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: EKG, blood work, CT scan with contrast, urine specimen.
Aktuelle Erkrankungen: None.
Vorgeschichte: Thyroid cancer with removal in 2002, high blood pressure, anxiety.
Andere Medikamente: Levothyroxine 150 mcg, Carvedilol 12.5 mg twice a day, Lisinopril 20 mg, Vitamin D every other day, Clonazepam 0.5 mg
Allergien: None.
Vorherige Impfungen: -

VAERS 2473452

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 10.10.2022
Impfdatum: 01.10.2022
Beginn: 08.10.2022
Tage bis Beginn: 7,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Bradycardia COVID-19 Dizziness SARS-CoV-2 test positive Syncope

Symptomtext

Pt transferred from outside hospital due to episodes of bradycardia. He presented with syncope and dizziness. He was found to be COVID positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2472478

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: -
Alter: 25,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 05.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Eyelid function disorder Facial asymmetry Facial paralysis

Symptomtext

Bell's Palsy left facial paralysis (mild) starting 1 day after vaccine. Asymmetry of smile and closing Left eye

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2466620

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: TX
Alter: 63,0
Geschlecht: F
Eingang: 01.10.2022
Impfdatum: 23.09.2022
Beginn: 24.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy Atrial fibrillation Cardiogenic shock Dyspepsia Echocardiogram Electrocardiogram abnormal Flatulence Heart rate increased Palpitations

Symptomtext

I was watching TV and I felt like I had indigestion/gas. My Watch alerted me that my heart rate had been high (over 125) for ten minutes. It continued to climb and my husband took me to a stand alone ER where they did an EKG and determined that I was experiencing atrial fibrillation. They started an IV of a medication designed to convert my heart back to normal sinus rhythm and administered an injection of a blood thinner into my abdomen. After more than an hour, my heart was still racing and I was still experiencing atrial fibrillation, so they found a hospital with an available bed and I was transported via ambulance. There, they continued to monitor my condition to determine if it would be necessary to sedate me and shock my heart, but at around 4:30 AM my heart returned to normal sinus rhythm. They weaned me off the IV medication and did an echocardiogram of my heart. I was released in the early afternoon. I have never had atrial fibrillation before this and I haven?t had a return of symptoms since leaving the hospital. I followed up with a Cardiologist and she said the echocardiogram the hospital performed and sent to her looked normal. She could not say for sure that this incident was caused by the vaccines, but cautioned me not to take two vaccines together in the future. I felt it was worth reporting and she agreed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiogenic shock
Hospital-Tage: -
Labordaten: EKG and echocardiogram
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroidism
Andere Medikamente: Armour Thyroid, DHEA, multivitamins, Elderberry/Vitamin C, Vitamin D
Allergien: Gluten allergy
Vorherige Impfungen: -

VAERS 2454720

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge As7148b

schwer

Staat: KY
Alter: 30,0
Geschlecht: F
Eingang: 22.09.2022
Impfdatum: 21.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chromaturia Disorientation Dizziness Ear pain Headache Loss of consciousness Nausea Pain in extremity Pharyngeal swelling Restlessness Urinary incontinence

Symptomtext

Five minutes after I receive the shot, my arm started to hurt really bad which has never happened before. Started to pass out as I was driving home. Was able to pull over before completely losing consciousness. When I woke up I had urinated myself and was very disoriented. I was very restless the rest of the day. Very dizzy and nauseous with a severe headache and sharp right ear pain throughout the day/night. The following morning my pee was very amber which has also never happened before, but cleared up as the day went on. My throat felt swollen as well. I have never had a reaction like this to any vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: I do not have health insurance and cannot afford to go to get tests done or get a check up.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: I take Spironolact 100mg at night for to help prevent acne.
Allergien: None
Vorherige Impfungen: -

VAERS 2450847

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: MN
Alter: 20,0
Geschlecht: F
Eingang: 19.09.2022
Impfdatum: 18.09.2022
Beginn: 18.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Nausea Syncope Vomiting

Symptomtext

Vasovagal syncope with nausea and vomiting. Resolved with time. Parents present and took daughter home once stable and feeling fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2448054

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: OH
Alter: 30,0
Geschlecht: M
Eingang: 16.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood pressure decreased Dizziness Eye movement disorder Hyperhidrosis Presyncope

Symptomtext

Vaso vagal Reaction - patient started feeling dizzy, rolled back eyes, sweats on for head. Blood pressure drop to 80/60. Pulse 62, O2 SAT 99.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: Amphetamines
Vorherige Impfungen: Vaso vagal

VAERS 2447745

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: OR
Alter: 68,0
Geschlecht: M
Eingang: 16.09.2022
Impfdatum: 11.09.2022
Beginn: 11.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Fall Fatigue Hypophagia Loss of consciousness Nausea Pyrexia Unresponsive to stimuli

Symptomtext

Developed febrile reaction to vaccine in early afternoon day of vaccine. Maintained hydration throughout day. Developed nausea through day but had small dinner. At 11:10 went to bathroom to take acetaminophen for fever of 101 and began feeling light headed. Attempted to walk to chair to sit down but lost consciousness and fell to floor. Partner reports that I was unresponsive for 45 seconds. Felt ok afterwards no further complications except fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypercholesterolemia; Asthma
Andere Medikamente: Atorvastatin; Vitamin D3; Famotidine; Cetirizine
Allergien: NKA
Vorherige Impfungen: Similar experience with Pfizer booster.

VAERS 2444701

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

schwer

Staat: VA
Alter: 51,0
Geschlecht: F
Eingang: 14.09.2022
Impfdatum: 09.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness Road traffic accident

Symptomtext

Got up at 6:00 a.m. feeling fine. Drove 15-20 minutes on the highway and began to feel lightheaded, so I immediately took the exit next to me. Before I could get to the side of the road, I lost consciousness. I do not know how long I was unconscious. The car hit something, waking my daughter, who was asleep in the passenger seat. She said that she shook me vigorously and called my name, but that I didn't wake up for about 20 seconds. I was able to pull in to the gas station to wait for my husband to arrive and drive us home. I did not seek medical attention because I had experienced lightheadedness, nearly "passing out" and vomiting with the first Moderna booster and was sure I would not have further problems by the following day. I am reporting this because of the potential safety hazard.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: osteoarthritis anxiety
Andere Medikamente: Sertraline Trazadone Celebrex
Allergien: None
Vorherige Impfungen: Ten hours following first Moderna booster, I had dizziness, lost balance, and nearly lost consciousness. Also had a few episodes

VAERS 2660636

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: -
Alter: 67,0
Geschlecht: M
Eingang: 25.07.2023
Impfdatum: 15.09.2022
Beginn: 13.11.2022
Tage bis Beginn: 59,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypotension Symptom recurrence

Symptomtext

HYPOTENSION 1/23/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2642211

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

moderat

Staat: OH
Alter: 71,0
Geschlecht: F
Eingang: 07.06.2023
Impfdatum: 11.10.2022
Beginn: 01.11.2022
Tage bis Beginn: 21,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diastolic dysfunction Dyspnoea Fluid retention Injection site pain Swelling Weight increased

Symptomtext

I little soreness at the injection site after receiving the vaccine. In 11/2022, I had gained 20 pounds in a short amount of time. I had swelling and shortness of breath. I went to my doctor, and I was given a prescription to help reduce the water gain. I was later diagnosed with diastolic dysfunction. I have to weigh my side every day and depending on the number, I have to take medication to get it back down.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2635490

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

moderat

Staat: -
Alter: 77,0
Geschlecht: M
Eingang: 23.05.2023
Impfdatum: 13.09.2022
Beginn: 27.10.2022
Tage bis Beginn: 44,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Aortic arteriosclerosis Atrial fibrillation Hypotension Pyrexia

Symptomtext

I95.9 HYPOTENSION 1/19/2023 ATHEROSCLEROSIS OF AORTA I95.9 HYPOTENSION 1/19/2023 ATRIAL FIBRILLATION, PAROXYSMAL I95.9 HYPOTENSION 1/19/2023 ATRIAL FIBRILLATION, PAROXYSMAL I95.9 HYPOTENSION 1/19/2023 ATHEROSCLEROSIS OF AORTA I95.9 HYPOTENSION 1/19/2023 FEVER I95.9 HYPOTENSION 1/19/2023 FEVER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2630522

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: OH
Alter: 80,0
Geschlecht: F
Eingang: 11.05.2023
Impfdatum: 12.09.2022
Beginn: 13.01.2023
Tage bis Beginn: 123,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anxiety Breast cancer female Breast cancer recurrent Breast pain COVID-19 Chest X-ray abnormal Chest X-ray normal Computerised tomogram thorax abnormal Exposure to SARS-CoV-2 Lung opacity Nipple pain Pneumonia SARS-CoV-2 test positive Scan with contrast abnormal

Symptomtext

I had breast cancer twice in my right breast. My left breast nipple was hurting really bad, and I started worrying. At dinner, I took ALEVE because my whole breast was hurting, and I was extremely worried. I called the hospital to see if they would give me any information and they told me to come in. There was a possibility of a pulmonary embolism. They performed a CAT Scan with contrast, they did not find anything. They found like broken glass in my lung, and they gave me a 7-days' worth of antibiotics. They told me to give it 7 days and I did and it cleared. I never had any symptoms that felt like pneumonia. My chest X-ray was clear when I went in for a follow up about 3 weeks later. I contracted COVID-19 on 05/2022, I thought it was allergy symptoms. I tested because I was going to be with family. I tested positive with a COVID-19 home test. I called the doctor, but I was not having any problems. I did not need treatment. December 2022, my husband tested positive for COVID-19 infection, so I tested, and I tested positive for COVID-19 infection, again I did not have any symptoms, so I did not need treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: -
Labordaten: 13JAN2023 CAT Scan with contrast, Pneumonia; X-ray, Suggestive of Pneumonia; APR2023 X-ray, Lungs were clear; MAY2022 COVID-19 home test, positive; DEC2022 COVID-19 home test, positive
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma
Andere Medikamente: Pantoprazole; ADVAIR HFA; albuterol; montelukast; atenolol; levothyroxine; atorvastatin; metformin; hydrochlorothiazide; aspirin; fexofenadine; azelastine; fish oil; OSTEO BIFLEX; multiple vitamin; pro-biotic; vitamin D3; coQ10; magnesium;
Allergien: No
Vorherige Impfungen: -

VAERS 2624650

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: TX
Alter: 64,0
Geschlecht: F
Eingang: 02.05.2023
Impfdatum: 24.09.2022
Beginn: 01.04.2023
Tage bis Beginn: 189,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Sciatica

Symptomtext

I had no adverse reaction to the vaccine. I have a history of sciatica pain. In 04/2023, I had a flare up and went to the doctor and got a prednisone shot. I have been referred to physical therapy and will start this week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetic
Andere Medikamente: Metformin
Allergien: Bees; penicillin; aloe vera; BACTRIM; strawberries; shellfish
Vorherige Impfungen: -

VAERS 2620629

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: ME
Alter: 51,0
Geschlecht: M
Eingang: 25.04.2023
Impfdatum: 29.09.2022
Beginn: 30.10.2022
Tage bis Beginn: 31,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Atrial fibrillation Cardioversion Dyspnoea Echocardiogram Electrocardiogram abnormal Heart rate increased Hypertension Illness Malaise Procedural failure

Symptomtext

Around October 30th I was having a lot of malaise. I was very short of breath and had physical weakness. I went for an exam in the first week of February and there was the suggestion that I might need an antibiotic to kick this illness. They also found that I was in atrial fibrillation. I had a rapid heart rate. I did my blood pressure and pulse through November to December and found that it was high. I didn't feel any fluttering, but I felt that my pulse and blood pressure was high. My health providers feel I was in atrial fibrillation for much longer than the initial finding in February. I am under treatment to get me out of atrial fibrillation. I have been started on numerous cardiac medications. They are planning to do an ablation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 07FEB2023 EKG Atrial fibrillation; 16FEB2023 Echocardiogram; 29MAR2023 Cardioversion failed
Aktuelle Erkrankungen: N/A
Vorgeschichte: ADHD
Andere Medikamente: ADDERALL; magnesium; TRAVATAN
Allergien: Ibuprofen; environmental
Vorherige Impfungen: -

VAERS 2619147

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: NY
Alter: 66,0
Geschlecht: M
Eingang: 21.04.2023
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation Blood pressure increased Condition aggravated Fatigue Heart rate increased

Symptomtext

I experienced atrial fibrillation with rapid heartbeat, fatigue and elevated blood pressure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Atrial fibrillation
Andere Medikamente: N/A
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2613907

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: -
Alter: 90,0
Geschlecht: F
Eingang: 12.04.2023
Impfdatum: 13.09.2022
Beginn: 10.04.2023
Tage bis Beginn: 209,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Blood creatinine increased Blood lactic acid Brain natriuretic peptide increased COVID-19 Chest X-ray abnormal Computerised tomogram abdomen abnormal Cough Dyspnoea Fatigue Haemophilus test positive Heart rate increased Hepatic cirrhosis Parainfluenzae virus infection Pleural effusion Pneumonia SARS-CoV-2 test positive Wheezing White blood cell count normal

Symptomtext

Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: "Patient is a 90 YO female with h/o paroxysmal atrial fibillation, HTN, CKD stage 3, CAD, and subdural hematoma presenting with fatigue, cough, and wheezing along with rapid heart rate in the 200s at home. She tested positive for COVID at home the day prior and Paxlovid was prescribed, however she did not start taking it yet. In the ED results showed: Lactate 2.9. repeat 1.5, BNP 2500, WBC 9.6, Afebrile, Cr 1.3, CXR significant for LLL pneumonia with mild effusion and Abd/pelvis CT significant for hepatic cirrhosis; Given 1 L IV fluids in ED. She was given rocephin and doxycycline pending viral panel. The viral panel showed parainfluenza # infection, therefore antibiotics were discontinued. She was placed on amiodarone drip and cardiology consulted. Overnight she converted to NSR with a heart rate in the 60s-70s. Dr. increased metoprolol to 50 and started her on a short course of PO amiodarone and stopping the drip. Of note the patient's respiratory status remained stable throughout with coughs and some subjective dyspnea without the need for oxygen. Crea stayed at 1.3, which may be her new baseline given that it was 1.2 in December.The case was discussed with Dr. who felt that she would be safe to discharge home from a cardiac standpoint on a short course of amiodarone 200 daily until her follow up with him in 2-3 weeks. Upon my examination the patient had improved significantly and her respiratory status was stable as well. Per PT recommendations patient could return home with home therapy. "

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 2,0
Labordaten: COVID-19 negative PCR 4/10/23. Tested positive at home 4/9/2023.
Aktuelle Erkrankungen: -
Vorgeschichte: Atrial fibrillation with rapid ventricular response Essential hypertension, benign Paroxysmal atrial fibrillation CAD (coronary artery disease) CKD (chronic kidney disease), stage III Hepatic cirrhosis Pure hypercholesterolemia
Andere Medikamente: -
Allergien: Adhesive Pcn [penicillins]
Vorherige Impfungen: -

VAERS 2613755

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: CA
Alter: 70,0
Geschlecht: F
Eingang: 12.04.2023
Impfdatum: 10.10.2022
Beginn: 23.03.2023
Tage bis Beginn: 164,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Ageusia Anosmia Cough Dyspnoea Dyspnoea exertional Influenza virus test negative Nausea Pyrexia Respiratory tract congestion SARS-CoV-2 test negative

Symptomtext

I had a fever of 101.4 was the max and I had a cough and chest congestion. I was whizzy and I lost my taste and smell. I would get short of breath doing things. I also was getting nauseous. O2 saturation 93 percent.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 26MAR23 COVID test nasal swab, negative. Flu test, negative
Aktuelle Erkrankungen: None
Vorgeschichte: Chronic Kidney Disease; High blood pressure; Depression
Andere Medikamente: Trazodone; lovastatin; TYLENOL
Allergien: None
Vorherige Impfungen: -

VAERS 2611033

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: MN
Alter: 63,0
Geschlecht: M
Eingang: 06.04.2023
Impfdatum: 21.09.2022
Beginn: 29.03.2023
Tage bis Beginn: 189,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Dyspnoea exertional Fatigue Headache Malaise SARS-CoV-2 test positive Throat irritation

Symptomtext

My COVID-19 symptoms started on 03/29/2023 in the morning. I had scratchy throat, cough, headaches, and tiredness. I would ran out of breath if I try to do anything. On 03/30/2023 I did a home COVID-19 test which was positive. I called the nurse's line after testing positive. They prescribe me Paxlovid for 5 days. As of today I've recovered 95% from COVID-19 infection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea exertional
Hospital-Tage: -
Labordaten: 29MAR2023 COVID-19 Test- Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes; High Blood Pressure; Heart Disease
Andere Medikamente: Metformin; Atorvastatin; Carvedilol; Multivitamins; Iron Supplements
Allergien: N/A
Vorherige Impfungen: -

VAERS 2609898

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

moderat

Staat: MI
Alter: 59,0
Geschlecht: M
Eingang: 05.04.2023
Impfdatum: 29.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Pruritus Psoriasis

Symptomtext

After my vaccine, I had a psoriasis flare up. My left elbow has quite a flare up psoriasis and it is very itchy and turned into a skin infection I got prescribed antibiotics for a couple of weeks. I am still treating my conditions with antibiotics.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Psoriasis; Gout
Vorgeschichte: Psoriasis; Gout; Hypertension
Andere Medikamente: Lorto; HTC; Otezla; Ziloprim; Lipitor
Allergien: Bactrim; Beer
Vorherige Impfungen: -

VAERS 2605890

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: MN
Alter: 40,0
Geschlecht: M
Eingang: 29.03.2023
Impfdatum: 27.09.2022
Beginn: 24.12.2022
Tage bis Beginn: 88,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dyspnoea Haemoptysis Infection Pyrexia Respiratory symptom SARS-CoV-2 test negative Secretion discharge

Symptomtext

My known RSV symptoms started on 12/24/2022 in the afternoon through evening. I think it was RSV but never tested for it. I had green mucus drainage, shortness of breath, coughed blood few times, fever back to back for 6 days straight. I took 3 COVID-19 test 2 were negative and 1 I never followed the instruction but I thought It might be COVID-19 but it wasn't. I did went to the urgent care and they did PCR test which was negative. I visited my doctor on 12/29/2022 e prescribe Steroids and decongestant for 2-3 days but it didn't help. I took over the counter Nyquil to help me sleep. My immune fought the infection I had by itself. It took me to fully 2-3 weeks to recover. I do not believe that it was vaccine related.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: DEC2023 PCR Test- Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2603387

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: MI
Alter: 85,0
Geschlecht: F
Eingang: 24.03.2023
Impfdatum: 22.09.2022
Beginn: 07.03.2023
Tage bis Beginn: 166,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary abnormal Asthenia Blood electrolytes abnormal Blood magnesium decreased Blood phosphorus decreased Blood potassium decreased COVID-19 Computerised tomogram head normal Computerised tomogram spine normal Delirium Electrolyte substitution therapy Fall Fibrin D dimer increased Hypokalaemia Hypothermia Hypoxia Leukocytosis Lung consolidation

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/7/2023 Discharge Date: Mar 11, 2023 PRESENTING PROBLEM: Hypoxemia Hypokalemia Weakness History of fall COVID-19 HOSPITAL COURSE: Patient is a 85 y.o. female with history of dementia, stage 3a CKD, hypothyroidism, hypertension, depression with anxiety and vitamin D deficiency who resides in Assisted Living Facility. She was diagnosed with COVID-19 on 03/02 and had progressively worsening weakness and fall prompting ER visit. On presentation, she was hypoxemic and hypothermic. D-dimer was elevated, CTA thorax was obtained and showed no PE, but did exhibit patchy and confluent areas of consolidation in the left lower lobe. Both CT head and CT cervical spine were negative for acute pathology. She had mild leukocytosis and procalcitonin was notably elevated at 2.19. She was started on Decadron, remdesivir for COVID and IV Rocephin/doxycycline for suspected superimposed bacterial pneumonia. Over the next 2 days patient was weaned to room air and respiratory symptoms improved. Patient also had low potassium, magnesium, and phosphorus. Electrolytes replaced and WNL at time of discharge. PT/OT did recommend SAR, however placement would be delayed until 3/13 COVID isolation status. The patient did have hospital delirium in the setting of dementia and acute infection. Family preferred that the patient returned back to her home Assisted Living Facility. Care management was able to arrange for patient to have PT/OT 5 days per week and 24hr assistance with family. Patient subsequently discharged back to Assisted Living Facility and stable condition. She completed 4 days of IV antibiotics and was transition to PO Ceftin at discharge to complete total 5 day course. Decadron and remdesivir stopped at discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia bacterial
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: acetaminophen (TYLENOL) 325 MG tablet aspirin 81 MG enteric coated tablet b complex vitamins capsule busPIRone (BUSPAR) 10 MG tablet Docosanol (ABREVA) 10 % CREA escitalopram (LEXAPRO) 20 MG tablet furosemide (LASIX) 20 MG tablet guaifenesi
Allergien: Dilantin [Phenytoin
Vorherige Impfungen: -

VAERS 2600397

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: AZ
Alter: 66,0
Geschlecht: M
Eingang: 21.03.2023
Impfdatum: 16.09.2022
Beginn: 08.11.2022
Tage bis Beginn: 53,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Asthenia Benign fasciculation syndrome Blood test Brain fog Computerised tomogram head normal Computerised tomogram pelvis Computerised tomogram thorax normal Condition aggravated Essential tremor Fatigue Flank pain Heart rate increased Hyperhidrosis Injection site erythema Injection site pain Insomnia Metabolic function test normal

Symptomtext

On 11/8/2022, I experienced some soreness in the right shoulder. I noticed that it was red and felt just sore. Then I realized that it was the site of the fifth vaccine dose injection. It lasted for a couple of days and went away, but then I started experiencing an increase in my essential tremors. I had pre-existing tremors, but they suddenly got worse. They continued to worsen, and I visited my neurologist. The neurologist diagnosed essential tremor, idiopathic peripheral neuropathy, and benign fasciculation syndrome. I have undergone various blood tests, and I am now awaiting a blood test for a neurological autoimmune disorder. I don't know if there is any relationship between my symptoms and the vaccines I received, but I have heard that there have been reports of neurological issues from some people who have received mRNA vaccines. I also think it's pretty coincidental that I had pain at the injection site two months after getting the injection and shortly before the beginning of the worsening of symptoms. I believe in the vaccines and believe that they are necessary, but I also feel that I have a responsibility to report this. These symptoms have caused me a great deal of difficulty. Before I developed the symptoms, I was very active and health-conscious. I intentionally lost 70 lbs. over the past few years by exercising and dieting. I regularly rode my mountain bike 10 miles a day. As of 3/1/2023, I was riding my bike 10 miles a day, but as 3/6/2023, I am very fatigued all the time. I have low energy and feel like I'm in a fog. I have been having difficulty sleeping for the past six weeks, because I'm very anxious. I have been prescribed Lexapro to treat the anxiety; as of yet, I have not noticed any changes, as I have only been taking it for two weeks. I went to the ER on 3/7/2023, 3/8/2023, and 3/10/2023, because I had pain in the left side of my side, exhaustion, tiredness, sweating, and rapid heartbeat. I underwent a brain CT scan, blood panels for heart-related enzymes, complete metabolic panels, and CT scans of the chest and pelvis. The results of all these tests were normal, so I was discharged and never admitted overnight.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: DATES UNKNOWN - Various Blood Tests - Normal Results
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Primidone; Amlodipine; Benicar; Pantoprazole; Pravastatin; Tamsulosin; Fish Oil; Multivitamins; Vitamin D
Allergien: None
Vorherige Impfungen: -

VAERS 2600106

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 21.03.2023
Impfdatum: 19.09.2022
Beginn: 15.10.2022
Tage bis Beginn: 26,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea exertional Stress echocardiogram

Symptomtext

In the past had afib. After vaccine, started having shortness of breath upon exertion. Went to my annual Cardiology appointment and doctor wanted me to get a Stress Echocardiogram. My doctor is sending me to a Pulmonary Specialist, where another Echocardiogram Stress can be done.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea exertional
Hospital-Tage: -
Labordaten: 01NOV2022 Stress Echocardiogram, inconclusive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; High Cholesterol; Hypothyroidism; Dry Macular Degeneration; Afib; Polymyalgia rheumatica; Osteopenia.
Andere Medikamente: Vitamin D; magnesium supplements; multivitamin; CALTRATE plus D; AREDS supplement; levothyroxine; hydrochlorothiazide; XARELTO; rosuvastatin; sotalol.
Allergien: N/A
Vorherige Impfungen: In 2018 Shingrix caused a rash on my arm that lasted 3 days.

VAERS 2599494

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: WI
Alter: 76,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 07.10.2022
Beginn: 09.03.2023
Tage bis Beginn: 153,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chronic obstructive pulmonary disease Condition aggravated Encephalopathy Pneumonia

Symptomtext

Patient was admitted on 3/10 as inpatient for encephalopathy, pneumonia, COPD exacerbation. Neurology is consulted and following. patient recenctly diagnosed with COVID on 2/26/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2596093

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: TX
Alter: 75,0
Geschlecht: F
Eingang: 14.03.2023
Impfdatum: 12.09.2022
Beginn: 22.01.2023
Tage bis Beginn: 132,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Drainage Dyspnoea Respiratory tract congestion Wheezing

Symptomtext

I am having a lot of drainage left over from having had COVID-19, along with a lot of congestion, a deep tight cough. I called the nurse who had treated me for the COVID-19 infection. I described my symptoms and let her know that I had also started wheezing. She prescribed an albuterol inhaler and an ADVAIR inhaler. I am feeling a bit better. But I notice that if I do not use the inhaler I am breathless.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: No
Vorgeschichte: Lower Back Pain
Andere Medikamente: Gabapentin; trazadone; atorvastatin; XIIDRA; OPZELURA; vitamin D; picolinate; hormone replacement ointment
Allergien: No
Vorherige Impfungen: -

VAERS 2595543

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: OH
Alter: 64,0
Geschlecht: F
Eingang: 13.03.2023
Impfdatum: 11.09.2022
Beginn: 12.02.2023
Tage bis Beginn: 154,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Condition aggravated Fatigue Hypoaesthesia Hypoaesthesia oral Pain Paraesthesia Paraesthesia oral Paranasal sinus hypersecretion Productive cough Pyrexia SARS-CoV-2 test positive

Symptomtext

I woke up with a cough productive of clear mucous and sinus drainage which was the same fatigue and I had a worsening of an existing condition of numbness and tingling around my mouth and cheeks. I took a COVID-19 test which was positive and I had minor aches and pain I had a fever which was a high of one hundred and one degrees.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: COVID-19 test positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; Glaucoma
Andere Medikamente: Metoprolol; hydrochlorothiazide; hydroxyzine; fexofenadine; omeprazole; PEPCID; latanoprost; multivitamin
Allergien: BACTRIM; kiwi
Vorherige Impfungen: -

VAERS 2594639

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

moderat

Staat: VT
Alter: 42,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 08.09.2022
Beginn: 03.02.2023
Tage bis Beginn: 148,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Fatigue Mobility decreased Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

So on 03FEB2023 I started feeling really really tired and I had had a known COVID-19 exposure I initially tested negative in the evening but the next morning I had a positive test but my husband tested negative later he tested positive on a molecular test. At that point I set up a telehealth appointment to try and get Pacxlovid appointments and we had no contra indications so I wanted Pacxlovid and wanted our children to not get the virus. We did our telehealth appoint and were prescribed Pacxlovid and we were able to get that Prescription late 04FEB2023. I was very tired and it was hard to get up to do anything. I took my first dose late 04FEB2023 in the afternoon , the next morning I had less fatigue and a mild sore throat on 05FEB2023 I felt more up to doing things and by 06FEB2023 we both felt pretty much fine and started back to work. I did to have to miss any work due to Pacxlovid it is a wonder drug.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: COVID-19 Test-Positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Shrimp
Vorherige Impfungen: -

VAERS 2546980

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: OH
Alter: 73,0
Geschlecht: F
Eingang: 30.12.2022
Impfdatum: 29.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inflammation Injected limb mobility decreased Loss of personal independence in daily activities Pain Pain in extremity Sleep disorder X-ray

Symptomtext

In October my arm started hurting and aching, it woke me up. I did not have mobility in my arm, I could not get dressed, use my arm to do simple task. I let it go for a month thinking it was related to my fibromyalgia. I woke up one morning and decided I needed to go in and see my doctor about this pain. She referred me Orthopedic doctor, he took x-rays to determine that it was not my roto cup but I did give me a steroid shot to help with the inflammation. It took a week for the shot and exercises to help. I do still have some pain if I move a certain way, sleep on it accidentally.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injected limb mobility decreased
Hospital-Tage: -
Labordaten: X-rays
Aktuelle Erkrankungen: No
Vorgeschichte: Osteoporosis; Fibromyalgia
Andere Medikamente: Eye vitamin; vitamin D; alendronate sodium; benzonatate
Allergien: LYRICA
Vorherige Impfungen: -

VAERS 2540852

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: FL
Alter: 75,0
Geschlecht: F
Eingang: 22.12.2022
Impfdatum: 13.09.2022
Beginn: 03.10.2022
Tage bis Beginn: 20,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chest X-ray abnormal Computerised tomogram thorax Cough Dyspnoea Fatigue Laboratory test abnormal Pyrexia SARS-CoV-2 test negative SARS-CoV-2 test positive

Symptomtext

October 3rd, I visited my daughter, that night I had fever of 101 fever, I had cough, I felt better, I then on October 10th went to another trip out of state, I have fever, shortness of breath, fatigue, it continued until I got home on the 19th of October. I took six home tests for COVID-19 and all of them were negative. I went to my doctor, the doctor did a PCR COVID-19 test and it was negative. I still had fatigue back then, shortness of breath and a cough, they checked my chest CT was done and chest X-ray doctor said I had COVID. I had a lab test and it showed a high sensitivity CRP, high protein.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 03NOV2022 COVID test negative; 26OCT2022 COVID-19 test; 26OCT2022 Lab abnormal; 25OCT 2022 chest X-ray abnormal
Aktuelle Erkrankungen: N/A
Vorgeschichte: Breast Cancer
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2535445

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge AS7148B

moderat

Staat: WI
Alter: 92,0
Geschlecht: F
Eingang: 16.12.2022
Impfdatum: 03.10.2022
Beginn: 13.11.2022
Tage bis Beginn: 41,0
Dosis: 4
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Bacterial test positive Blood creatine phosphokinase normal Blood creatinine normal Blood lactic acid normal Blood urea increased Chest X-ray normal Cough Dyspnoea Full blood count normal Glomerular filtration rate decreased Laboratory test abnormal Metabolic function test normal Nitrite urine present Troponin normal Urine analysis abnormal Urine leukocyte esterase positive White blood cells urine positive

Symptomtext

Adverse event information provided in this submission, is per a report received by Health Department from a submitting facility. Health Department does not have any further information on this patient remaining hospital course or outcome. Please contact Hospital for any and all additional follow up. Covid-19 vaccination information is from Immunization Registry. MODERNA 3/11/2021 LOT # 001B21A MODERNA 4/8/2021 LOT # 038B21A MODERNA 12/22/2021 LOT # 013F21A MODERNA BvlntBstr 10/3/2022 LOT # AS7148B Admitted TO HOSPTIAL 11/13/2022 Per note submitted: ?Patient was sent to ED from her nursing home because of shortness of breath, cough and generalized weakness. Patient denies any chest pain, palpitations, lightheadedness etc. She is a poor historian and hence much of the information is obtained from previous notes. Review of systems is negative for any the findings. States to be compliant with her medications. Social history is negative for tobacco, alcohol or any recreational drugs. Upon examination of the bedside patient was lying in the bed in no apparent distress. She appeared weak. Her vitals are notable for T-max of 99.8, heart rate in the 70s, respirate r ate of 22 blood pressure was 125/72. She was saturating 100% on 3 L nasal cannula. Of note is the patient's saturation on admission was 85% on room air. Chemistry was notable for creatinine of 1.01 with BUN of 21 and GFR of 40. Troponin and CK within normal limit. CBC unremarkable. UA was positive for leukocyte esterase, nitrites, WBCs and bacteria. Chest x-ray was unremarkable. Patient was given empiric antibiotics, steroids in the E D and is being admitted to hospital for further management.? Health Department does not have any further information on this patient remaining hospital course or outcome. Contact Hospital for any and all additional follow up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: lab work up "Lactic acid is normal. CBC, CMP are relatively unremarkable. Chest x-ray is unremarkable Chest Xray Final Result No acute cardiopulmonary findings
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: ? Blindness of left eye ? Cataract extraction 2007 ? Osteoporosis ? Phthisic cornea, left eye ? Pseudophakia, right eye ? Thyroid disease ? Vitreous degeneration
Andere Medikamente: UNKNOWN
Allergien: NO KNOWN ALLERGIES PER WEB REPORT RECEIVED
Vorherige Impfungen: -

VAERS 2516761

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: MN
Alter: 74,0
Geschlecht: F
Eingang: 25.11.2022
Impfdatum: 22.09.2022
Beginn: 16.11.2022
Tage bis Beginn: 55,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chest X-ray Dyspnoea Respiratory syncytial virus test positive SARS-CoV-2 test positive

Symptomtext

Presented to ER for SOB, tested positive (outside our system) 7 or 8 days prior to admission. Received Paxlovid and completed treatment on 11/20/22. Also tested positive for RSV.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: COVID 19 Positive, RSV Positive, Chest Xray
Aktuelle Erkrankungen: -
Vorgeschichte: COPD
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2508343

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: MI
Alter: 54,0
Geschlecht: F
Eingang: 15.11.2022
Impfdatum: 07.11.2022
Beginn: 08.11.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Gait disturbance Muscle spasms Pain Tremor

Symptomtext

Patient reports that she experienced extreme chills, violent shaking, and muscle spasms that lasted approximately 1 hour before subsiding. She notes aches and pain for several days following, as well as increased difficulty in walking, Symptoms resolved without the need to seek medical care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Fibromyalgia, hx of cancer x 2
Andere Medikamente: Colate Vitamin D
Allergien: Alvesco Inhaler Amitriptyline Amoxicillin Arimidex Bactrim Decadron Influenza Vaccine Lipitor Methyl-Pred Pack Venlafaxine B12 Zolpidem Adhesive tape Aged cheese Caffeine Cats Cobalt Antibacterical Soap Dogs Eggs Mold Powder in gloves Timothy Grass Tomatoes Trees
Vorherige Impfungen: Pt reports difficulty breathing with influenza vaccine approximately 30 years or more years ago. Cannot recall date or brand nam

VAERS 2495070

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: MN
Alter: 50,0
Geschlecht: F
Eingang: 01.11.2022
Impfdatum: 14.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Nephrolithiasis Renal pain Ultrasound bladder Ultrasound kidney abnormal Urine analysis normal

Symptomtext

A week after receiving my fourth dose of Moderna, I began experiencing symptoms of a kidney stone. Beginning around 09/21/2022, the pain was really bad by 09/24/2022. I was able to see a urologist on 09/29/2022. I did have to have some kidney stones removed 3 months after my first dose of my COVID-19 vaccine in 2021 as well as after my third dose in 2022. Before beginning my COVID-19 vaccines, I had not had a kidney stone since 2009. After seeing my urologist, she prescribed a medication, and I had an ultrasound of my kidney and bladder where they discovered a kidney stone in my right kidney. She advised to continue drinking water and if it became symptomatic, they would do a CAT scan and decide on further treatment but hasn't been bothering me since I began the medication.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: 29SEPT2022 UA/UC negative; 26OCT2022 Ultrasound of kidney and bladder, kidney stone discovered; 17OCT2022 UA/UC negative
Aktuelle Erkrankungen: Upper Respiratory Illness
Vorgeschichte: Asthma; Poly Cystic Ovary Syndrome
Andere Medikamente: Vitamin D; iron supplement; vitamin B6; fish oil; probiotic; cilium fiber; magnesium citrate; vitamin B12; SAMe; taurine; glutathione; biotin; zinc; calcium citrate; turmeric; vitamin E; potassium citrate ER; P5P
Allergien: Sulfa; metformin; coco aminopropyl betaine
Vorherige Impfungen: 2021/2022 Previous Moderna vaccines, kidney stones

VAERS 2487288

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

moderat

Staat: CA
Alter: 29,0
Geschlecht: F
Eingang: 24.10.2022
Impfdatum: 16.09.2022
Beginn: 28.09.2022
Tage bis Beginn: 12,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood magnesium abnormal Blood pressure increased Blood test abnormal Enzyme level abnormal Exposure during pregnancy Gestational diabetes Gestational hypertension Labour induction

Symptomtext

I received the second booster on September 16, 2022. On the 27th my blood pressure was slightly elevated and on the 28th it was 181/99 I went to the ER and was given Labetalol. I was almost 36 weeks pregnant. I was sent home and told to contact OBGYN. I was not prescribed anything else. My blood pressure spiked again and it 175/90 (about) and I went to the emergency room again. They monitored me and was not given any prescription and did not stay overnight. I was diagnosed with gestational hypertension. I was set up for labor induction on October 7th. On October 7th during labor my pressure spiked again, and I was given magnesium and Labetalol again. After delivery, I was monitored, and my pressure went down. But on October 17th it spiked again to 190/70?s and I went back to the emergency room. I was admitted to the hospital and upon discharge prescribed Labetalol.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Gestational hypertension
Hospital-Tage: 2,0
Labordaten: Blood panels for enzymes and magnesium, abnormal;
Aktuelle Erkrankungen: N/A
Vorgeschichte: Gestational diabetes just diagnosed during pregnancy
Andere Medikamente: Prenatal Vitamin; Baby Aspirin
Allergien: Pet dander; Pollen; Intolerance for red peppers
Vorherige Impfungen: -

VAERS 2486390

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: VA
Alter: 48,0
Geschlecht: F
Eingang: 22.10.2022
Impfdatum: 01.10.2022
Beginn: 22.10.2022
Tage bis Beginn: 21,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Heart rate increased Immediate post-injection reaction Paraesthesia

Symptomtext

Patient verbalized feeling "fast heartbeats and tingling in the feet" immediately after receiving the vaccine. Patient denied experiencing similar reaction to previous doses of COVID vaccine. Patient's vitals checked, BP=140/64, HR=79, SPO2=99%, RR=18 non-labored. Patient was advised to relax, take deep breaths and take her time until she feels better. Anaphylactic shock kit was brought near the patient. Team lead and managers attended to the patient. Patient verbalized feeling better after a few minutes, was able to walk independently to the post vax observation area, accompanied by manager.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No illnesses reported.
Vorgeschichte: No chronic or long-standing health conditions reported.
Andere Medikamente: -
Allergien: Denied allergies.
Vorherige Impfungen: -

VAERS 2485931

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: MI
Alter: 70,0
Geschlecht: M
Eingang: 21.10.2022
Impfdatum: 09.09.2022
Beginn: 23.09.2022
Tage bis Beginn: 14,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Atrial fibrillation Atrial flutter Blood test Chest X-ray Echocardiogram Electrocardiogram Heart rate increased Hypertension

Symptomtext

This happened twice. Second visit to Medical Center with elevated heart rate after receiving Moderna vaccine. First time diagnosed with atrial flutter, this reported time with atrial fib. First time flutter converted with course of IV diltiazem and IV blood thinner. Diltiazem increased from 240 dose used for high blood pressure to 320 with new script for rivaroxaban, then discharged. This time fib converted with an IV course of diltiazem, since blood thinner was on board. New script for Metoprolol, then discharged.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: 1,0
Labordaten: EKG, blood tests, echo cardiogram and chest xray during first visit. EKG, blood tests and chest xray during second visit.
Aktuelle Erkrankungen: -
Vorgeschichte: High Blood Pressure, Mild Asthma, High Cholesterol, Non-Essential Tremors, Atrial Flutter (diagnosed on 4/20/2022 after Maderna vaccination on 4/11/2022)
Andere Medikamente: Primidone 50 mg, Gemfibrozil 600 mg, Rivaroxaban20 mg, Diltiazem 360 mg, Lisinopril 10mg, QVAR 80 mcg Fexofenadine 180 mg, Glucosamine Sulfate 500 mg, Vegetarian Chondroitin 1000 mg
Allergien: Shell Fish
Vorherige Impfungen: -

VAERS 2481997

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: CA
Alter: 46,0
Geschlecht: M
Eingang: 18.10.2022
Impfdatum: 12.09.2022
Beginn: 15.10.2022
Tage bis Beginn: 33,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram normal Headache Magnetic resonance imaging normal Malaise Ophthalmic migraine Pain

Symptomtext

Began having suspected ocular migraines approx. 1st or 2nd week of July, 2022. Was seen, received CT and MRI with no abnormalities noted. Received most recent bivalent Moderna vaccine 9/12/2022. Today is 10/18/2022 and I have had 3 migraines with exacerbating symptoms since 10/15/2022. This may have nothing to do with the vaccines, as I have had 3 previous and only experienced minor side effects of body aches, malaise, headache after the previous 3. The vaccine on 9/12/2022 I experienced no side effects afterward.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ophthalmic migraine
Hospital-Tage: -
Labordaten: CT scan on 7/30/2022, MRI on 08/04/2022
Aktuelle Erkrankungen: none
Vorgeschichte: major depressive disorder
Andere Medikamente: Effexor XR 70mg daily Creatine Monohydrate 3g daily Vitamin D3 2000IU daily Combination capsules containing: Ceylon Cinnamon 1000mg daily, Turmeric root powder 750mg daily, Ginseng root powder 100mg daily, Bioperine 5mg daily
Allergien: Morphine allergy
Vorherige Impfungen: -

VAERS 2480387

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: NJ
Alter: 47,0
Geschlecht: M
Eingang: 17.10.2022
Impfdatum: 16.09.2022
Beginn: 18.09.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dyspnoea Electrocardiogram normal Fatigue Heart rate increased Pyrexia

Symptomtext

I went for a hike and felt extremely fatigued. That evening (9/18) through the following day I experienced fever (peak was 101.5), difficulty breathing, and elevated HR. HR was in 80's and 90's at rest, which is 20+ bpm higher than usual (I monitor my fitbit closely).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: EKG was done and "showed no acute findings". They said to go to the ER to be evaluated for a PE. I did not go the the ER.
Aktuelle Erkrankungen: I had a runny nose around the time of the vaccine
Vorgeschichte: None
Andere Medikamente: Wellbutrin, Focalin, Vit D, Calcium, glucosamine chondroitin, fish oil, vitamin B complex
Allergien: None I know of
Vorherige Impfungen: -

VAERS 2478368

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: MD
Alter: 71,0
Geschlecht: M
Eingang: 14.10.2022
Impfdatum: 14.09.2022
Beginn: 17.09.2022
Tage bis Beginn: 3,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acoustic stimulation tests Blood test Cardiac flutter Deafness bilateral Dizziness Electrocardiogram normal Ophthalmological examination Palpitations Vertigo

Symptomtext

A couple days after receiving the bivalent dose of Moderna, I started to experience some dizziness. I thought it may have been my new prescription of contacts, but I changed them out and nothing changed. I tried the Epley maneuver, but it did not help. I started experiencing some heart palpitations also and decided to spend the day resting. I woke up the next day and started experiencing vertigo. By Monday, the heart palpitations somewhat diminished and turned into a flutter. I went to the doctor. She checked my BP and performed an EKG. Both tests came back normal. I went and saw my ENT and she did the Epley maneuver and it helped a bit. I am still experiencing dizziness plus hearing loss in both ears, but it is more pronounced in my left ear. The dizziness becomes worse if I am looking down trying to read or write. I have an appointment with my audiologist and she is going to do an audiogram.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: Blood work; EKG; eye exam; ear exam.
Aktuelle Erkrankungen: None
Vorgeschichte: Chronic degenerative joint disease
Andere Medikamente: PRADAXA; gabapentin; tadalafil
Allergien: None
Vorherige Impfungen: -

VAERS 2470649

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: NY
Alter: 84,0
Geschlecht: F
Eingang: 06.10.2022
Impfdatum: 04.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Fatigue Feeding disorder Mobility decreased Myalgia

Symptomtext

on 10/5 in the morning the patient woke up with: severe weakness could not sit up, fatigue, muscle pain, temperature of 99.8, unable to eat food due to the extreme weakness No nausea, no vomiting, no diarrhea patient and family were advised to contact their physician to report the event and family did so and they called again today 10/6/22 to report patient was much improved

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: none ordered
Aktuelle Erkrankungen: none
Vorgeschichte: hypertension, depression, CAD with Stent, TAVR May 2021
Andere Medikamente: citolapram 10 mg, carvedilol 6.25mg, clopidogrel 75 mg, lisoprinopril 10 mg, multivitamin
Allergien: NKDA allergy to shellfish and alcohol when taken together, causes her to faint this has not happened in 15 years
Vorherige Impfungen: -

VAERS 2468808

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

moderat

Staat: AL
Alter: 60,0
Geschlecht: F
Eingang: 04.10.2022
Impfdatum: 09.09.2022
Beginn: 20.09.2022
Tage bis Beginn: 11,0
Dosis: 6
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blister Condition aggravated Herpes zoster Pain Psoriatic arthropathy Pyrexia

Symptomtext

I experienced shingles after vaccination. I had alot of pain for psoriatic arthritis and also had blisters in my stomach and fever. I am still having some blisters in my stomach. I have other symptoms but they are due to not taking my psoriatic medications which caused an increase in my arthritis. No tests were performed. I still recovering at the moment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Psoriatic Arthritis; Psoriasis
Vorgeschichte: Psoriatic Arthritis; Psoriasis
Andere Medikamente: Psoriatic Arthritis; Percocet; Humira; Prilosec; Folic Acid; Metformin; Gabapentin; Lexapro; Diazole; Xyzal; Calcium With Vitamin D; CO Q10; Centrum Silver
Allergien: Penicillin; Amitrax; NSAID's; Bactrim; Trees; Grass
Vorherige Impfungen: After first dose of COVID-19 vaccine, had a big increase in my rheumatoid arthritis.

VAERS 2462919

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: IL
Alter: 63,0
Geschlecht: M
Eingang: 28.09.2022
Impfdatum: 21.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Discomfort Pain Paraesthesia

Symptomtext

No concerns after shot. Felt good, so decided to spray for spiders about 6:30 pm. Mixed Tempo SC Ultra Premise in pump sprayer and sprayed. Rinsed hands afterwards, no soap. No gloves or respirator used. 9PM, started having tingling of lips and stinging of eyelids and skin around eyes but not in eyes. Put cool washcloth on for relief. Went to bed, awakened about 2 am with continued stinging and tingling. No rash, trouble breathing or swelling but it was uncomfortable. 9/22/22 am patient called office, spoke with myself. Some tingling of lips and still has some stinging of skin around eye, much better. Encouraged patient to call his provider NP to advise of situation. Called patient back at 4:30 pm 9/22/22. He said he had called provider NP and advised her of situation, she didn't advise doing anything further. He said he had almost no stinging left on eyes. Says not much on lips at noon but none now at all. Phone call 9/26/22- he said by the morning of 9/23/22 had no symptoms at all. Advised patient that VAERS form would be filled out by health office.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: high cholesterol and ^B/P
Andere Medikamente: Atorvastatin, amlodipine/Benzapril 10/20
Allergien: None
Vorherige Impfungen: -

VAERS 2460854

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: TX
Alter: 57,0
Geschlecht: F
Eingang: 26.09.2022
Impfdatum: 08.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac monitoring Dyspnoea Echocardiogram normal Extra dose administered Heart rate decreased Hyperventilation Injection site induration Injection site mass Injection site pain Injection site warmth

Symptomtext

Sometime after my fifth dose of my Moderna COVID-19 vaccine I was having shortness of breath and I was also having a pretty low pulse. I was feeling like I was hyperventilating. I went to my cardiologist who ordered an echocardiogram and a heart monitor. I am still waiting on the heart monitor that I'm supposed to wear for month, and I will see her again on 10/31/2022. I also experienced arm soreness with a hard knot in my arm at injection site. It was hot to the touch, and it lasted around 4 days before it went away on its own.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 09/21/2022-Echocardiogram- normal results
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure; Type 2 Diabetes; High cholesterol; Thyroid issue; Psoriasis
Andere Medikamente: Amlodipine; Losartan; Victoza; Metformin; Synthroid; Zetia; Lexapro; Meloxicam; Stelara injection every three months; Multivitamin; Glucosamine; Vitamin D; Vitamin B; Zinc; Turmeric; Zyrtec
Allergien: Penicillin; Bactrim; Diflucan
Vorherige Impfungen: Flu shot-heat and soreness after injection

VAERS 2452157

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

moderat

Staat: -
Alter: 29,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 19.09.2022
Beginn: 20.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chills Dyspnoea Feeling abnormal Tremor

Symptomtext

Patient woke up in middle of the night about 12 hours after receiving the vaccine with severe shaking and chills. He also noted slight difficulty in breathing. His shaking was so bad he could barely hold a glass of water. Patient states it lasted about 2 hours and has since resolved and just feels the normal "under the weather" feeling after a vaccine like the past vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2447900

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

moderat

Staat: HI
Alter: 80,0
Geschlecht: F
Eingang: 16.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal discomfort Arthralgia Asthenia Decreased appetite Dizziness Fatigue Feeling abnormal Flushing Headache Heart rate increased Injection site pain Malaise Mental impairment Mobility decreased Nausea Neck pain Oropharyngeal pain Pain

Symptomtext

These symptoms apply to both me and my husband who got the injection at the same time. Around 3:30 - 4 PM, I began to feel flushed, light-headed and VERY shaky, weak with some thirst and fatigue and a headache at the back of my head (I never get headaches). NO FEVER. At 4AM, 9/13/22, I began to have severe body aches and stabling pains especially neck and shoulders at site of injection along with rapid heartbeat and mental fuzziness. At 9:20 AM on 9/13/22, the same symptoms were there only stronger and a very strong all-over body sickness; so ill that both of us laid on the sofa with some nausea and increased leg pain and body aches, but there was also some pain at back of throat--no appetite and NO FEVER . Late 9/13/22 the all-over sickness abated and felt fairly normal on Wednesday 9/14 and Thursday 9/15; however, today 9/16/22, the all-over body sickness, mild headache and body aches plus some stomach and GI upset have occurred. The weakness is such that we not be active today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: right hip replacement spinal stenosis
Andere Medikamente: none
Allergien: Allergies to penicillin, and other drugs
Vorherige Impfungen: Same sort of reactions to other 4 COVID 19 vaccines

VAERS 2442937

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge As7148B

moderat

Staat: IL
Alter: 73,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 01.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 12,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Headache Myalgia Tremor

Symptomtext

shaking, chills, muscle aches, headache over 12 hours. I have had similar reaction to previous Covid immunizations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: lymphocytic colitis
Vorgeschichte: rheumatoid arthritis
Andere Medikamente: Leflunamide, Sertriline, Alendronate, Budesonide, multi-vitamin, vitamin B6 , vitamin E, Calcium
Allergien: Erothromycin, , Miralax
Vorherige Impfungen: similar chills, shaking, muscle aches, headache

VAERS 2679556

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: -
Alter: -
Geschlecht: U
Eingang: 06.09.2023
Impfdatum: 04.11.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain in extremity

Symptomtext

Sore arm with all 4; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm with all 4) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. The patient's past medical history included Breast cancer in October 2021. Concurrent medical conditions included Sulfonamide allergy (Sulfa), Drug allergy (Zofran) and Psoriatic arthritis. On 04-Nov-2022 at 12:00 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm with all 4). At the time of the report, PAIN IN EXTREMITY (Sore arm with all 4) outcome was unknown. Concomitant medication was not reported. Patient received monovalent doses of Moderna. Dose 1 on 28-Dec-2020; Batch/Lot No: 039K20A. Dose 2 on 29-Jan-2021; Batch/Lot No: 012L20A and Dose 3 on 02-Sep-2021; Batch/Lot No: 002F21A. Patient received unspecified drug from 14-AUG-2023 to 18-AUG-2023 for treatment of COVID-19. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-738998 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-738998:Monovalent case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (Zofran); Psoriatic arthritis; Sulfonamide allergy (Sulfa)
Vorgeschichte: Medical History/Concurrent Conditions: Breast cancer
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667146

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: CA
Alter: 77,0
Geschlecht: F
Eingang: 07.08.2023
Impfdatum: 28.07.2023
Beginn: 28.07.2023
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test normal Body temperature increased Chest X-ray normal Malaise Pain in extremity

Symptomtext

Patient states after the injection she had a sore arm and didn't feel well. Stated she can't remember the times it all happened. Stated she went to sleep. Stated her son in law came home from work at around 11:00 pm and woke her up. Stated she told him she didn't feel well, he took her temperature and that it was 102. He took her to the ER. Stated she had blood work and a chest x-ray in the ER and results negative. She was there for a few hours and they sent her home. Patient stated she feels fine now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: patient states she doesn't know what tests were done except she had blood work and a chest x-ray and results were fine
Aktuelle Erkrankungen: States she has had no illnesses prior to vaccine.
Vorgeschichte: States she has no chronic conditions other than high blood pressure and arthritis
Andere Medikamente: A BP med and states she can't remember the name. Arthritis medication states she can't remember the name. States she can t remember any of her medication names.
Allergien: states she has no known allergies
Vorherige Impfungen: states he only had a sore arm

VAERS 2760962

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: KY
Alter: 69,0
Geschlecht: F
Eingang: 07.06.2023
Impfdatum: 06.10.2022
Beginn: 19.12.2022
Tage bis Beginn: 74,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test normal Myalgia Osteoarthritis Pain in extremity Peripheral swelling Rheumatoid arthritis

Symptomtext

rheumatoid arthritis / severe pain in one of her arms; osteoarthritis / pain, the index finger on left had is also swollen.; Muscle pain; This spontaneous case was reported by a patient and describes the occurrence of RHEUMATOID ARTHRITIS (rheumatoid arthritis / severe pain in one of her arms) in a 69-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. The patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that patient had no family history of arthritis. The patient's past medical history included Influenza (She was very healthy and had influenza 30 years ago). Family history included Rheumatoid arthritis (Oldest brother has RA) since an unknown date. On 06-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Dec-2022, the patient experienced RHEUMATOID ARTHRITIS (rheumatoid arthritis / severe pain in one of her arms) (seriousness criterion medically significant), OSTEOARTHRITIS (osteoarthritis / pain, the index finger on left had is also swollen.) and MYALGIA (Muscle pain). At the time of the report, RHEUMATOID ARTHRITIS (rheumatoid arthritis / severe pain in one of her arms), OSTEOARTHRITIS (osteoarthritis / pain, the index finger on left had is also swollen.) and MYALGIA (Muscle pain) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: alright. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. From 19-Dec-2022, patient went to primary care doctor with severe pain in one of arms. Blood work taken there was alright. She was diagnosed with rheumatoid arthritis and osteoarthritis. In addition to that pain, the index finger on left had been also swollen. Pain comes and goes. Had an appointment with arthritis doctor this month. Patient thinks that rheumatoid arthritis might be hereditary. No treatment drug was reported. Company comment: This is a spontaneous case concerning a 69-years-old female patient, with no relevant medical history reported, who experienced the unexpected and serious (medically significant) event of rheumatoid arthritis (RA) (AESI) that occurred approximately 2,5 months after dose mRNA-1273.222 administration, which was 4th dose in COVID-19 vaccination schedule. The event was accompanied by non-serious events of osteoarthritis and myalgia. The patient was vaccinated with mRNA-1273 as primary series and 3rd dose of COVID-19 vaccination schedule; muscle pain observed afterwards. No further clinical information clinical course of the event, diagnostic work up, concurrent conditions and concomitant medications, differential diagnosis, treatment and outcome were provided for medical review. It was reported that there was family history of rheumatoid arthritis diagnosed in the patient's oldest brother. Based on the provided information it cannot be differentiated if this event represented an instance of reactive arthritis or rheumatoid arthritis itself. Outcome of rheumatoid arthritis was not recovered at the time of the report. The benefit-risk relationship of mRNA-1273.222 is not affected by this report. This case was linked to MOD-2023-722965 (Patient Link). Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 06-Jun-2023: Follow-up was received: Medical (family) history and narrative was updated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myalgia
Hospital-Tage: -
Labordaten: Test Name: Blood test; Result Unstructured Data: alright
Aktuelle Erkrankungen: Rheumatoid arthritis (Oldest brother has RA)
Vorgeschichte: Medical History/Concurrent Conditions: Influenza (She was very healthy and had influenza 30 years ago); Comments: The patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that patient had no family history of arthritis.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2632158

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148-B

mild

Staat: CA
Alter: 57,0
Geschlecht: F
Eingang: 15.05.2023
Impfdatum: 14.10.2022
Beginn: 18.03.2023
Tage bis Beginn: 155,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Headache Oropharyngeal pain Pain in extremity SARS-CoV-2 test positive

Symptomtext

I had my vaccination on 10/14/2022. On 03/18/2023 I had a really bad sore throat fatigue and headache. I tested COVID-19 Negative on 03/19/2023. On 03/22/2023 I was having extreme pain in both legs and I tested COVID-19 Positive. I contacted my physician on 03/22/2023 and they prescribed Paxlovid. I do feel better as of 05/15/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 03/22/2023 test COVID-19 Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: COVID-19 vaccination dose 4; headache and fatigue

VAERS 2626041

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: NV
Alter: 51,0
Geschlecht: M
Eingang: 03.05.2023
Impfdatum: 14.09.2022
Beginn: 01.02.2023
Tage bis Beginn: 140,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Blood test normal Gait inability Hypoaesthesia Musculoskeletal pain Pain Pain in extremity

Symptomtext

In February on night, I went to bed and when I woke up, I could not walk. It was the burning pain from my back all the way down my left leg to my foot. My foot was numb and stayed numb for about a week. I felt it mostly numb in my outside 3 toes. It was sharp pain and burning in my back and leg and buttock. It did not improve over time. I consulted with my doctor and received a steroid and TYLENOL. My pain got a little better but did not go away completely. As of today, I am not longer feeling pain from the sciatic nerve.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Back pain
Hospital-Tage: -
Labordaten: Blood panel, normal, 022023
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Cholesterol
Andere Medikamente: Rosuvastatin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2624685

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: OH
Alter: 75,0
Geschlecht: M
Eingang: 02.05.2023
Impfdatum: 28.10.2022
Beginn: 25.04.2023
Tage bis Beginn: 179,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Anosmia COVID-19 Cough Fatigue Influenza like illness Oropharyngeal pain Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I tested positive for COVID-19 on 4/25/23. I had congestion, cough, sore throat, body aches, fever of 100.5, fatigue, loss of taste and smell. I felt like I had the Flu. I contacted my doctor and was prescribed Paxlovid and Albuterol. I took an at home test 4/30/23 and was negative, but I am still having symptoms at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 25APR2023 COVID-19 Test - Positive; 25APR2023 Flu Test - Negative; 30APR2023 COVID-19 Test - Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma; Heart Disease; Arthritis
Andere Medikamente: Metformin; Montelukast; Losartan; Hydrochlorothiazide; Simvastatin; Metoprolol; Glipizide; Aspirin; Vitamin B12; Multivitamin; Breo-Ellipta; Probiotic
Allergien: N/A
Vorherige Impfungen: -

VAERS 2623165

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MD
Alter: 77,0
Geschlecht: M
Eingang: 28.04.2023
Impfdatum: 25.10.2022
Beginn: 13.03.2023
Tage bis Beginn: 139,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Fatigue Pyrexia SARS-CoV-2 test positive

Symptomtext

The first symptoms that I had were chills and a fever of 101 degrees. On the second day I had no fever, I tested positive that day as well. I developed cough and fatigue. Those symptoms stayed with me until 03/21/2023. The cough resolved to normal. The fatigue lasted through the 03/26/2023. I didn't take any medication for my symptoms. I did not seek medical care at all.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 14MAR2023 COVID-19 test, positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension
Andere Medikamente: DEXILANT; olmesartan; olmesartan HCT; metoprolol
Allergien: Aspirin
Vorherige Impfungen: -

VAERS 2621534

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: VA
Alter: 66,0
Geschlecht: F
Eingang: 26.04.2023
Impfdatum: 25.10.2022
Beginn: 20.04.2023
Tage bis Beginn: 177,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Burning sensation COVID-19 Cough Eye irritation Fatigue Pain Pruritus Pyrexia SARS-CoV-2 test positive Toothache

Symptomtext

I tested positive for COVID-19 on 4/20/23. I had burning and itching lungs, sore throat, burning eyes, fever, cough, body aches, fatigue, and painful teeth. I contacted my doctor and we talked about Paxlovid but decided not to take that. Instead, I took Mucinex, Vitamin C, Zinc, and Vitamin B Complex. I am feeling, but still testing positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 20APR2023 COVID-19 Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; High Cholesterol
Andere Medikamente: Lisinopril; Atorvastatin; Fish Oil; COQ10; Calcium; Vitamin D; Magnesium Citrate; Turmeric; Multivitamin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2619916

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CT
Alter: 75,0
Geschlecht: F
Eingang: 24.04.2023
Impfdatum: 19.09.2022
Beginn: 13.04.2023
Tage bis Beginn: 206,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Conjunctivitis Cough Fatigue Nasal congestion Nasopharyngitis Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I tested positive and felt fine. I had a sore throat and a stuffy nose and a cough. It felt like a bad cold. The following evening, I had a fever which lasted 12 hours. I also felt tired. Mostly the symptoms were sore throat and tired. My husband had COVID as well, he took Paxlovid and had a rebound. I did not take any medication other than Tylenol for the fever. I think we both might have COVID again. We both have pink eye as well. One week I test positive, and I felt fine, but then I have pink eye. I do still have a little cough but that is it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2617193

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 44,0
Geschlecht: F
Eingang: 18.04.2023
Impfdatum: 14.10.2022
Beginn: 10.04.2023
Tage bis Beginn: 178,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bronchitis COVID-19 Cough Headache Night sweats Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

On April 10, 2023, I had a slight cough but the next day it progressed, and I had a low-grade fever. I had a headache, and no pain reliever would help. Thursday, I had very mild body aches. I continued to cough. I had night sweats. I went to the clinic on the 13th and tested positive for COVID-19. When the doctor checked my lungs, she noted I had a bit of bronchitis. I was prescribed a Z-PAK.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID-19, lab test at doctor, positive, 04/13/2023.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma; Hypertension; Type 2 Diabetes; Obesity
Andere Medikamente: MOUNJARO; bisoprolol; aspirin; naproxen; PROAIR
Allergien: Ibuprofen; environmental; local
Vorherige Impfungen: -

VAERS 2612991

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: IL
Alter: 72,0
Geschlecht: M
Eingang: 11.04.2023
Impfdatum: 07.04.2022
Beginn: 22.03.2023
Tage bis Beginn: 349,0
Dosis: 5
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

Had cough and fever and sore throat starting night of March 19. Tested negative for Covid Mach 20 when fever and other symptoms appeared but tested positive March 22.. Began Paxlovid March 23,2023 following Virtual appointment March 22, 2023 with primary physician, DO. Did not take Atorvastin, per Dr. for 10 days after initiating Paxlovid for 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: At home Covid Test test showing positive to Covid 19 on March 22, 2023
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure; High Cholesterol
Andere Medikamente: Atorvasatin Calcium 5mg 1 x day; Losartan Potasium 100 mg 1 x day; Vitamin D 25 mcg; Omeprazole 20 mg; Naicin 500mg L-Arginine 500 mg
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2610739

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 66,0
Geschlecht: M
Eingang: 06.04.2023
Impfdatum: 21.09.2022
Beginn: 22.03.2023
Tage bis Beginn: 182,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Malaise Respiratory disorder SARS-CoV-2 test positive

Symptomtext

I was at an event at a cafe the weekend prior to getting sick. I started to have a slight cough and upper respiratory reactions. The next day it continued so I took a at home test, and it was positive. On the 23rd of January I had symptoms. I notified my doctor to setup a visit via telehealth, NP. They did not say I was a good fit for Paxlovid since my other medications. The prescribed Levario. I took that as directed. I did have some reactions to the antiviral; it included vomiting and abdominal distress. I am still testing postive and I still have a very slight cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma; Depression; Bipolar Disorder
Andere Medikamente: Albuterol; Brevoalipita; Spironolactone; Atorstatin; Singular; Losartan; Emlotapen; Sarquil; Pentopril; Nasal Spray; Flonase; One a Day Centrum Silver; Vitamin E
Allergien: Iodine Dye
Vorherige Impfungen: Moderna; 1st dose; Vomiting. 07/2021

VAERS 2610649

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: SC
Alter: 68,0
Geschlecht: F
Eingang: 06.04.2023
Impfdatum: 15.09.2022
Beginn: 28.12.2022
Tage bis Beginn: 104,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Decreased appetite Diarrhoea Feeling abnormal Gastrointestinal disorder Influenza Nasopharyngitis Nausea Pain Paranasal sinus hypersecretion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

The first day the symptoms were just nasal drainage, like turning on a faucet, it was just running. It felt like a cold but I took a COVID19 test the next day and it was positive. I called my PCP and he prescribed PAXLOVID and I started taking that the next day. Mostly I had head cold symptoms but I also got stomach symptoms that I think were COVID19, and those were the ones that lingered. I don't know if it was the PAXLOVID or COVID19 but I had loss of appetite, diarrhea, nausea, and just feeling poorly. The worst part of the PAXLOVID was the horrible taste in my mouth, which impacted what I wanted to eat too. I want to say I felt the worst on Saturday and Sunday, body aches and just kind of Flu-y. Once the head cold and flu symptoms went away the stomach problems lingered until the first week of January and that was it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: 2022Dec29 COVID19 rapid at home (positive); 2023Jan3 COVID19 rapid at home (negative)
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Magnesium; vitamin D; rosuvastatin; vitamin B12; omeprazole; amitriptyline ; zinc; montelukast; meloxicam; CLARITIN; IMITREX
Allergien: Codeine; dust; mold; grasses; pets
Vorherige Impfungen: -

VAERS 2610019

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MI
Alter: 69,0
Geschlecht: F
Eingang: 05.04.2023
Impfdatum: 04.10.2022
Beginn: 21.03.2023
Tage bis Beginn: 168,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Nasopharyngitis Respiratory tract congestion SARS-CoV-2 test positive Vomiting

Symptomtext

I woke up on March 21, 2023, feeling like I was coming down with a cold. I had a cough and was congested. The next day, the symptoms were getting worse. I took a COVID-19 test. The result was negative. On the March 23, 2023, I took another COVID-19 test. The result was positive. I called my doctor and told them I tested positive for COVID-19. I also told them I had been throwing up and couldn't hold down water. They prescribed anti-nausea medication and PAXLOVID. I started the anti-nausea medication right away and started the PAXLOVID late the next day. I took it for five days. Each day, my symptoms got a little better. They also told me to test my oxygen and to go to the hospital if it got too low.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vomiting
Hospital-Tage: -
Labordaten: 03/22/2023 COVID-19 test negative; 03/23/2023 COVID-19 test positive; 03/30/2023 COVID-19 test negative
Aktuelle Erkrankungen: None
Vorgeschichte: Chronic Idiopathic Urticaria
Andere Medikamente: Fexofenadine; fluticasone propionate; cranberry; calcium citrate plus vitamin D3; adult 50+ multivitamin; PEPCID; XOLAIR
Allergien: Seasonal; bananas; melons; kiwi
Vorherige Impfungen: -

VAERS 2607545

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MA
Alter: 65,0
Geschlecht: F
Eingang: 31.03.2023
Impfdatum: 29.09.2022
Beginn: 06.03.2023
Tage bis Beginn: 158,0
Dosis: 5
Route/Site: IM / LG

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Ageusia Anosmia Body temperature increased COVID-19 Exposure to SARS-CoV-2 Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

My husband had tested positive for COVID-19 two days before I did. I awoke on 03/06/2023 with the worse runny that I could not get to stop for a bit. I took a home COVID-19 test that came back positive, I called the COVID-19 hotline was prescribe Paxlovid. Started taking it that after, in five days I was testing negative. By day three I had a sore throat, took a home COVID-19 test and was positive again, I also had a temperature of 101F. I quarantined for a week, took another home COVID-19 test, this test came back negative. I had lost my sense of taste and smell. I am getting both sense of taste and smell back.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 06MAR2023 Home COVID-19 - positive; 10MAR2023 Home COVID-19 - negative; 10MAR2023 Home COVID-19 - negative; 13MAR2023 Home COVID-19 - positive; 20MAR2023 Home COVID-19 - negative
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Vitamin E; Fish Oil
Allergien: Penicillin
Vorherige Impfungen: Influenza, acute bursitis

VAERS 2607498

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: PA
Alter: 69,0
Geschlecht: M
Eingang: 31.03.2023
Impfdatum: 04.02.2023
Beginn: 04.02.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Chills Cough Fatigue Headache Malaise Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I had headache, cough, chest congestion, chills, fever, weakness, and fatigue. I contacted the doctor and was given Paxlovid which did help. I was sick for about three weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19
Aktuelle Erkrankungen: N/A
Vorgeschichte: Heart Attack 20 years ago; Heart Illness
Andere Medikamente: Simvastatin; Enalapril; Metoprolol
Allergien: Aspirin
Vorherige Impfungen: -

VAERS 2607474

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 51,0
Geschlecht: F
Eingang: 31.03.2023
Impfdatum: 23.09.2022
Beginn: 22.02.2023
Tage bis Beginn: 152,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Herpes zoster Rash Rash pruritic Scar

Symptomtext

I had a rash on my back about the size of a ping pong ball. At time it was itching, I thought it was a cluster of bug bites. It was itchy and it hurt, and I used the pain-relieving NEOSPORIN, and was treating it that way. It didn't go away. I went to the doctor, and they confirmed that I had Shingles. That was the vaccine I kept putting off, but in September they advised against it being all done at the same time. At the doctor's they gave a prescription for an antiviral it was a mild case. It ended being two spots on my back the other was the size of a half dollar. I was covering it on a gauze pads. It was right next to my bra strap being irritated and I was taking acetaminophen for the mild pain. It was as bad as I heard people described. I finished the prescriptions of valacyclovir HCL, and I scheduled in six months to get the vaccine. I feel fine now. It looks a scar on my back, but I feel recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Celiac Disease
Andere Medikamente: Fish oil; multivitamin; vitamin D
Allergien: Penicillin; sulfa drugs
Vorherige Impfungen: -

VAERS 2606808

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 65,0
Geschlecht: M
Eingang: 30.03.2023
Impfdatum: 28.09.2022
Beginn: 25.02.2023
Tage bis Beginn: 150,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Asthenia COVID-19 Chills Oropharyngeal pain Pain Respiratory tract congestion SARS-CoV-2 test positive Upper-airway cough syndrome

Symptomtext

I went to the doctor on February 26, 2023, and started taking PAXLOVID. I had postnasal drip, sore throat, congestion, and body aches. After a few days I experienced chills and an overly weakness. I was taking ibuprofen, so I don't know if I had a headache. I started taking MUCINEX to assist with the congestion and it seemed to help. Overall, my symptoms lasted six days. After seven days, I tested positive again. I had a rebound case and all I experienced was congestion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 25FEB2023 COVID-19 test, positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Arthritis
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2606761

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: AZ
Alter: 52,0
Geschlecht: F
Eingang: 30.03.2023
Impfdatum: 28.12.2022
Beginn: 08.02.2023
Tage bis Beginn: 42,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Oropharyngeal pain SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

I experienced a breakthrough case of COVID-19 with fatigue, cough, sore throat. I feel like having took the vaccine my symptoms were more mild than they would be without receiving the COVID-19 vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 08February2023 - COVID-19 Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma
Andere Medikamente: Famotidine; Pantoprazole; Adderall; Vitamin D3; Albuterol Sulfate; Vitamin C; Super Vitamin B Complex; Magnesium
Allergien: Erythromycin
Vorherige Impfungen: -

VAERS 2605956

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: OH
Alter: 43,0
Geschlecht: M
Eingang: 29.03.2023
Impfdatum: 23.09.2022
Beginn: 17.03.2023
Tage bis Beginn: 175,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Chills Fatigue Headache Pain Paranasal sinus inflammation Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I was feeling a lot of inflammation in my sinuses. I had a runny nose with fatigue and a slight headache. I had aches and pains and chills. I had a great loss of energy. This was the 17th so I called my doctor's office that same day. They told me to take TYLENOL and MUCINEX D. I am back to normal now, I started feeling better on the 24th.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 17MAR2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Ondancitron; lorazepam
Allergien: N/A
Vorherige Impfungen: -

VAERS 2605498

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: TX
Alter: 71,0
Geschlecht: F
Eingang: 28.03.2023
Impfdatum: 23.09.2022
Beginn: 09.03.2023
Tage bis Beginn: 167,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Pyrexia SARS-CoV-2 test positive

Symptomtext

I had severe fatigue, mild cough, and low grade fever. I tested positive for COVID-19 and called my doctor. She prescribed me Paxlovid and it made me feel worse. I still have fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 Test, Positive, 03/10/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Hyperlipidemia; Fibromyalgia; Insomnia; Hyperthyroidism Anemia; Gerd; Diverticulitis; Irritable bowel Syndrome; Obesity; History of GI bleed; History of Chronic Back Pain
Andere Medikamente: Gabapentin; Zolpidem; Almarstan; Atorvastatin; Metoprolol; Amlodipine; Duloxetine; Levothyroxine; D3; B12; Biotin; Calcium; Tylenol
Allergien: Codeine; Iodine; Abilify; Sulfa; Penicillin; Latex
Vorherige Impfungen: Hep B, 1986; Tetanus, 1980, Severe swelling, pain, and redness in vaccination site.

VAERS 2604132

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: KY
Alter: 74,0
Geschlecht: F
Eingang: 27.03.2023
Impfdatum: 24.09.2022
Beginn: 01.12.2022
Tage bis Beginn: 68,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal distension Blood test abnormal Diarrhoea Flatulence Gastrointestinal disorder Hepatic enzyme increased Laboratory test abnormal Magnetic resonance imaging normal Scan with contrast normal X-ray abnormal

Symptomtext

12/1/2022 I had loose bowels, bloating and gas. I had an appointment already with my PCP on 12/8/22. He told me maybe the gut bacteria were out of whack. I took a Probiotic for 30 days, but still had the problem, but was better. Then I had bowels that were like they were locked up. On 2/9/2023 I saw a GI doctor. She ordered a sitz marker test and labs. On 2/13/23 I went back for an x-ray to see if I had passed the markers and I had not passed any. I went back on 2/16/23 and had another x-ray and still had 8 markers let. The doctor ordered LINZESS and my liver enzymes were a little elevated with the bloodwork I had. I started taking the LINZESS. On 3/13/23 I had an appointment with my PCP and felt like the LINZESS was working. I had my routine bloodwork done. The next day they called and said my liver enzymes were extremely high. On 3/20/23 I saw my GI doctor. She ordered more bloodwork. Three different markers were high. She did an MRI with contrast on 3/23/23 which showed no liver mass or no problems. I have an abdominal ultrasound tomorrow. I also have a colonoscopy scheduled.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: 9FEB23- Bloodwork - Liver Enzymes elevated; 13FEB23- X-Ray for Sitz Marker- Had not passed any markers; 16FEB23- X-Ray for Sitz Markers- 8 markers left; 13MAR23-Bloodwork- Markers were extremely high; 23MAR23-MRI with Contrast- no liver problems and no mass.
Aktuelle Erkrankungen: None
Vorgeschichte: Hashimoto's Hypothyroidism, Sleep Apnea, Hereditary Hemochromatosis, GERD, Osteoporosis, Micro Valve leakage, Hearing Loss, Melanoma in the past
Andere Medikamente: Levothyroxine, Amlodipine, Atorvastatin, Estradiol, Meloxicam, Famotidine, Omeprazole, Atenolol , Fluoxetine, Melatonin, Biotin, Selenium, Baby Aspirin, Viactiv Calcium 2, Centrum Silver Multi Vitamin, Tylenol PM, Mega Red Krill Oil
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2601939

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 61,0
Geschlecht: F
Eingang: 22.03.2023
Impfdatum: 20.09.2022
Beginn: 24.12.2022
Tage bis Beginn: 95,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Fatigue Malaise Oropharyngeal pain Pain Pain in extremity Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Sinus congestion

Symptomtext

On 12/24/2022, I began to feel sicker and sicker. I had a sore throat and felt feverish. I had been testing myself with home antigen tests, because my husband had tested positive on 12/20/2022. I took another test on 12/24/2022, and the result was negative. On 12/25/2022, I tested positive. I contacted my medical provider, and I was prescribed Paxlovid, a cough medicine, and an albuterol inhaler. I started taking the Paxlovid and began feeling better pretty quickly. I had a fever for about three days, but I gradually got better. Around 1/1/2023, I tested negative on a home antigen test. I then felt like I was coming down with a sore throat, and then I tested positive again. This time, I had major sinus congestion and a fever. I also had body aches and tiredness, but the main symptom was the head congestion. I contacted my doctor, because I thought I had a sinus infection. My doctor told me I didn't have an infection and that it was just a rebound, but she did prescribe me an antibiotic. I felt sick for about five or six days, and I felt a bit worse than I did during the first round. It then took another five days or so afterwards before I tested negative again. During my second round of COVID-19, I developed soreness in my right foot. It's on the lateral side of the foot under the ankle bone. The pain is intermittent, but ever since I had COVID-19, I have continued to have issues with it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 24DEC2022 - Home Antigen Test - Negative Result; 25DEC2022 - Home Antigen Test - Positive Result; 01JAN2023 - Home Antigen Test - Negative Result; JAN2023 - Home Antigen Test - Positive Result; JAN2023 - Home Antigen Test - Negative Result
Aktuelle Erkrankungen: None
Vorgeschichte: Inflammatory Polyarthritis; Thyroid Nodules; Migraines
Andere Medikamente: Estrogen Vaginal Cream
Allergien: Radiographic Dye (Anaphylactic Reaction); Clindamycin; Possibly Amoxicillin; Grass Pollen; Onion (Mild Allergy)
Vorherige Impfungen: The last time I had a tetanus shot, I had a delayed rash at the injection site.

VAERS 2601888

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 68,0
Geschlecht: F
Eingang: 22.03.2023
Impfdatum: 13.09.2022
Beginn: 17.03.2023
Tage bis Beginn: 185,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Body temperature increased COVID-19 Chills Cough SARS-CoV-2 test positive

Symptomtext

I first noticed a cough and was hoping it was just a cough. It kind of got worse or worse. By the next day I was getting chills and my temperature was 100.5 degrees. I did a COVID-19 At Home Test and it was positive. I contacted a place called clinic and they asked a lot of questions about symptoms and my test and my health information. She called some Paxlovid for me.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 17/JAN/2023 COVID-19 At Home Test- Positive; 22/MAR/2023 COVID-19 At Home Test - Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Comb Estrogen Patch; Vitamin D; Lexapro
Allergien: Sulfa; Seafood; Fish
Vorherige Impfungen: -

VAERS 2601883

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: OR
Alter: 72,0
Geschlecht: F
Eingang: 22.03.2023
Impfdatum: 16.09.2022
Beginn: 15.03.2023
Tage bis Beginn: 180,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Exposure to SARS-CoV-2 Headache Malaise Nasal congestion Oropharyngeal pain Pain SARS-CoV-2 test negative

Symptomtext

On 3/14/2023, my husband tested positive for COVID-19, and I tested negative. On 3/15/2023, I took a home antigen test and got a second negative result. I began having symptoms on 3/16/2023. I had a sore throat, a little bit of a headache, body aches, and nasal congestion. I called my doctor, who had already prescribed PAXLOVID to my husband two days before. Even though I had gotten a negative result on the antigen test, he also prescribed me PAXLOVID, which I began taking the evening of 3/16/2023. Before I could begin taking it, though, I had to go to the clinic to be examined prior to my getting the prescription. For the first couple of days, I still had some COVID-19 symptoms. By the third or fourth day, I was doing fine. At the time of this writing, I still feel fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 14MAR2023 home antigen test, negative result; 15MAR2023 home antigen test, negative result
Aktuelle Erkrankungen: None
Vorgeschichte: History of Thyroid Cancer and Removal; History of Bladder Cancer and Removal of Right Kidney; History of Bladder Cancer Metastasis in Upper Left Lobe of Lung and Removal; Cancer Currently in Remission
Andere Medikamente: Levothyroxine; sertraline; estradiol cream; multivitamin; EPA/DHA; coQ10; berberine; vitamin D3; SHILAJIT; mushroom powder mixture; lion's mane mushroom tonic
Allergien: Sulfa drugs; latex; chlorhexidine
Vorherige Impfungen: -

VAERS 2601836

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MN
Alter: 64,0
Geschlecht: F
Eingang: 22.03.2023
Impfdatum: 20.09.2022
Beginn: 11.02.2023
Tage bis Beginn: 144,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Decreased appetite Diarrhoea Fatigue Headache Oropharyngeal pain Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Secretion discharge Sinus disorder Sneezing Vomiting

Symptomtext

I started out with a sore throat and it felt like my head was stuffed up. It was like a headache feeling. It wasn't terrible at first but it did worsen over time. I did end up with a really runny nose, mucus, and had a low grade fever for about 4-5 days. Anywhere from 99 to 100.4. I didn't lose my sense of taste and smell, but I did lose my appetite. Food didn't sound good to me at the time. I was tired and coughing. I had a lot of sneezing. I called my doctor and she prescribed PAXLOVID. I did take that for the entire course. The first couple of days I had vomiting and some diarrhea but I did keep taking it. I also took regular TYLENOL and MUCINEX D. I did use some nasal spray as well for the symptoms. I continued to have sinus and head symptoms through to March. Sometime around 03/13 was when I started to feel better. I did see my doctor on 03/08, but we did also talk about the COVID-19 infection. I was prescribed doxycycline due to a possible secondary infection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: 12FEB2023 at home COVID-19 test positive; 28FEB2023 at home COVID-19 test positive; 05MAR2023 at home COVID-19 test positive; 06MAR2023 at home COVID-19 test negative; 07MAR2023 at home COVID-19 test positive; 08MAR2023 at home COVID-19 test negative; 10MAR2023 at home COVID-19 test negative
Aktuelle Erkrankungen: Tooth infection
Vorgeschichte: Hyperthyroidism; History of Diverticulitis (Multiple Cases); Sleep Apnea; History of Cancer (20 years ago)
Andere Medikamente: Levothyroxine; calcium; vitamin D; probiotic; ZYRTEC
Allergien: Amoxicillin; intolerance to dairy products; environmental allergies; AUGMENTIN
Vorherige Impfungen: -

VAERS 2601827

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MI
Alter: 82,0
Geschlecht: F
Eingang: 22.03.2023
Impfdatum: 20.09.2022
Beginn: 19.02.2023
Tage bis Beginn: 152,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Brain fog COVID-19 Dysgeusia Fatigue Malaise Nasopharyngitis Paranasal sinus hypersecretion Parosmia Productive cough SARS-CoV-2 test positive

Symptomtext

Started feeling like I got a cold, and on 2/24 that Friday I had a very strong chemical, like bleach or ammonia, taste and smell. It was afterhours when I tested positive on at home COVID-19 test. I went to ER as it was after hours. ER doctor proscribed PAXLOVID. Pharmacy consulted with ER doctor and got a slightly lower dose of PAXLOVID due to concerns about liver function. Experienced metallic taste while taking PAXLOVID. Productive cough with sinus drainage slowly cleared up. This took about 7 days for those to clear up, though fatigue and brain fog lingers at time of reporting.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 24Feb2023 at home COVID-19 test, positive
Aktuelle Erkrankungen: No
Vorgeschichte: Sinus Bradycardia
Andere Medikamente: LIPITOR; menbutone; latanoprost; SYNTHROID; losartan; vitamin B12, D3, C; cinnamon capsule
Allergien: PAXIL; FOSAMAX
Vorherige Impfungen: -

VAERS 2601753

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: IL
Alter: 67,0
Geschlecht: M
Eingang: 22.03.2023
Impfdatum: 20.09.2022
Beginn: 13.02.2023
Tage bis Beginn: 146,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Arthralgia COVID-19 Headache Pain Paranasal sinus hypersecretion Pyrexia SARS-CoV-2 test positive

Symptomtext

Monday I woke up with a bad headache and that lasted for 2 and a half days. I had body aches all over especially in the joints. I also had sinus drainage. I had a fever as well and that lasted into Tuesday. I went into the clinic Monday morning after taking 2 at home COVID-19 tests. I immediately went to the urgent care and I was sick for about 2 and a half days. They confirmed it was COVID-19 at urgent care as well. I was prescribed LAGEVRIO (molnupiravir) 200 mg and I took 4 of them twice daily for 5 days. Shortly after I took my first dosage, within 4-6 hours I felt like I was improving. I started getting better from there. My best guess of where I got it could have been from my local gym.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: 13FEB2023 at home COVID-19 test positive; 13FEB2023 at home COVID-19 test positive; 13FEB2023 rapid COVID-19 test positive
Aktuelle Erkrankungen: None
Vorgeschichte: Type 2 Diabetes; Hypertension; History of Large Prostate (Operated on)
Andere Medikamente: Multivitamin
Allergien: None
Vorherige Impfungen: 2nd Moderna COVID-19 vaccine, mild cold like symptoms for a day after vaccination

VAERS 2600189

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: OH
Alter: 37,0
Geschlecht: F
Eingang: 21.03.2023
Impfdatum: 15.09.2022
Beginn: 29.01.2023
Tage bis Beginn: 136,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Headache Infection Influenza virus test Injection site pain Paranasal sinus discomfort Pyrexia Respiratory syncytial virus test SARS-CoV-2 test positive Sinus pain

Symptomtext

I had a breakthrough case of Covid with sinus pressure and congestion, fever and headache with some soreness at injection site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: PCR test for Flu, Covid-19 and RSV.
Aktuelle Erkrankungen: None
Vorgeschichte: No
Andere Medikamente: Womens Nulti-Vitamin
Allergien: Oxycodone
Vorherige Impfungen: -

VAERS 2600144

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: SC
Alter: 72,0
Geschlecht: F
Eingang: 21.03.2023
Impfdatum: 16.09.2022
Beginn: 25.12.2022
Tage bis Beginn: 100,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Oropharyngeal pain SARS-CoV-2 test

Symptomtext

I got COVID-19, it started with a sore throat, and cough. I was very fatigued. I reached out to a doctor on 12/26.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19
Aktuelle Erkrankungen: N/A
Vorgeschichte: Arthritis
Andere Medikamente: Pantoprazole; VESICARE; cyclobenzaprine; CELEBREX; TYLENOL
Allergien: N/A
Vorherige Impfungen: -

VAERS 2599876

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: VA
Alter: 73,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 15.09.2022
Beginn: 13.02.2023
Tage bis Beginn: 151,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Arthritis Gait disturbance

Symptomtext

My right knee became very sore and it was difficult for me to walk on about February 13, 2023. I visited my doctor about 2 weeks later. My doctor told me it was arthritis. I was given a anti inflammatory shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: COVID-19 2-3 weeks before booster
Vorgeschichte: Benign familial tremor; Glaucoma; Hypoglycemia; Macular Degeneration; Osteoporosis; Sleep Apnea
Andere Medikamente: OSPHENA; propranolol; PROLIA; B complex; black cohosh; brewer's yeast; calcium citrate; lysine; focus AREDS2; magnesium; chromium picolinate; omega 3 fish oil; vitamin C; vitamin D3; zinc picolinate
Allergien: N/A
Vorherige Impfungen: -

VAERS 2599873

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CO
Alter: 54,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 17.09.2022
Beginn: 21.02.2023
Tage bis Beginn: 157,0
Dosis: 4
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Anosmia Asthenia Brain fog COVID-19 Chest X-ray normal Chills Cough Dizziness Electrocardiogram normal Headache Hypoaesthesia Oropharyngeal pain Oxygen saturation decreased Pyrexia SARS-CoV-2 test positive

Symptomtext

I had a sore throat, a little cough, fever, headache, chills that lasted for 2 days, weakness, brain fog for 2 and a half weeks, low oxygen, loss of smell, and loss some of my taste. I tested positive for COVID-19. I talked to my doctor about my symptoms, and she said I was not qualified for PAXLOVID. A few days after my positive test, I felt so weak, and I felt like I was about to pass out. My hands and feet started feeling numb. I could barely pick up the phone to call my doctor. When the ambulance came they gave me fluids and by the time I got to the hospital, I started to feel better. They did an EKG, lung x-ray, monitoring blood pressure, and oxygen. Everything seemed to be normal. I still have a touch of brain fog.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 test, 02/22/2023, positive, EKG, Lung X-ray, monitoring blood pressure, oxygen, 02/24/2023, normal
Aktuelle Erkrankungen: N/A
Vorgeschichte: Factor V Leiden
Andere Medikamente: Multivitamin
Allergien: Beets
Vorherige Impfungen: -

VAERS 2599664

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: FL
Alter: 59,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 14.09.2022
Beginn: 13.03.2023
Tage bis Beginn: 180,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Diarrhoea Fatigue Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

That evening I was exhausted, fever peaking at 103, chills, body aches, congestion and developed a cough later that evening. Went to doctor., Gave me an IV with fever and pain meds. Fever, chills and body aches lasted 3 days. Bad diarrhea 1 day. Symptoms subsided on days 4 and 5 with no fever, and body aches gone. fatigue and cough lingered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 13Feb2023 Rapid and PCR tests positive
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma; Painful Bladder Syndrome; Gurd; Gastritis; Haydal Hernia; High Blood Pressure; High Cholesterol
Andere Medikamente: Zyrtec; Atenolol; Nexium; Lisinopril; Estrodil; Vitamin B6; Lipitor; Co Qu 10; Caltraite; Uro-MP; Valium; Magnisium; Advair
Allergien: Sulfa; Cephalosporin; Tetracycline; Doxycycline; Bactrim; Percocet; Eremomycin
Vorherige Impfungen: -

VAERS 2599651

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: CA
Alter: 72,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 17.09.2022
Beginn: 04.03.2023
Tage bis Beginn: 168,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Hypersomnia Pain Pyrexia Sinus congestion

Symptomtext

I had chills and a fever and sinus congestion, and my body hurt and slept for 24 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Clopidogrel; Lisinopril; carvedilol;
Allergien: None
Vorherige Impfungen: -

VAERS 2599514

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: TN
Alter: 67,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 17.09.2022
Beginn: 14.02.2023
Tage bis Beginn: 150,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Feeling abnormal Hypersomnia Influenza virus test negative Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

On 02/14/2023, I felt fine in the morning. I had a runny nose, but nothing more than that. Around 02:30PM, I began feeling feverish. I was able to get into a local clinic by around 05:30PM. I was tested for flu and COVID-19 and was positive for COVID-19. They prescribed Paxlovid. My fever got up to around 102 degrees. I had extreme fatigue and would sleep any time I closed my eyes. They runny nose persisted for a few days. By the third day, I was still fatigued, but was feeling better. I developed a cough in my upper chest which lasted around a day. For around five days, I felt dull. I self-isolated for five days and wore a mask when I went out for four or five more days after that.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 14FEB2023 - Flu Test - Negative; COVID-19 Test - Positive
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure; High Triglycerides; Prediabetes
Andere Medikamente: Losartan; Azelaic Acid Gel; Turmeric; Magnesium; Vitamin D3; Combigan; Ozempic
Allergien: None
Vorherige Impfungen: -

VAERS 2599478

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: TN
Alter: 68,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 17.09.2022
Beginn: 10.10.2022
Tage bis Beginn: 23,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthritis Gingival pain Headache Hepatic enzyme increased Hepatic steatosis Laboratory test normal Magnetic resonance imaging abnormal Noninfective gingivitis Pain Spinal stenosis Ultrasound abdomen abnormal

Symptomtext

10/10/2022 I saw my PCP because I was having pain all over my body. She did a lot of tests which were normal and referred me to a Rheumatologist which I saw on 10/31/2022. All tests came back negative, except bloodwork which showed liver enzymes were elevated. On 11/30/22 I was sent to an outpatient facility to have an ultrasound done on my liver. The only thing they said was I had fatty liver. On 12/1/2022 I had a follow up visit with my PCP. During that time, I continue to have headaches from my previous vaccine which I reported. I saw a Chiropractor for this traveling pain. He was unable to find anything. I went back to my PCP who ordered physical therapy which made it worse. I then had an MRI; nothing was found that was an emergency. I did have arthritis and stenosis of the spine. Next week I will have a spinal epidural with an Orthopedist who specializes in spine. If needed, I will be referred to a spine surgeon. On top of all this, I had a dental appointment today because I have some soreness in my gums which I have never had before. Antibiotic powder was injected into my gums. The dentist is not sure if it will work. The only thing they found was inflamed gums. I have a follow up in two weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Gingival pain
Hospital-Tage: -
Labordaten: Bloodwork, Liver enzymes were elevated; Ultrasound of liver, fatty liver; MRI of back, normal
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Olmesartan; chlorthalidone, AJOVY injection
Allergien: Codeine
Vorherige Impfungen: 3rd Moderna vaccine on 11/02/2021, headaches

VAERS 2598789

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: GA
Alter: 73,0
Geschlecht: M
Eingang: 17.03.2023
Impfdatum: 18.09.2022
Beginn: 20.10.2022
Tage bis Beginn: 32,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chromaturia Fatigue Immunology test abnormal Linear IgA disease Oxygen saturation decreased Rash Rash vesicular

Symptomtext

I broke out in a blistering rash on both buttocks, both hands, and both arms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: I was diagnosed with linear immunoglobulin A bullous dermatosis (LABD) on November 21, 2022 by Dermatology Dr., via direct immunofluorescence testing. I visited Dr. on February 14, 2023. He reduced my dapsone dosage from 50mg/day to 25mg//day. Due to low blood oxygen saturation, tiredness, and dark urine he put me on 25mg dapsone every other day. Dr. indicated I will be on dapsone therapy for one year.
Aktuelle Erkrankungen: Type 2 diabetes
Vorgeschichte: Type 2 diabetes since 2003
Andere Medikamente: Levemir, Novolog, Lipitor
Allergien: None
Vorherige Impfungen: -

VAERS 2598609

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: OH
Alter: 66,0
Geschlecht: M
Eingang: 17.03.2023
Impfdatum: 14.09.2022
Beginn: 10.02.2023
Tage bis Beginn: 149,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Fatigue Pyrexia SARS-CoV-2 test positive

Symptomtext

When I first had it, I have a fever of 101F, body chills, and fatigue early morning on 02/10/2023. I took an at-home COVID-19 on 02/11/2023 which came back positive. I called my doctor's office telehealth line and informed them about my positive test; they mentioned since I was diabetic, it was best to take Paxlovid. The fever went away after the first day of the prescription. I had intense fatigue for a couple of weeks after taking Paxlovid. Since then, I'm feeling just fine and recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 11FEB2023 -- COVID-19 Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes Retinotopy; Diabetes Macular Edema
Andere Medikamente: Metformin; Lisinopril; Januvia; Atorvastatin; Trazadone; Sildenafil; Jardiance; Daily Multivitamin; Loratadine; Baby Aspirin; Fish Oil
Allergien: Seasonal Allergies
Vorherige Impfungen: -

VAERS 2598600

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: IL
Alter: 52,0
Geschlecht: M
Eingang: 17.03.2023
Impfdatum: 01.09.2022
Beginn: 01.03.2023
Tage bis Beginn: 181,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diarrhoea Hypersensitivity SARS-CoV-2 test negative Stool analysis normal

Symptomtext

My adverse event started on 03/01/2023 in the afternoon. I had diarrhea for 2 weeks. On 03/15/2023 I went to the clinic. They did a number of stool test to see if there were pathogens present. The results were all negative. I am drinking plenty of water to hydrate myself but they haven't prescribe me any medication. It is still ongoing. I am waiting for my doctor to respond me back. 2 years ago I had the same problem, it turned out that I had an allergic reaction to medication.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: 17MAR2023 COVID-19 test negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Liver Condition; Pre-Diabetic; Severe Migraines; High Blood Pressure; High Cholesterol
Andere Medikamente: Vitamin E; omeprazole; lisinopril; atorvastatin; CLARITIN; ZYRTEC; fish oil; multivitamins; calcium; vitamin D
Allergien: N/A
Vorherige Impfungen: -

VAERS 2597725

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 59,0
Geschlecht: M
Eingang: 16.03.2023
Impfdatum: 14.09.2022
Beginn: 10.02.2023
Tage bis Beginn: 149,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Oropharyngeal pain Sinus congestion

Symptomtext

It started with a mild sore throat then heavy sinus congestion. It last about 3-4 days before I started feeling better then it got worst and happened about 3 times in the span of 4 weeks. I saw a doctor on March 6th, I was prescribed an antibiotic azithromycin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure; Acid reflux; Asthma
Andere Medikamente: Losartan; atorvastatin; montelukast; omeprazole; vitamin D; st john's wort; saw palmetto
Allergien: Dairy products; seasonal allergies
Vorherige Impfungen: -

VAERS 2597106

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 82,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 13.09.2022
Beginn: 28.01.2023
Tage bis Beginn: 137,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

My symptoms were a lot of coughing, body aches, and low-grade fever. These symptoms lasted for several days. I tested positive for COVID-19 on March 1, 2023. I spoke with the doctor on day 3 of my symptoms and received PAXLOVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: COVID-19 home, positive, 03/01/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Glaucoma; Hypothyroidism; Asthma
Andere Medikamente: Levothyroxine; ELIQUIS; eye drops; albuterol inhaler; SPIRIVA; WIXELA; ARED; krill oil; TYLENOL; CYMBALTA
Allergien: Latex; bananas; sweet potatoes
Vorherige Impfungen: -

VAERS 2597099

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: VA
Alter: 69,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 13.09.2022
Beginn: 06.10.2022
Tage bis Beginn: 23,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Blood cholesterol increased Blood pressure increased Blood test abnormal Chills Headache Peripheral coldness Pyrexia

Symptomtext

After my shot I got a fever of 101, and chills. My hands and feet felt like ice, and I was having headaches. It lasted about 24 hours. I had a physical on and my doctor noticed increase in my levels. I have recently been experiencing spikes in my cholesterol counts and blood pressure. She had me come for testing on March 10, 2023. The blood pressure is higher than ever before. I have been ordered a CT Cardio Scoring Scan, to see if I have plaque buildup. I am scheduled for this on March 16, 2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 10MAR2023 Blood testing abnormal
Aktuelle Erkrankungen: N/A
Vorgeschichte: Glaucoma; High Blood Pressure
Andere Medikamente: Lisinopril; aspirin; probiotic; prebiotic; calcium; fiber; CLARITIN
Allergien: COMPAZINE; Hay fever
Vorherige Impfungen: -

VAERS 2597014

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: SC
Alter: 76,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 13.09.2022
Beginn: 24.12.2022
Tage bis Beginn: 102,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Malaise Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I tested positive for COVID-19 on 12/24/22. I had fatigue, runny nose, cough, sore throat, and not feeling well in general. This lasted for about 5 days. I was not prescribed medication because I am on Dialysis, and I am unable to take PAXLOVID. I am feeling much better now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 24DEC2022 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: No Kidneys
Andere Medikamente: NEXIUM; gabapentin; sevelamer; calcitriol; DIALYVITE; probiotic
Allergien: NEOSPORIN
Vorherige Impfungen: -

VAERS 2597009

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: PA
Alter: 68,0
Geschlecht: M
Eingang: 15.03.2023
Impfdatum: 12.09.2022
Beginn: 09.03.2023
Tage bis Beginn: 178,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Oropharyngeal pain SARS-CoV-2 test positive Throat irritation

Symptomtext

I did not have an adverse reaction to the vaccine. I started feeling a sore and scratchy throat on 03/09/2023. I tested positive for COVID-19 on 03/10/2023. I contacted my doctor and got a prescription PAXLOVID and FLONASE. The doctor wanted me to wait to use FLONASE until I completed PAXLOVID. I had a little bout of diarrhea while taking the medication and the awful after taste. As of today, I still have a cough in the morning.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 10MAR2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Coronary Artery Disease
Andere Medikamente: Levothyroxine; LIPITOR; FLOMAX; lisinopril; PLAVIX
Allergien: N/A
Vorherige Impfungen: -

VAERS 2596487

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: NJ
Alter: 43,0
Geschlecht: F
Eingang: 14.03.2023
Impfdatum: 09.09.2022
Beginn: 09.02.2023
Tage bis Beginn: 153,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Fatigue Headache Nasal congestion Oropharyngeal pain Pain SARS-CoV-2 test positive

Symptomtext

My COVID-19 symptoms started on 02/09/2023 around 02:00am in the morning. It started with chills then through out the day I had cough, sore throat, body aches, fatigue, headaches, and nasal congestion. In the same morning I took a COVID-19 at 2;00am which was negative. I took another COVID-19 home test on 02/10/2023 at 07:00am which was positive. At 9:00am -10:00am I went to the clinic they did rapid test which was positive. They didn't prescribe me since I wasn't at the risk. I took over the counter medications such as Ibuprofen, Nyquil and Dayquil, Sudafed, Allegra as per needed. On 02/21/2023 I tested negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 10FEB2023 COVID-19 Test-Positive; 10FEB2023 RAPID Test- Positive; 21FEB2023 COVID-19 Test- Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypo Thyroid
Andere Medikamente: Levothyroxine; Probiotics; Restasis
Allergien: Bactrim
Vorherige Impfungen: -

VAERS 2596153

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge AS7148B

mild

Staat: VA
Alter: 71,0
Geschlecht: M
Eingang: 14.03.2023
Impfdatum: 10.09.2022
Beginn: 11.03.2023
Tage bis Beginn: 182,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chills Cough Feeling abnormal Feeling cold Nasal congestion SARS-CoV-2 test positive

Symptomtext

3/11/23 I started coughing a little bit and it just felt like allergies. That night I had cold chills. The next morning, I had a temperature above 100 degrees. I took an at home COVID test that was negative. On 3/13/23, because I knew I was not feeling right, I went to the urgent care and tested positive for COVID. I felt like I had been run over by a Mack truck. I was prescribed PAXLOVID. I wanted to be considered for the molnupiravir, but discouraged it because they said PAXLOVID would work better. I am three days into taking the PAXLOVID. My temperature has gone to normal, I still have a lot of nasal congestion. I am recovering.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Flu test, negative, at home COVID test was negative; COVID PCR test was positive
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: CENTRUM men's 50 plus multivitamin; low dose aspirin; calcium magnesium zinc supplement; NP thyroid supplement; ZYRTEC; VYTORIN; carvedilol; hydrochloride; vitamin B complex; stool softener; olopatadine; latanoprost eye drops; BENEFIBER; t
Allergien: None
Vorherige Impfungen: -

VAERS 2595607

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: VT
Alter: 76,0
Geschlecht: F
Eingang: 13.03.2023
Impfdatum: 08.09.2022
Beginn: 31.01.2023
Tage bis Beginn: 145,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Malaise Nasal congestion SARS-CoV-2 test positive

Symptomtext

I was positive for COVID-19 on 31JAN2023, I was very tired and fatigued. I was prescribed PAXLOVID, then I started to feel sick few days after like I had a rebound. I was really stuffed up with my sinuses for 3 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 31JAN2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: ARMOUR THYROID; fish oil vitamins; magnesium; calcium; folic acid
Allergien: Gluten; casein
Vorherige Impfungen: -

VAERS 2594799

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: GA
Alter: 74,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 08.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 7,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose abnormal Blood test Erythema Erythema of eyelid Eyelids pruritus Pruritus Rash Swelling face Swelling of eyelid

Symptomtext

My eyelids were itching and became swollen and red then it went all around my eyes, I used cream to try and help and CERAVE to help or moisturize plus some steroid ointment about a month later. Most recently or back in November I got alclometasone dipropionate it helped some. In January my entire face was swollen red and itchy and I was prescribed DUPIXENT on 13FEB2023, I had an initial dose but still had problems all over my face, on 20FEB2023 fluconazole was prescribed. On 23FEB2023 I quit taking the niacin I had been taking for years. 27FEB2023 I saw my Dermatologist again and she asked me to stop DUPIXENT and prescribed SOTYKTU tablets and the redness is gone and rash is very minimal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Eyelids pruritus
Hospital-Tage: -
Labordaten: Blood profile results were in normal range, except my sugar.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension
Andere Medikamente: Niacin ER; famotidine; amlodipine
Allergien: NEOSPORIN; meloxicam
Vorherige Impfungen: -

VAERS 2593976

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: GA
Alter: 76,0
Geschlecht: M
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 01.02.2023
Tage bis Beginn: 147,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Brain fog COVID-19 Cough Fatigue Headache Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I started coughing. I had a recurrent dry cough, headache, fatigue and developed a brain fog. I took the COVID-19 test on February 01, 2023, and was positive. I was given molnupiravir for 5 days as well as benzonatate. It took 7 to 8 days to feel better. I used NASACORT allergy spray and DELSYM cough and congestion to treat the symptoms. My nose was also running. I still have some brain fog but I am getting everything back.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 home test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Coronary Artery Disease-Bypass Surgery 2008
Andere Medikamente: RANEXA; metoprolol; simvastatin; tamsulosin; omeprazole; baby aspirin; isosorbide; vitamin D; multivitamin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2579608

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MI
Alter: 92,0
Geschlecht: F
Eingang: 10.02.2023
Impfdatum: 10.11.2022
Beginn: 15.01.2023
Tage bis Beginn: 66,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Dizziness SARS-CoV-2 test positive

Symptomtext

01/15/23 presents to ED for "lightheadedness". PMHx "HLD, overactive bladder"

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: 01/15/23 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2569368

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MI
Alter: 50,0
Geschlecht: F
Eingang: 27.01.2023
Impfdatum: 30.09.2022
Beginn: 07.10.2022
Tage bis Beginn: 7,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site bruising Injection site discolouration Injection site erythema Injection site indentation Injection site pruritus Ultrasound scan

Symptomtext

Within one week, noted injection site to be bright red with subsequent bruising to area after a few days. The bruising has decreased, but discoloration remains at site as does an indentation at injection site. The site has been itchy since vaccine given. Notes she did receive a covid vaccine at outside pharmacy in same arm in May 2022. The indentation, discoloration and itching was not evident until after the 9/30/2022 vaccine. She was seen by PCP this week and ultrasound to site ordered for today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site bruising
Hospital-Tage: -
Labordaten: Ultrasound right arm to be done 1/27/2023
Aktuelle Erkrankungen: none
Vorgeschichte: Lichen Planus
Andere Medikamente: -
Allergien: sulfa, adhesive tape
Vorherige Impfungen: -

VAERS 2567701

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 65,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 25.10.2022
Beginn: 07.01.2023
Tage bis Beginn: 74,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Diarrhoea Fatigue Pain SARS-CoV-2 test positive Throat irritation

Symptomtext

I had vaccination on 10/25/2022. On 01/07/2023 I started to experience fatigue, cough, body aches, scratchy throat and diarrhea. I tested COVID-19 positive on 01/08/2023. My doctor prescribed PAXLOVID. I am feeling presently fine on 01/25/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: COVID-19 01/08/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Atopic Dermatitis; Migraines
Andere Medikamente: Atorvastatin; vitamin D3; multivitamin; zinc; DUPIXENT; magnesium glycinate
Allergien: Sulfa; penicillin; bee stings
Vorherige Impfungen: -

VAERS 2557637

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 68,0
Geschlecht: F
Eingang: 11.01.2023
Impfdatum: 19.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Neuralgia Vaccine positive rechallenge

Symptomtext

Starting 09/21/2022, the nerve pain returned more quickly than the last dose and the fatigue returned. I did not have flu like symptoms or dizziness. I still have the nerve pain to this day. I see a rheumatologist for arthritis and I will be having an MRI of the neck and spine to make sure nothing structural is causing the nerve pain. The fatigue did not last as long as the previous dose, but the nerve pain is more intense and is still ongoing. I'm taking TYLENOL arthritis and MOTRIN twice daily for the pain which only sometimes helps.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: MRI of the neck and spine: to be done this Friday (01/13/23)
Aktuelle Erkrankungen: None
Vorgeschichte: Hashimoto's Thyroiditis
Andere Medikamente: SYNTHROID; vitamin D every other week; clonidine; ZYRTEC
Allergien: Sulfa; meloxicam
Vorherige Impfungen: 2nd, 3rd and 4th dose of Moderna: Fatigue and Nerve pain that progressively worsened with each dose

VAERS 2555040

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: -
Alter: 98,0
Geschlecht: F
Eingang: 10.01.2023
Impfdatum: 02.12.2022
Beginn: 01.12.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pruritus Rash

Symptomtext

he started having a lot of itching on her back. The itching then randomly appeared on other places on the body.; 4 Weeks later a rash appeared on her body.; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (he started having a lot of itching on her back. The itching then randomly appeared on other places on the body.) and RASH (4 Weeks later a rash appeared on her body.) in a 98-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (First Dose Lot:012M20A & Exp. Date: unknown) on 18-Feb-2021, Moderna COVID-19 Vaccine (Second dose Lot: 014M20A & Exp. Date: unknown) on 18-Mar-2021 and Moderna COVID-19 Vaccine (First Monovalent Booster dose Lot: 035121A & Exp. Date unknown) on 22-Nov-2021. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine. On 02-Dec-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Dec-2022, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced PRURITUS (he started having a lot of itching on her back. The itching then randomly appeared on other places on the body.). In December 2022, the patient experienced RASH (4 Weeks later a rash appeared on her body.). At the time of the report, PRURITUS (he started having a lot of itching on her back. The itching then randomly appeared on other places on the body.) had not resolved and RASH (4 Weeks later a rash appeared on her body.) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Patient reported that doctor suggested to use a lotion. She stated even Benadryl did not help her.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2552584

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: VA
Alter: 40,0
Geschlecht: F
Eingang: 06.01.2023
Impfdatum: 30.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Myalgia

Symptomtext

Severe muscle pain in right arm since booster on 9/30. Tried rest, heat, cold pack, NSAIDS, pain relief gels (arnica and biofreeze), and medical massage. Medical provider prescribed Meloxicam on 1/4/23.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myalgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: Headaches, glaucoma, polycystic ovarian syndrome
Andere Medikamente: Slynd, Alphagan drops, etc. multvitamin, omega-3, metformin, Diamox, propranolol, Claritin, magnesium, Nurtec, fioricet, Maxalt
Allergien: Penicillin, Zyrtec, Zioptan, bleach, gluten, cats, hyacinth
Vorherige Impfungen: -

VAERS 2552443

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MI
Alter: 61,0
Geschlecht: F
Eingang: 06.01.2023
Impfdatum: 04.01.2023
Beginn: 05.01.2023
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Blood pressure increased Chills Dysstasia Flushing Heart rate increased Impaired work ability

Symptomtext

Pt reported feeling very weak, BP elevated 154/74, temp 99.1F, facial flushing , teeth chattering, HR increase to 105 per minute. Unable to work or stand. Pt sent home from work due to extreme weakness. Instructed to call physician from home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: -
Allergien: N/a
Vorherige Impfungen: -

VAERS 2550116

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: TX
Alter: 75,0
Geschlecht: F
Eingang: 04.01.2023
Impfdatum: 30.09.2022
Beginn: 19.12.2022
Tage bis Beginn: 80,0
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Tested positive for COVID-19 two months after vaccination; Felt congested with a sore throat; Called doctor and was prescribed PAXLOVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: Home COVID-19 test positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Famotidine; ADVIL as needed; TYLENOL as needed
Allergien: N/A
Vorherige Impfungen: -

VAERS 2547657

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MI
Alter: 60,0
Geschlecht: F
Eingang: 30.12.2022
Impfdatum: 29.09.2022
Beginn: 15.12.2022
Tage bis Beginn: 77,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Headache Oral herpes zoster Oral pain Pain in jaw Stomatitis

Symptomtext

Developed oral shingles. Approximate onset date of symptoms was 12-15-22. Initial symptoms were jaw/mouth pain, chills, headache. Developed sores in mouth on 12-21-22. Shingles initially diagnosed by dentist on 12-21-22 and diagnosis confirmed by PCP on same date via televisit. Only treatment received was ibuprofen/ acetaminophen/topical medication for pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: NKA
Vorherige Impfungen: -

VAERS 2544969

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 76,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 19.09.2022
Beginn: 28.11.2022
Tage bis Beginn: 70,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Mucosal hypertrophy Nasopharyngitis Oropharyngeal pain Pain Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

For a few days I felt like I was coming down with a cold. I had a sore throat, runny nose, and a little fever 99.7 degrees. In the evening it went up to 100.6 degrees. I had congestion with thick mucous. I still get thick mucous in my throat. I was doing a lot one day and I was aching all over. I don't know if I was exposed to something over Christmas but I took a COVID-19 and it was negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 28NOV2022 COVID-19 at home test positive; 03DEC2022 COVID-19 at home test positive; 08DEC2022 COVID-19 at home test negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Type 2 Diabetic; High Cholesterol
Andere Medikamente: Antihistamine; simvastatin
Allergien: -
Vorherige Impfungen: COVID-19 vaccine 1st dose Moderna 01/07/2021 Lot: 0371C20A

VAERS 2544733

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: IL
Alter: 74,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 23.09.2022
Beginn: 23.11.2022
Tage bis Beginn: 61,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Decreased appetite Fatigue Headache Influenza virus test negative Malaise Oropharyngeal pain Pain Pain in extremity Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

My COVID-19 symptoms started on 11/23/2022 in the morning with sneezing which continued till evening. On 11/24/2022 in the morning I had low grade fever, headache, fatigue, runny nose, severe sore throat, body aches, loss of appetite and chest congestions. I didn't think that I had COVID-19 infection but on the 11/27/2022 I tested with a home COVID-19 test which was positive. I realized that my symptoms were getting worse so that's when I decided to take the home COVID-19 test. The same day I went to the urgent care they also tested me for COVID-19 and FLU. My COVID-19 test was positive and FLU was negative. The urgent care advised me to take TYLENOL or take over the counter sore throat medication. I took TYLENOL for at least 6 days and I also took lozenges with zinc in it. I did recover from COVID-19 infection but I get easily tired. My legs would hurt even if I sit down or lay down. This is something new I am experiencing after COVID-19 infection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 28DEC2022 COVID-19 test positive
Aktuelle Erkrankungen: None
Vorgeschichte: Sjogren's Disease; High Blood Pressure; Arthritis
Andere Medikamente: Amlodipine; atenolol; aspirin; multivitamins
Allergien: Pain killers (tramadol); milk
Vorherige Impfungen: -

VAERS 2542217

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MT
Alter: 71,0
Geschlecht: M
Eingang: 23.12.2022
Impfdatum: 16.09.2022
Beginn: 15.12.2022
Tage bis Beginn: 90,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Diarrhoea Fatigue Headache Oropharyngeal pain Productive cough SARS-CoV-2 test positive

Symptomtext

On December 15, 2022, I woke up extremely fatigued with a sore throat, headache, cough and severe diarrhea. I tested positive for COVID-19 with a home test. These symptoms lasted for 4 days. My cough was productive with a lot of phlegm; however, it was intermittent. I took Theraflu, Mucinex and Robitussin. On day 5 my symptoms seemed to lesson quite a bit. As of today, I am still fatigued and have a slight, intermittent cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: Home COVID-19 test, positive, 12152022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Acid Reflux; Hypothyroidism; Polymyalgia
Andere Medikamente: Prednisone; Omeprazole; Levothyroxine; Calcium; Folic Acid
Allergien: Sulfa Drugs; Penicillin; Diesel Fumes
Vorherige Impfungen: -

VAERS 2542199

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: CA
Alter: 65,0
Geschlecht: M
Eingang: 23.12.2022
Impfdatum: 22.09.2022
Beginn: 07.12.2022
Tage bis Beginn: 76,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Cough Eye discharge Headache Oropharyngeal pain Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had contracted COVID-19 on 12/08/2022 and I had a sore throat, chest congestion, nosy and eyes running, headache, fever, cough. The doctor did prescribe Paxlovid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 08DEC2022- COVID-19- Positive
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma; Emphysema
Andere Medikamente: Multivitamin; Vitamin A; Vitamin D; Vitamin C; Liver oil
Allergien: N/A
Vorherige Impfungen: -

VAERS 2542198

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CO
Alter: 76,0
Geschlecht: M
Eingang: 23.12.2022
Impfdatum: 17.09.2022
Beginn: 21.10.2022
Tage bis Beginn: 34,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bronchitis COVID-19 Cough Oropharyngeal pain Productive cough Rhinorrhoea SARS-CoV-2 test negative SARS-CoV-2 test positive

Symptomtext

I got a sore throat and a severe cough with a runny nose starting about a month after the vaccination. I tested 3X for Covid and all were negative. I didn't recover completely and kept coughing up phlegm. On Nov 11 I tested positive for Covid with a rapid test. I have now fully recovered

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: Antibiotics for bronchitis;
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Rosuvastatin, celebrex, daily vitamin, fish oil, D3
Allergien: none
Vorherige Impfungen: -

VAERS 2541970

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MI
Alter: 58,0
Geschlecht: F
Eingang: 23.12.2022
Impfdatum: 22.09.2022
Beginn: 16.12.2022
Tage bis Beginn: 85,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Decreased appetite Fatigue Headache Pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I started becoming really tired which was abnormal for me because I have high energy. I lost my appetite and had a pounding headache with a runny nose, but put it off thinking it was my sinuses due to weather change. The entire weekend, I stayed in bed resting and forced myself to eat something. By 12/19/2022, my body started aching terribly as if I was just beat with a baseball bat. That's when I knew something was terribly wrong; I woke up in the middle of that evening and took an at-home COVID-19 test which came back positive so fast. So the next morning, I called my doctor to see what I should do. My physician prescribed me PAXLOVID which I started taking the same day. Since taking the treatment, my body aches have gone; but I still have slight headaches, slight fatigue, and slowly regaining my appetite back.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 test: 12/19/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: VITAFUSION multivitamin; chlorthalidone; TYLENOL
Allergien: N/A
Vorherige Impfungen: -

VAERS 2539485

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: OR
Alter: 75,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 20.09.2022
Beginn: 06.12.2022
Tage bis Beginn: 77,0
Dosis: 5
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Influenza like illness SARS-CoV-2 test positive

Symptomtext

I contracted Covid in December. Symptoms from the Vaccine in September were fatigue and flu like symptoms that lasted only a day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home antigen test for Covid. No tests for symptoms from vaccine.
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure
Andere Medikamente: Tylenol
Allergien: Niacin
Vorherige Impfungen: Moderna 031-20a, Covid, 02/12/21

VAERS 2539343

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: VA
Alter: 66,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 20.09.2022
Beginn: 19.12.2022
Tage bis Beginn: 90,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Fatigue Influenza virus test positive Pain Pyrexia SARS-CoV-2 test negative

Symptomtext

I tested positive for the flu on 12/19/22, but negative for COVID-19. I had fatigue, body aches, chills, a fever of 102.6. I contacted my doctor and was prescribed TAMIFLU. I also took TYLENOL as needed. I am feeling better, but still dealing with some of these symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 19DEC2022 COVID-19 test negative; 19DEC2022 flu test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Multivitamin
Allergien: Codeine; AMBIEN
Vorherige Impfungen: -

VAERS 2536906

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: IL
Alter: 67,0
Geschlecht: M
Eingang: 19.12.2022
Impfdatum: 16.09.2022
Beginn: 05.12.2022
Tage bis Beginn: 80,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Biopsy artery Blindness Computerised tomogram abdomen Computerised tomogram head normal Headache Scan with contrast Sinusitis

Symptomtext

Symptoms began with a severe headache. I had a sinus infection and was given antibiotics. I lost my vision temporarily. A CAT scan was done on Friday without contrast and was negative. On Sunday I began bleeding from my crotch and was sent to the emergency room. Second CAT scan Sunday on head without contrast and abdominal CAT scan with contrast. I was admitted and discharged on Sunday.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: 7,0
Labordaten: Temporal Arterial Biopsy
Aktuelle Erkrankungen: Post nasal drip
Vorgeschichte: Diabetes; Heart Stent; A-fibrillation; Arthritis; Morbid Obesity; GERD; Acid reflux
Andere Medikamente: Lactobacillus acidophilus; metformin; benazepril; carvedilol; chlorthalidone; ELIQUIS; pantoprazole; metoclopramide HCL; potassium; sucralfate; atorvastatin; tamsulosin; finasteride; vitamin B-complex; iron ferrous sulfate; cranberry supple
Allergien: Onions; mushrooms; penicillin; sulfa; morphine; tetracycline
Vorherige Impfungen: -

VAERS 2535452

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: TN
Alter: 66,0
Geschlecht: F
Eingang: 16.12.2022
Impfdatum: 16.12.2022
Beginn: 16.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood glucose normal Dizziness Hyperhidrosis Nausea

Symptomtext

A few minutes after administering the vaccine, patient began sweating and became very dizzy and nauseous. She was monitored and given a drink of water (Epi-pen brought but deemed not necessary). She began improving after given water. 911 was called and patient evaluated by EMTs; BP and blood sugar within normal limits. Patient improved enough to go home without going to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: none known
Vorgeschichte: none reported
Andere Medikamente: -
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2518067

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 59,0
Geschlecht: F
Eingang: 28.11.2022
Impfdatum: 19.09.2022
Beginn: 23.09.2022
Tage bis Beginn: 4,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue SARS-CoV-2 test positive Secretion discharge

Symptomtext

I received the Moderna Bivalent booster for COVID-19 on 9/19/2022. On 9/24/2022, I had a very slight cough and very slight fatigue. I was visiting a friend, so I took 2 home antigen tests, and both yielded positive results. I isolated and only visited with my friend outdoors. I was fatigued and spent much of the time sleeping. I had a lot of nasal mucus discharge, but I never developed a fever. On 10/2/2022, I took another home antigen test and got a negative result, and I was then able to fly home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 9/24/2022--2 Home Antigen Tests--Positive Results; 10/2/2022--Home Antigen Test--Negative Result.
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: Multivitamin; Fish Oil; Glucosamine Chondroitin; Collagen; Escitalopram.
Allergien: None.
Vorherige Impfungen: -

VAERS 2517951

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: TX
Alter: 64,0
Geschlecht: F
Eingang: 28.11.2022
Impfdatum: 09.09.2022
Beginn: 28.09.2022
Tage bis Beginn: 19,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain COVID-19 Cough Fatigue Foreign travel Nasal congestion Nasopharyngitis Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I developed Covid after a trip, returning home on 9/25 and testing positive on 9/28. This was NOT a reaction to my third booster which I got just prior to the trip. I sought advice from my doctor/clinic because I have Type2 diabetes and I knew that was a complicating factor. I experienced cold-like symptoms (stuffy head and nose, cough) for a few days, with a very slight fever. The worst symptom was abdominal pain, likely from diverticulitis, for four days. I had ongoing fatigue for about six weeks. Because my symptoms were mild, my doctor did not prescribe any treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: Type 2 diabetes
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2507310

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: NY
Alter: 32,0
Geschlecht: F
Eingang: 14.11.2022
Impfdatum: 29.09.2022
Beginn: 02.10.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Rash SARS-CoV-2 test positive

Symptomtext

Developed a rash that looks like dermatographism that has been ongoing since. I have taken antihistamines, and cortisone treatment. I saw my PCP and she referred me to dermatology.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: Saw PCP on 10/28/22.
Aktuelle Erkrankungen: N/a Covid positive on 10/3/22
Vorgeschichte: -
Andere Medikamente: synthroid 112mcg
Allergien: NA
Vorherige Impfungen: -

VAERS 2504480

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: VA
Alter: 40,0
Geschlecht: F
Eingang: 10.11.2022
Impfdatum: 09.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Axillary pain Drainage Oedema peripheral

Symptomtext

I have armpit swelling to the point where is was incredibly painful, I had to go to an urgent care center and they performed a procedure there to have it drained.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Axillary pain
Hospital-Tage: -
Labordaten: No.
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Melatonin
Allergien: Brewers yeast
Vorherige Impfungen: -

VAERS 2500069

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 76,0
Geschlecht: M
Eingang: 06.11.2022
Impfdatum: 29.09.2022
Beginn: 24.10.2022
Tage bis Beginn: 25,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dermatitis contact Pruritus Rash Rash erythematous Rash pruritic

Symptomtext

Adverse event: Large, itchy rash with hives located at: -both armpits and extending down inside of upper arms -inside of both upper thighs -above and below navel -tennis ball sized bright red rash around both nipples Treatment: -Benadryl Outcome: -Rash slowly resolved over 24-48 hours, with residual itchiness and contact dermatitis on inner arms, inner thighs, and stomach over the next few days, after which rash and itchiness was fully resolved

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Herpes Simplex
Andere Medikamente: Famciclovir, Metamucil
Allergien: Penicillin, Ceclor, Keflex
Vorherige Impfungen: Soreness and rash at injection site, tenderness and swelling of left nipple after first Moderna vaccine injection, age 75

VAERS 2495214

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: NH
Alter: 77,0
Geschlecht: F
Eingang: 01.11.2022
Impfdatum: 23.09.2022
Beginn: 24.09.2022
Tage bis Beginn: 1,0
Dosis: 6
Route/Site: UN / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Cough Fatigue Headache Limb discomfort Pain

Symptomtext

Tired, chills, body aches, legs discomfort, cough, headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension, type 2 diabetes, spinal stenosis
Andere Medikamente: Quinapril, Amlodapine, ozampique, protonix, hydrothychlorozide.
Allergien: Erythromycin, Vitamin D, Lipator
Vorherige Impfungen: -

VAERS 2495011

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: IL
Alter: 41,0
Geschlecht: M
Eingang: 01.11.2022
Impfdatum: 28.10.2022
Beginn: 28.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypoaesthesia oral Neck pain

Symptomtext

Patient received his COVID, then his flu vaccine. He waited 15 minutes then returned to his office. A little while later he returned to the clinic (in his place of employment) and stated he had neck pain in the middle of his lower neck and numbness of the left corner of his mouth. His neck pain resolved within 5 minutes, the numbness persisted. Denied SOB, throat tightness, itching, and other symptoms. Watched for approximately 20 minutes. Numbness began to resolve. Given follow-up instructions to call 911 if symptoms worsened and to call his physician to schedule an appointment within the next 24 hours. Verbalized understanding.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Neck pain
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2494704

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: OH
Alter: 65,0
Geschlecht: F
Eingang: 31.10.2022
Impfdatum: 23.09.2022
Beginn: 23.10.2022
Tage bis Beginn: 30,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia COVID-19 Discomfort Fatigue Feeling abnormal Headache Musculoskeletal discomfort Oropharyngeal pain Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

The morning of woke feeling like I was getting a small head cold. I was okay all day until about 6pm. My throat was starting to get sore, and I had a few body aches. A couple hours later my head started to hurt, my knees were bothering me. They hurt to walk. By 11pm I was running a 99.2 fever. Everything was hurting from head to toe. By 12:30AM my temperature went up to 101.9. I couldn't get comfortable. By 6 in the morning my fever broke, and I was still feeling bad, so I called my doctor, and we went in, and I ended up testing positive for COVID-19. They prescribed me Azithromycin 250mg and cough syrup. I was antibiotics for 5 days. A few days ago, I started getting fatigued.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: 10/24/2022 COVID-19 test -Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Levothyroxine; Meloxicam; Satala pram; Melatonin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2494184

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: TX
Alter: 43,0
Geschlecht: F
Eingang: 31.10.2022
Impfdatum: 17.09.2022
Beginn: 23.10.2022
Tage bis Beginn: 36,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Cough Fatigue Headache Malaise Oropharyngeal pain Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test negative

Symptomtext

On 10/23/2022, I had a sore throat in the afternoon and throughout the day. I took a nighttime TYLENOL and an elderberry and ginger cough syrup. In the morning, I felt malaise, body aches, fever, headache, congestion, fatigue, sore throat, and was just very unwell. Tuesday morning, I felt really heavy in my chest when I woke up. When I did cough, I had a lot of congestion and all of my other symptoms persisted. I continued coughing throughout the week and called my doctor on Friday. I had taken an at home COVID-19 test on Tuesday and it was negative. I had a virtual visit with a doctor on Friday who prescribed a stronger cough medicine. I have been improving but have still been coughing since then.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 25OCT2022 at home COVID-19 test negative
Aktuelle Erkrankungen: None
Vorgeschichte: Grave's Disease; Thyroid Eye Disease
Andere Medikamente: Methimazole
Allergien: Shellfish; fish; pollen associated food allergies; ibuprofen; penicillin
Vorherige Impfungen: -

VAERS 2490040

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CO
Alter: 68,0
Geschlecht: F
Eingang: 26.10.2022
Impfdatum: 15.10.2022
Beginn: 15.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain

Symptomtext

Reported that the patient felt the injection site may have been too high. Reported soreness at the injection site and in the arm/shoulder the next day. This was educated as a potential side effect. Was also educated on the proper location of the deltoid muscle and the proper injection site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2489230

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS 7148B

mild

Staat: MI
Alter: 48,0
Geschlecht: M
Eingang: 25.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Head discomfort Headache Hypoacusis Tinnitus

Symptomtext

Has progressed since shot into extreme debilitating tinnitus, partial hearing loss, head pain and pressure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: Multiple Urgent care and Dr's office visits. Trying to get into Ear Nose & Throat Dr still. I need help finding emergency Ear Nose and Throat care.
Aktuelle Erkrankungen: 2 weeks prior water on ears. Healthy at injection time. Advised by drs office that even though it's only been 2 weeks since sick it was ok to do vaccination since there only real concern was if there had been a temperature.
Vorgeschichte: Chronic disk issues in back.
Andere Medikamente: Nexium Amitriptylene Tizanidine
Allergien: amoxicillin class of antibiotics, Amoxicillin and Keflex. Minor and Major Rash
Vorherige Impfungen: -

VAERS 2484834

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: -
Alter: 22,0
Geschlecht: F
Eingang: 20.10.2022
Impfdatum: 26.09.2022
Beginn: 26.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Cold sweat Dizziness Feeling cold Nausea

Symptomtext

Pt reported nausea, feeling cold & clammy, and dizziness. Vitals: 97/56, 79, 20 -- > 109/57, 63, 100% O2 Sat Pt given water and biscuits. Pt placed in T-Berg position x 30mins. Pt stable and released from the vaccination site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: PMH: unknown to this writer
Andere Medikamente: Medications: Estradiol 2mg Spironolactone 100mg
Allergien: Allergies: Shrimp
Vorherige Impfungen: -

VAERS 2480367

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: VA
Alter: 76,0
Geschlecht: F
Eingang: 17.10.2022
Impfdatum: 07.10.2022
Beginn: 12.10.2022
Tage bis Beginn: 5,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Ear pain Fatigue Headache Pain SARS-CoV-2 test positive Somnolence Upper-airway cough syndrome

Symptomtext

I started to feel really tired. By 5PM I was so tired I wanted to nap. On Thursday I developed a cough and by Friday I woke up with a cough and my daughter indicated that it sounded different. I woke up Friday with pain in my ears, so I decided to complete an at home COVID-19 test which was positive. The cough got worse with a headache. I called my doctor and he prescribed PAXLOVID. I just rested. On Saturday the cough was much more pronounced. Yesterday I started to feel like I was over the worse part, but I am still very tired, and I still cough if I move much. I have a lot of postnasal drip and aches. I have not had a temperature so far.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear pain
Hospital-Tage: -
Labordaten: COVID-19 home test on 10/14/2022.
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Hormone replacement therapy; SYNTHROID; TYLENOL; diazepam; vitamin; multivitamin
Allergien: Penicillin; buckwheat; bees
Vorherige Impfungen: Whooping Cough 5 years ago; 2 additional breakthrough cases after 3rd dose mild.

VAERS 2478007

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: NJ
Alter: 63,0
Geschlecht: F
Eingang: 14.10.2022
Impfdatum: 21.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspepsia Lymphadenopathy Rash

Symptomtext

Heartburn radiating from left to right of body; Rash; Lymph nodes on the side of Neck are swollen; This spontaneous case was reported by a patient and describes the occurrence of DYSPEPSIA (Heartburn radiating from left to right of body), RASH (Rash) and LYMPHADENOPATHY (Lymph nodes on the side of Neck are swollen) in a 63-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 immunisation. The patient's past medical history included COVID-19 in 2020. On 21-Sep-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 21-Sep-2022, the patient experienced DYSPEPSIA (Heartburn radiating from left to right of body), RASH (Rash) and LYMPHADENOPATHY (Lymph nodes on the side of Neck are swollen). At the time of the report, DYSPEPSIA (Heartburn radiating from left to right of body), RASH (Rash) and LYMPHADENOPATHY (Lymph nodes on the side of Neck are swollen) outcome was unknown. No concomitant medications were provided. No treatment medication was provided. The patient was screaming and asking, what vaccine did they give and did not want to speak health department. This case was linked to MOD-2022-658039 (Patient Link). Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2477369

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: IL
Alter: 42,0
Geschlecht: F
Eingang: 13.10.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Cough Discomfort Facial pain Headache Insomnia Lymphadenopathy Pain Pain in jaw Paranasal sinus discomfort Pyrexia Respiratory tract congestion SARS-CoV-2 test negative Sinusitis Wheezing

Symptomtext

I was developing fever, chills, body aches, sinus pressure and cough. Major congestion was a factor and made sleeping difficult and wheezing began. I took a COVID-19 test just in case and was going to see my allergist, my test was negative. I went to see my allergist or nurse Practitioner, I was put on a ten day antibiotic and was diagnosed with a sinus infection plus I had congestion with pressure on my face, cheeks, nose, and forehead mainly on my left side, this included pain and sensitivity in my forehead, jaw and head. I also had swelling of my lymph nodes in my left armpit area. I was prescribed a steroid recently 10/12/2022 Prednisone and was told to take Sudafed over the counter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 test negative.
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma
Andere Medikamente: Montelukast; Xyzal; Sertraline; Albuterol; Topiramate; Diethyl Propion
Allergien: Benadryl
Vorherige Impfungen: -

VAERS 2477110

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MI
Alter: 56,0
Geschlecht: F
Eingang: 13.10.2022
Impfdatum: 06.10.2022
Beginn: 12.10.2022
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Pain Skin lesion Skin swelling

Symptomtext

On October 12th, red raised lesion appeared on lower right arm/wrist area. Another smaller red raised lesion appeared on the pinky finger of the left hand. Both lesions painful.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: Saw PCP on October 12th.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2473345

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: AZ
Alter: 76,0
Geschlecht: F
Eingang: 10.10.2022
Impfdatum: 28.09.2022
Beginn: 28.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chills Diarrhoea Discomfort Feeling abnormal Feeling hot Injection site swelling Peripheral swelling Pruritus Rash Skin discolouration Sleep disorder Somnolence

Symptomtext

The next day injection site swelled and I felt awful, hot, and severe chills. I had diarrhea and slept a lot. Two days post vaccination I broke out in a rash that continued to get worse. I was told by my allergist to double up on ZYRTEC. A week after I was then prescribed prednisone which did not work. I could not sleep and I would wake up continuously scratching my skin. I then went to my primary care and was given a stronger dose of prednisone and hydroxyzine. As of now, my symptoms of the rash flares up when I make contact with the site and clothes. The rash seems to be reducing in color, however, it varies throughout the day how intense the symptoms feel. It is extremely uncomfortable. The higher dose of prednisone and hydroxyzine seem to help however it still will come back. I am no longer experiencing the diarrhea or arm swelling. The rash is pretty much everywhere on my body except my head.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: COPD; Chronic Bronchitis
Andere Medikamente: ZYRTEC; inhaler albuterol
Allergien: Penicillin; LEVAQUIN; clindamycin; IV contrast dye; FOSAMAX
Vorherige Impfungen: -

VAERS 2469828

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: -
Alter: 36,0
Geschlecht: F
Eingang: 05.10.2022
Impfdatum: 18.09.2022
Beginn: 18.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Tunnel vision

Symptomtext

Pt reported dizziness and "tunnel vision". Vitals: 102/57, 72, 16, 99% -- > 94/58, 73, 16, 99% Pt placed in Trendelenburg position. Pt monitored, given juice and water. Pt stable and released from vaccination site

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2467062

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: MI
Alter: 74,0
Geschlecht: F
Eingang: 03.10.2022
Impfdatum: 28.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vaccination site erythema Vaccination site pruritus Vaccination site reaction

Symptomtext

Itching injection site left arm after Bivalent booster; Spreading reaction injection site left arm after Bivalent booster; Red injection site left arm after Bivalent booster; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (Itching injection site left arm after Bivalent booster), VACCINATION SITE REACTION (Spreading reaction injection site left arm after Bivalent booster) and VACCINATION SITE ERYTHEMA (Red injection site left arm after Bivalent booster) in a 74-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. Concurrent medical conditions included Blood cholesterol abnormal. Concomitant products included VITAMINS NOS for an unknown indication. On 28-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Sep-2022, the patient experienced VACCINATION SITE PRURITUS (Itching injection site left arm after Bivalent booster), VACCINATION SITE REACTION (Spreading reaction injection site left arm after Bivalent booster) and VACCINATION SITE ERYTHEMA (Red injection site left arm after Bivalent booster). At the time of the report, VACCINATION SITE PRURITUS (Itching injection site left arm after Bivalent booster), VACCINATION SITE REACTION (Spreading reaction injection site left arm after Bivalent booster) and VACCINATION SITE ERYTHEMA (Red injection site left arm after Bivalent booster) outcome was unknown. Patient was taking Cholesterol Medication. It was reported that patient received 2 primary and 2 Monovalent Booster shots of Moderna COVID-19 vaccine. On 21-Jan-2021 (lot 029L20A) patient received the first dose of Moderna Vaccine. On 18-Feb-2021 (lot 013M20A) patient received the second dose of Moderna Vaccine. On 25-Oct-2021 (lot 039D21K) patient received the first booster dose of Moderna Vaccine. On 26-May-2022 (lot 038A22A) patient received the second booster dose of Moderna Vaccine. It was reported that 24 hrs after receiving the bivalent booster patient had injection site was red, itching, and spreading. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Blood cholesterol abnormal
Vorgeschichte: -
Andere Medikamente: VITAMINS NOS
Allergien: -
Vorherige Impfungen: -

VAERS 2466942

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: VA
Alter: 61,0
Geschlecht: F
Eingang: 02.10.2022
Impfdatum: 27.09.2022
Beginn: 28.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Axillary pain Breast pain Fatigue Injection site discomfort Injection site erythema Injection site swelling Injection site warmth Malaise Pain Pain in extremity Pyrexia Skin texture abnormal Skin tightness

Symptomtext

Shortly after midnight, I awoke with general body aches and severe discomfort in the arm where I got the shot- my arm, my shoulder, axilla, breast, and back of my shoulder ached, and my temperature was 100.9. I had started taking naprosyn the day before the vaccination, and continued taking every 12 hours. In the morning of 9/28, i still had a temperature of 100.5 and also developed joint aches in addition to the body aches. I was too sick to work that day (wednesday). Thursday my temperature was 99.5 and I continued naprosyn. Later that day the fever broke and the overall pain was better but the arm /shoulder pain continued. Friday, my left arm was swollen from the injection site down to about an inch above my elbow. The skin continued to be hot and red, and later in the day became shiny and taut. My left arm at the deltoid was 2 inches larger than my right arm. I continued naprosyn and began applying ice packs to my arm in 20-minute intervals. Saturday and today, the arm swelling is better, but I am still fatigued. I have had reactions to my previous covid vaccinations but not this bad, and my arm never swelled up before.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: None except temperatures noted above
Aktuelle Erkrankungen: None
Vorgeschichte: Mild asthma Hypothyroidism ADD Depression Hypercholesterolemia
Andere Medikamente: Naprosyn Concerta Fluoxetine Levothyroxine Trazodone Simvastatin Advair Flonase Vitamin D3
Allergien: No allergies Levaquin- tendinitis Benadryl- serotonin syndrome
Vorherige Impfungen: Moderna (non-bivalent)

VAERS 2466692

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: PA
Alter: 29,0
Geschlecht: M
Eingang: 01.10.2022
Impfdatum: 19.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 12,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Rash

Symptomtext

Mother called stating patient received vaccination a few weeks ago [9/20/22] and today [10/1/22] woke up with rash all over body, mostly torso but also on elbow of arm he received shot. She asked if it could be related to vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: going to seek treatment from teledoc or urgent care, however they are out of town and not sure what the options are where they are currently located.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: PENICLLIN
Vorherige Impfungen: -

VAERS 2464733

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: AZ
Alter: 69,0
Geschlecht: M
Eingang: 29.09.2022
Impfdatum: 27.09.2022
Beginn: 27.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration Malaise

Symptomtext

Patient was given Moderna bivalent booster too soon. Last monovalent booster on records with public health was administered on 08/10/2022. Patient wad administered bivalent booster on 09/27/22. Patient was notified of error and is doing well. Patient denies having any adverse reactions. Patient advised to return to clinic if he begins to feel unwell or to call911 or go to the nearest hospital if he experiences any adverse effects or any signs of a severe allergic reaction.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2464415

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: GA
Alter: 57,0
Geschlecht: F
Eingang: 29.09.2022
Impfdatum: 24.09.2022
Beginn: 24.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Erythema Injection site pain Injection site swelling Mouth ulceration Pyrexia Stomatitis

Symptomtext

MOUTH SORES AND ULCERS; PAIN @ INJECTION SITE (LEFT LEG), SWELLING @ INJECTION SITE, REDNESS ( 2 INCHES AND ENLARGING); HIGH FEVER 101-102f

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: NO MEDICAL TEST
Aktuelle Erkrankungen: -
Vorgeschichte: CHAIARNOLD SYNDROME
Andere Medikamente: -
Allergien: TETRACYLINE, MACROLIDE, SULFA, BETA-ADRENERGIC, VALPROIC ACID, TRICYCLIC COMPOUNDS, TRIPTANS 5-HT,SULFA, OPIOD, BARBITURATES, FORMETEROL, HYDANTOINS, CODEINE,
Vorherige Impfungen: -

VAERS 2464411

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: MI
Alter: 65,0
Geschlecht: F
Eingang: 29.09.2022
Impfdatum: 27.09.2022
Beginn: 28.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pruritus Rash Urticaria

Symptomtext

Started with a rash yesterday afternoon on the face and chest. Has small dots all over forehead and along the cheek can jawbone. Itchy and also has welts all over her body. Took Nyquil for some relief last evening. Plans to take Benadryl today to help with the welts, rash, and itching.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: Hypertension and High Cholesterol
Andere Medikamente: Lisinopril Rosuvastatin Singulair
Allergien: Seasonal Amoxicillin
Vorherige Impfungen: -

VAERS 2464389

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: IL
Alter: 50,0
Geschlecht: F
Eingang: 29.09.2022
Impfdatum: 23.09.2022
Beginn: 24.09.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Burning sensation Lip erythema Lip pain Lip pruritus Lip swelling

Symptomtext

Upper and lower lip swelling, redness, burning and itching that started approximately 24 hours after the Moderna Bivalent Booster (Saturday Sept 24th) and worsened over the course of 3 days before I contacted my provider on Tuesday September 27th. Treatment was first applied at home and included ice packs, Lysine lip treatment, Aspirin and Benadryl 50 mg on Tuesday morning, with no improvement noted. My NP prescribed a Steroid Injection that I received on Wednesday morning Sept 28th. Symptoms gradually improved that day and this morning the 29th the swelling is gone but my lips are still tender and slightly itchy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lip pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: CREST syndrome
Andere Medikamente: Wellbutrin 300 mg qd, Vitamin D3, Vitamin C
Allergien: None
Vorherige Impfungen: -

VAERS 2463315

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 38,0
Geschlecht: F
Eingang: 28.09.2022
Impfdatum: 27.09.2022
Beginn: 28.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Injection site pain Lethargy Pain

Symptomtext

injection site pain, body aches, lethargy/fatigue, headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: no
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2463294

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: TX
Alter: 69,0
Geschlecht: M
Eingang: 28.09.2022
Impfdatum: 23.09.2022
Beginn: 24.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Gait disturbance Ultrasound Doppler normal

Symptomtext

I don't know if it is directly caused it but I started having severe joint pain in my left knee. I normally walk 5 miles most days and I do walk several times a week but I noticed I couldn't walk Sunday at all. I could walk outside a little bit but managed with just 1/10 of mile walk and limped in and it got progressively worse and I was having to use a roller stand to get around the house without an aide device. So on Tuesday I called my doctor and went to see her and since I have had blood clots in my right leg she ordered a Sonogram doppler test which came back normal and the nurse called today for me to take steroids' that she ordered from the pharmacy since she thinks it might just be inflammation. I will start those in the morning and take them for about 6-7 days. My knees have been bothering me for several years but walking helps loosen that up but not now with this new joint pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: Doppler Sonogram 9/27/22- Normal
Aktuelle Erkrankungen: Deep Vein Thrombosis Right Lower Extremity
Vorgeschichte: Hypertension; Acid Reflux; Enlarged Prostate
Andere Medikamente: Terazosin; Lisinopril; Omeprazole; Aspirin; Multivitamin; Aleve; Turmeric; Tylenol
Allergien: Chicken; Sulfa; Piroxicam
Vorherige Impfungen: -

VAERS 2461473

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: CA
Alter: 34,0
Geschlecht: F
Eingang: 27.09.2022
Impfdatum: 16.09.2022
Beginn: 09.05.2022
Tage bis Beginn: -
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

COVID-19 immunisation Feeling abnormal Insomnia Interchange of vaccine products Maternal exposure during pregnancy Muscular weakness Pain in extremity Peripheral swelling Pruritus Urticaria

Symptomtext

Did not sleep at all; Extreme pain in arms and legs; Both arms and legs were swollen /hands swelled and ballooned up; Felt like no blood in arm; Arms weak and hurting; Interchange of vaccine products; Revaccination with different COVID-19 vaccine; Hives from head to toe all over their body; Itchy; Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of INSOMNIA (Did not sleep at all), PAIN IN EXTREMITY (Extreme pain in arms and legs), PERIPHERAL SWELLING (Both arms and legs were swollen /hands swelled and ballooned up), FEELING ABNORMAL (Felt like no blood in arm) and MUSCULAR WEAKNESS (Arms weak and hurting) in a 34-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for Drug use for unknown indication: Pfizer (Patient received first 3 doses of Pfizer vaccine.). Past adverse reactions to the above products included No adverse event with Pfizer. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] and IRON for an unknown indication. On 16-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 18-Oct-2022. On 09-May-2022, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). On 16-Sep-2022, the patient experienced PRURITUS (Itchy). On 17-Sep-2022, the patient experienced INSOMNIA (Did not sleep at all) (seriousness criterion hospitalization), PAIN IN EXTREMITY (Extreme pain in arms and legs) (seriousness criterion hospitalization), PERIPHERAL SWELLING (Both arms and legs were swollen /hands swelled and ballooned up) (seriousness criterion hospitalization), FEELING ABNORMAL (Felt like no blood in arm) (seriousness criterion hospitalization), MUSCULAR WEAKNESS (Arms weak and hurting) (seriousness criterion hospitalization) and URTICARIA (Hives from head to toe all over their body). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and ALUMINIUM HYDROXIDE, MAGNESIUM TRISILICATE, SODIUM ALGINATE (PEPCID [ALUMINIUM HYDROXIDE;MAGNESIUM TRISILICATE;SODIUM ALGINATE]) at an unspecified dose and frequency. On 09-May-2022, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. At the time of the report, INSOMNIA (Did not sleep at all), PAIN IN EXTREMITY (Extreme pain in arms and legs), PERIPHERAL SWELLING (Both arms and legs were swollen /hands swelled and ballooned up), FEELING ABNORMAL (Felt like no blood in arm), MUSCULAR WEAKNESS (Arms weak and hurting), URTICARIA (Hives from head to toe all over their body), PRURITUS (Itchy), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) to be related. No further causality assessments were provided for INSOMNIA (Did not sleep at all), PAIN IN EXTREMITY (Extreme pain in arms and legs), PERIPHERAL SWELLING (Both arms and legs were swollen /hands swelled and ballooned up), FEELING ABNORMAL (Felt like no blood in arm), MUSCULAR WEAKNESS (Arms weak and hurting), URTICARIA (Hives from head to toe all over their body), PRURITUS (Itchy) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). It was reported that patient was almost 36 weeks pregnant. Patient received first 3 doses of Pfizer vaccine. Patient received Bivalent booster of Moderna and felt uncomfortable overnight. Patient received first booster vaccine of Moderna on 09-May-2022, with batch number - 056M21A. Patient was admitted to emergency department and treated with e steroids and fluids. Patient was discharged post treatment. Health care professionals from ER guessed adverse reactions were due to Moderna booster. Company comment- This is a spontaneous case of interchange of vaccine products (received 3 doses of Pfizer vaccine and a booster dose of mRNA 1273 vaccine) concerning a 34-year-old pregnant patient, with no reported medical history, who experienced maternal exposure during pregnancy at 36 weeks of gestation, who experienced the unexpected and serious (hospitalization) events of insomnia, pain in extremity, peripheral swelling, feeling abnormal and muscular weakness the following day a dose of mRNA-1273.222 vaccine, given as a fifth dose of COVID vaccine schedule, was administered. It was reported patient did not sleep at all the night of the following day vaccine was given because she had extreme pain in arms and legs, hands swelled and ballooned up and both arms and legs were swollen. She said it felt like no blood in arm and arms were weak and hurting. She went to the emergency room, and they check her out and ruled out a bunch of things and guessed it was an adverse reaction to the booster. Steroids, Pepcid (aluminum hydroxide, magnesium trisilicate, sodium alginate) and fluids were given and then she was discharged. Patient?s pregnancy state can contribute to the events insomnia, pain in extremity and peripheral swelling. The benefit-risk relationship of the mRNA-1273.222 is not affected by this report.; Sender's Comments: This is a spontaneous case of interchange of vaccine products (received 3 doses of Pfizer vaccine and a booster dose of mRNA 1273 vaccine) concerning a 34-year-old pregnant patient, with no reported medical history, who experienced maternal exposure during pregnancy at 36 weeks of gestation, who experienced the unexpected and serious (hospitalization) events of insomnia, pain in extremity, peripheral swelling, feeling abnormal and muscular weakness the following day a dose of mRNA-1273.222 vaccine, given as a fifth dose of COVID vaccine schedule, was administered. It was reported patient did not sleep at all the night of the following day vaccine was given because she had extreme pain in arms and legs, hands swelled and ballooned up and both arms and legs were swollen. She said it felt like no blood in arm and arms were weak and hurting. She went to the emergency room, and they check her out and ruled out a bunch of things and guessed it was an adverse reaction to the booster. Steroids, Pepcid (aluminum hydroxide, magnesium trisilicate, sodium alginate) and fluids were given and then she was discharged. Patient?s pregnancy state can contribute to the events insomnia, pain in extremity and peripheral swelling. The benefit-risk relationship of the mRNA-1273.222 is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS ; IRON
Allergien: -
Vorherige Impfungen: -

VAERS 2460726

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: PA
Alter: 35,0
Geschlecht: F
Eingang: 26.09.2022
Impfdatum: 23.09.2022
Beginn: 24.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Injection site erythema Injection site reaction Lymphadenopathy Skin warm

Symptomtext

Pt has red circle about 5 inches in diameter around site of injection. pt has swollen lymph notes and the arm is hot to the touch

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: same reaction to past moderna shots

VAERS 2459932

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 24,0
Geschlecht: F
Eingang: 25.09.2022
Impfdatum: 24.09.2022
Beginn: 24.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Impaired driving ability Nausea

Symptomtext

Patient left waiting area and was waiting outdoor in the sun. She felt dizzy, nausea, light headed. We brought the patient inside in the AC room and did her vitals. Vitals were BP 98/53 and pulse of 51 and repeated again BP 101/54 Pulse 56. Patient stated she is a active runner as well. We had patient wait for 45 mins. Provided her with a snack and water as well. Vitals were BP 99/59 Pulse 76. Patient was not longer dizzy and felt good enough to drive home. Did not want us to call family to pick her up initially, but ended up calling parents for a ride home. Pharmacist followed up with patient around 4pm and she said she was doing ok with nothing new to report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2459852

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: OH
Alter: 59,0
Geschlecht: M
Eingang: 25.09.2022
Impfdatum: 22.09.2022
Beginn: 23.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue

Symptomtext

Extreme tiredness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: CHF, OSA
Andere Medikamente: aspirin, 81mg, 1x/day escitaloplam, 20mg, 1x/day metoprolol ER, 50mg 1x/day lisinopril, 10mg, 1x/day atorvastatin, 40mg, 1x/night
Allergien: none known
Vorherige Impfungen: light flu-like symptoms, age ~54, late 2017, herpes zoster, Shingrix

VAERS 2456755

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 84,0
Geschlecht: F
Eingang: 23.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration Pain in extremity

Symptomtext

Moderna bivalent dose(09/16/2022) given only 1 month after the last moderna booster dose (08/11/2022) patinet was notified 1 hour after the shot and was not experiencing any side effects except sore arm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: high blood pressure, high cholesterol
Andere Medikamente: Amlodipine 5mg, Atorvastatin 40mg
Allergien: none
Vorherige Impfungen: -

VAERS 2456161

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: TX
Alter: 47,0
Geschlecht: F
Eingang: 23.09.2022
Impfdatum: 18.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Fatigue Headache Pyrexia

Symptomtext

18 hours after vaccination onset (9/19/22): low grade fever, chills, fatigue. 9/20/22-9/22: low grade fever, fatigue, headache 9/23/22: fatigue, headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma, bi polar 2
Andere Medikamente: Latuda, Lamictal, Lunesta, modafinil, zoloft, metformin, deplin, collagen, hyaluronic acid, biotin, magnesium glycinate, vitamin D3
Allergien: Penicillin, sulfa drug, macrodantin
Vorherige Impfungen: -

VAERS 2456038

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: TX
Alter: 62,0
Geschlecht: F
Eingang: 23.09.2022
Impfdatum: 15.09.2022
Beginn: 17.09.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Headache SARS-CoV-2 test Wheezing

Symptomtext

I developed Covid with symptoms approximately 2 days after vaccination. Symptoms were similar to a bad case of bronchitis, severe headaches, coughing, wheezing. Never had a temperature.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: At home Covid test.
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure controlled with medication
Andere Medikamente: Diovan and Wellbutrin
Allergien: None known
Vorherige Impfungen: -

VAERS 2456019

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: TN
Alter: 14,0
Geschlecht: M
Eingang: 23.09.2022
Impfdatum: 21.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Headache Injection site pain Product administered to patient of inappropriate age

Symptomtext

PATIENT WAS UNDER AGE OF RECOMMENDED AGE OF 18. Mom said on 9-22-2022 no reaction occurred other than than the normal pain at injection sight, tiredness and headache

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2456011

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: IL
Alter: 64,0
Geschlecht: M
Eingang: 23.09.2022
Impfdatum: 14.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 5,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain Injection site reaction Pain Sensory disturbance

Symptomtext

Case receive Moderna bivalent dose on 09-14-22 in his left deltoid muscle using a 1 inch needle. 5 days later, he states he started getting a burning sensation at site; a "deep cutting" sensation that comes and goes; and is worse with certain movements of his arm. He states his wife has looked at site and not observed any abnormality. He has had no fever. He also stated that when he touches site, he has sensation but that he does not feel much in the way of a deeper sensation. He states that 40 years ago he had a torn muscle in this arm but that he has not felt anything like this with a previous shot. He has also noticed this same deep cutting sensation in both wrist and ankle area. He has history of fibromyalgia and is due to have low back surgery in November.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: He states he reported this to secretary of his neurologist and has not received call back.
Aktuelle Erkrankungen: fibromyalgia
Vorgeschichte: fibromyalgia
Andere Medikamente: unknown
Allergien: sulfa
Vorherige Impfungen: -

VAERS 2460329

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: OH
Alter: 52,0
Geschlecht: M
Eingang: 22.09.2022
Impfdatum: 10.09.2022
Beginn: 11.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Peripheral swelling Pruritus

Symptomtext

Received vaccine @ facility so lot # etc unavailable to me. Presented 3d later w/ arm swelling (severe) and itching x 2d.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hyperlipidemia
Andere Medikamente: lipitor, flexeril, coQ10, MVI
Allergien: PCN
Vorherige Impfungen: -

VAERS 2455228

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CA
Alter: 86,0
Geschlecht: M
Eingang: 22.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration Pain in extremity Product administration error

Symptomtext

Moderna Bivalent dose (given on 9/16/22) only 1 month after the last Moderna booster dose (given on 8/11/22 ) Patient was informed of the administration error 1 hour after the shot. He is not experiencing any side effects other than sore arm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: High blood pressure, High cholesterol
Andere Medikamente: Atorvastatin 20mg, Amlodipine 10mg , Losartan 100mg
Allergien: none
Vorherige Impfungen: -

VAERS 2452282

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7148b

mild

Staat: OH
Alter: 63,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 16.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Illness Peripheral swelling Rash Skin warm

Symptomtext

sick all weekend then Monday night arm swollen and Tuesday am rash on arm and warm to touch

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452076

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: PA
Alter: 60,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 19.09.2022
Beginn: 20.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Arthralgia Body temperature increased

Symptomtext

Temperature was elevated (99.2) and patient states every joint in her body hurts.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2451503

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: WA
Alter: 62,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 17.09.2022
Beginn: 18.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain upper Body temperature increased Chills Discomfort Fatigue Feeling abnormal Headache Myalgia Nausea

Symptomtext

The night after getting the shot, I could tell I wasn't reacting well. I woke up Sunday morning with chills and later had a temp of 100.8 degrees F. I had a bad headache & muscle aches and didn't feel I could eat without risking throwing up. I laid in bed all day taking sips of water I felt miserable and not comfortable enough to sleep until about 10pm Sunday night. I was still tired and achy Monday morning including painful stomach cramps but gradually felt better by Monday evening and felt well enough to eat a normal dinner Monday night. Prior to that I had one egg Sunday and one egg Monday and about a dozen wheat thins, then some banana bread about 3pm Monday afternoon

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain upper
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: chronic sinus headaches, about 1 per month
Andere Medikamente: Niaspan 1500mg, rosuvastatin 5mg, aspirin 81mg, B-complex supplement, Calcium Citrate, magnesium, zink & D3 suplement, cetirizine 5mg, iron 65 mg, fish oil 1200 mg
Allergien: sulfa drugs
Vorherige Impfungen: -

VAERS 2442964

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: OH
Alter: 65,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 12.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration Injection site pain

Symptomtext

I was given the COVID booster shot SQ, not IM. The nurse firmly squeezed a large portion of my left upper arm and gave the shot . I weigh 165 pounds , 5 foot 6 inches, and have large fatty upper arms . I am an RN and didn't realize until it was done that I was given a SQ, not IM vaccine. I am looking for guidance on what to do ? Should I get a second booster ? I have contacted my doctor and also the pharmacist , where I received the vaccine . No one has an answer for what I should do. Was the vaccine effective, even if it was given in into SQ tissue with poor circulation.? I had minimal reaction to this last vaccine. Just a tiny bit of soreness at the site. No swelling, redness or warmth at the site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2442964

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: OH
Alter: 65,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 12.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration Injection site pain

Symptomtext

I was given the COVID booster shot SQ, not IM. The nurse firmly squeezed a large portion of my left upper arm and gave the shot . I weigh 165 pounds , 5 foot 6 inches, and have large fatty upper arms . I am an RN and didn't realize until it was done that I was given a SQ, not IM vaccine. I am looking for guidance on what to do ? Should I get a second booster ? I have contacted my doctor and also the pharmacist , where I received the vaccine . No one has an answer for what I should do. Was the vaccine effective, even if it was given in into SQ tissue with poor circulation.? I had minimal reaction to this last vaccine. Just a tiny bit of soreness at the site. No swelling, redness or warmth at the site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2444780

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

mild

Staat: CT
Alter: 76,0
Geschlecht: F
Eingang: 14.09.2022
Impfdatum: 10.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Abnormal dreams Chills Depressed level of consciousness Diarrhoea Fatigue Gastrointestinal disorder Lethargy Myalgia Nausea

Symptomtext

Chills Muscle aches and pains Semi-consciousness for 2 days Stomach pain Nausea Diarrhea Weird dreams Fatigue Worst symptoms for 2 days, with fatigue , lethargy, GI symptoms continuing additional 2 days

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain upper
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: -
Vorgeschichte: CKD
Andere Medikamente: Rosuvastatin Duloxitine Amlodipine Olmesertan/hctz Tylenol
Allergien: -
Vorherige Impfungen: Pfizer Covid Booster #2 - April. 28, 2022 - similar effects but not as intense and lasting longer.

VAERS 2440333

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

mild

Staat: VT
Alter: 59,0
Geschlecht: M
Eingang: 11.09.2022
Impfdatum: 08.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Fatigue Headache

Symptomtext

Fatigue, Chills, Headache lasting approximately 24 hours

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes
Andere Medikamente: Mirtazapine, Duloxetine, Fenofibrate, Simvastatin
Allergien: None
Vorherige Impfungen: COVID-19 Pfizer Lot FK893 Fatigue, Chills, Headache lasting approximately 24hrs

VAERS 2712505

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MN
Alter: 21,0
Geschlecht: F
Eingang: 10.11.2023
Impfdatum: 22.09.2022
Beginn: 06.11.2023
Tage bis Beginn: 410,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient vaccinated against and then tested positive for COVID 19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2693999

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MN
Alter: 74,0
Geschlecht: F
Eingang: 11.10.2023
Impfdatum: 22.09.2022
Beginn: 10.10.2023
Tage bis Beginn: 383,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient vaccinated against and then tested positive for COVID19

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2681314

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7148b

gering

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 12.09.2023
Impfdatum: 11.09.2023
Beginn: 11.09.2023
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Discontinued product administered

Symptomtext

pt got bivalent covid vaccine a few hours before the fda revoked them

Weitere VAERSDATA-Felder

Praegender Schweregrund: Discontinued product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2674155

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 50,0
Geschlecht: M
Eingang: 21.08.2023
Impfdatum: 14.12.2022
Beginn: 18.08.2023
Tage bis Beginn: 247,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Breakthrough COVID-19 SARS-CoV-2 test positive

Symptomtext

COVID vaccine breakthrough case. Moderna 9/21/21 048B21A and Moderna bivalent 12/14/22 AS7148B

Weitere VAERSDATA-Felder

Praegender Schweregrund: Breakthrough COVID-19
Hospital-Tage: -
Labordaten: Positive COVID test on 8/18/23
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2661229

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 26.07.2023
Impfdatum: 13.09.2022
Beginn: 11.01.2023
Tage bis Beginn: 120,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chronic respiratory failure Hypoxia Respiratory failure

Symptomtext

CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chronic respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2660600

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 44,0
Geschlecht: M
Eingang: 25.07.2023
Impfdatum: 16.09.2022
Beginn: 16.11.2022
Tage bis Beginn: 61,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Obstructive sleep apnoea syndrome

Symptomtext

OBSTRUCTIVE SLEEP APNEA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Obstructive sleep apnoea syndrome
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2655181

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 60,0
Geschlecht: M
Eingang: 11.07.2023
Impfdatum: 02.12.2022
Beginn: 02.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

No adverse event; 17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml; This spontaneous case was reported by a physician and describes the occurrence of UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event) in a 60-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. Patient had no allergies to medications, food and other products. Concurrent medical conditions included Pain. Concomitant products included ACETAMINOPHEN from 03-Aug-2022 to an unknown date for Pain, TAMSULOSIN from 02-Dec-2022 to an unknown date and INFLUENZA VACCINE INACT SPLIT 3V (FLULAVAL) for an unknown indication. On 02-Dec-2022 at 2:17 PM, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 02-Dec-2022 at 2:17 PM, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml). This case contains information about 5th patient out of 17 patients as described by the reporter. Concomitant medication dose details of Acetominophen was reported as to take 1-2 tabs, by mouth every 6 hours, as needed for pain. Concomitant medication dose details of Tamsulosin was reported as to take 2 capsules, by orally every day after half hour, following the same meal each day. On 10-Mar-2021, the patient received first dose of 0.5 ml of Moderna COVID-19 vaccine. On 09-Apr-2021, the patient received second dose of 0.5 ml of Moderna COVID-19 vaccine. The patient was administered with a wrong third dose and no other adverse event was reported. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2023-707980 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Follow up received included Reporter added, patient details updated, suspect product dose details and narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-707980:master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Pain
Vorgeschichte: Comments: Patient had no allergies to medications, food and other products.
Andere Medikamente: ACETAMINOPHEN; TAMSULOSIN; FLULAVAL
Allergien: -
Vorherige Impfungen: -

VAERS 2649892

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 91,0
Geschlecht: M
Eingang: 27.06.2023
Impfdatum: 13.09.2022
Beginn: 24.10.2022
Tage bis Beginn: 41,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Symptom recurrence Transient ischaemic attack

Symptomtext

TRANSIENT CEREBRAL ISCHEMIA 11/27/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Symptom recurrence
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2644078

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 84,0
Geschlecht: F
Eingang: 12.06.2023
Impfdatum: 23.01.2023
Beginn: 11.06.2023
Tage bis Beginn: 139,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Pfizer 2/25/21 lot# EN6202; Pfizer 3/18/21 lot# EN6207; Pfizer 6/29/22 lot# FM0173; Moderna 1/23/23 lot# AS7148B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2636399

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 25.05.2023
Impfdatum: 22.05.2023
Beginn: 22.05.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

Unfortunately, it had been administered to 1 patient on 22May2023. no adverse event; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Unfortunately it had been administered to 1 patient on 22May2023.) and NO ADVERSE EVENT (no adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 22-May-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-May-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Unfortunately it had been administered to 1 patient on 22May2023.) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Unfortunately it had been administered to 1 patient on 22May2023.) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Unfortunately it had been administered to 1 patient on 22May2023.). No concomitant medication details was reported. No treatment medication details was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2634897

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: NY
Alter: 63,0
Geschlecht: M
Eingang: 22.05.2023
Impfdatum: 22.05.2023
Beginn: 22.05.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered Medication error No adverse event

Symptomtext

Moderna Covid Bivalent lot # AS7148B expiration 05/17/2023 was admintered on 05/22/2023. Pt was monitor for 30 minutes tolerated vaccine well no adverse reaction reported . Pt was informed of medication error immedately . Nurse called Moderna Manufacturer to confirm if expiration date was extented waiting on call back .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: -
Vorgeschichte: HTN, DM
Andere Medikamente: Metformin HCL 1000MG Basaglar Kwik pen 100 unit/ Lisinapril 10 mg Amlopidine Beylate 5 mg
Allergien: Penciliinin
Vorherige Impfungen: -

VAERS 2628810

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: TN
Alter: 68,0
Geschlecht: F
Eingang: 08.05.2023
Impfdatum: 30.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event

Symptomtext

There were no adverse events or symptoms at the time or now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Constipation Depression Diabetes Osteoarthritis
Andere Medikamente: FLUTICASONE PROPIONATE DICLOFENAC SODIUM CETIRIZINE HCL LATANOPROST LINZESS FOLIC ACID LISINOPRIL PROZAC ROSUVASTATIN CALCIUM AMLODIPINE BESYLATE METHOCARBAMOL ASPIR 81
Allergien: -
Vorherige Impfungen: -

VAERS 2624776

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: IL
Alter: 71,0
Geschlecht: F
Eingang: 02.05.2023
Impfdatum: 04.10.2022
Beginn: 27.04.2023
Tage bis Beginn: 205,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Nasopharyngitis Rhinorrhoea SARS-CoV-2 test negative Sinusitis Tenderness

Symptomtext

I had a cold before discovering that I had Sinusitis on 04/27/2023 this happen few months after receiving my 4th vaccine. I had a cold above the neck. I had facial tenderness and runny nose. I went to my doctor's office on 04/27/2023 after explaining my symptoms to my doctor she prescribed me with Antibiotics.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nasopharyngitis
Hospital-Tage: -
Labordaten: 02MAY2023 COVID-19 Test- Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Tendency to Migraines
Andere Medikamente: Propranolol; Atorvastatin; Vitamin C; Vitamin B12; Calcium; Vitamin D
Allergien: N/A
Vorherige Impfungen: -

VAERS 2620093

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CT
Alter: 63,0
Geschlecht: M
Eingang: 24.04.2023
Impfdatum: 24.09.2022
Beginn: 27.01.2023
Tage bis Beginn: 125,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Deafness Ear discomfort Feeling hot SARS-CoV-2 test positive Sinus congestion Tinnitus

Symptomtext

On the morning of 01/27/2023, I was away at a business meeting, out of state. I felt warm and developed a cough and sinus congestion. I flew home and tested myself for COVID-19 and, I was positive. That night, I took Tylenol and Advil. I called my doctor the next morning. He advised that I take Paxlovid, which I started on 01/28/2023. Saturday and Sunday were no fun, but by Monday, I was feeling better. I was able to work remotely Monday and Tuesday. I finished the Paxlovid and had significant symptom relief. I was probably a full week before I felt normal. It was 17 days until I tested negative. During that day, I stayed home and isolated. With the acute event on the 27th, my ears became clogged. For about 6 weeks after, I would have intermittent ringing and popping in my ears with a bit of hearing loss. It wasn't constant. It slowly faded away on its own.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 27JAN2023 - At Home COVID-19 Test - Positive; 02FEB2023 - At Home COVID-19 Test - Positive; 03FEB2023 - At Home COVID-19 Test - Positive; 04FEB2023 - At Home COVID-19 Test - Positive; 06FEB2023 - At Home COVID-19 Test - Positive; 08FEB2023 - At Home COVID-19 Test - Positive: 13FEB2023 - At Home COVID-19 Test - Negative
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; High Cholesterol; GERD; Urinary Tract Infections
Andere Medikamente: Protonix; Zetia; Pravachol; Lisinopril; Macrodantin; Flonase
Allergien: Penicillin; Sulfa
Vorherige Impfungen: -

VAERS 2617679

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 80,0
Geschlecht: F
Eingang: 19.04.2023
Impfdatum: 18.11.2022
Beginn: 16.04.2023
Tage bis Beginn: 149,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 5 vaccines Moderna 1/22/21 Lot# 027L20A; Moderna 2/19/21 Lot# 038K20A; Moderna 12/1/21 Lot# 034F21A; Moderna 6/10/22 Lot# 056M21A; Moderna 11/18/22 Lot# AS7148B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2615466

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CO
Alter: 75,0
Geschlecht: F
Eingang: 14.04.2023
Impfdatum: 10.10.2022
Beginn: 01.12.2022
Tage bis Beginn: 52,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Choking sensation Increased viscosity of upper respiratory secretion Nasal disorder Pharyngeal disorder Productive cough Secretion discharge

Symptomtext

In around December 2022, I began coughing up a large amount of mucus every day. This symptom has persisted and continues to this day. I went to my PCP on 3/20/2023. He determined that I had cobblestone throat and nasal passages. He said that my lungs and my ears were clear, however. He prescribed me pantoprazole. He also recommended OTC Claritin and Flonase. He instructed me to take all three medications for 30 days. Sometimes, I feel like there's been an improvement, but sometimes I cough up phlegm until I want to choke. The mucus I cough up now is thick, but usually clear, though it does sometimes have a yellowish tinge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Choking sensation
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Crestor; Levothyroxine; Oxybutynin; Multivitamin; Omega 3; Turmeric; Vitamin C; Glucosamine Chondroitin; Calcium; Vitamin D
Allergien: Sulfa Drugs
Vorherige Impfungen: -

VAERS 2615256

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: MI
Alter: 48,0
Geschlecht: M
Eingang: 14.04.2023
Impfdatum: 19.12.2021
Beginn: 13.04.2023
Tage bis Beginn: 480,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID vaccine breakthrough case

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID positive test 4/4/23
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2609884

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: TX
Alter: 63,0
Geschlecht: F
Eingang: 05.04.2023
Impfdatum: 19.09.2022
Beginn: 06.03.2023
Tage bis Beginn: 168,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

SARS-CoV-2 test negative Upper respiratory tract infection

Symptomtext

I came down with an upper respiratory infection on 03/08/2023. They prescribed me prednisone and the infection went away after two weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: SARS-CoV-2 test negative
Hospital-Tage: -
Labordaten: At-home Covid test 03/07/2023 negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma
Andere Medikamente: SINGULAIR; CLARITIN; vitamin D; inhaler
Allergien: N/A
Vorherige Impfungen: -

VAERS 2609069

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: IL
Alter: 75,0
Geschlecht: M
Eingang: 04.04.2023
Impfdatum: 29.09.2022
Beginn: 14.12.2022
Tage bis Beginn: 76,0
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Exposure to SARS-CoV-2 Hypertonic bladder Renal disorder SARS-CoV-2 test positive Upper-airway cough syndrome

Symptomtext

In December, my wife contracted COVID-19. Six days later, I tested positive for COVID-19. I contacted my doctor. She prescribed Paxlovid. I tested positive for COVID-19 for the next four days. I had I had a slight cough and postnasal drip for about two weeks. In January, I contacted my doctor again because COVID-19 seemed to have affected my kidneys. Now, I also take Mirabegron for an overactive bladder.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 12/14/2022 COVID-19 Test - Positive
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure; Heart Murmur
Andere Medikamente: Enalapril Maleate; Low Dose Aspirin; Atorvastatin; Centrum Silver; Citrucel; Asmanex
Allergien: Dust Mite; MSG
Vorherige Impfungen: -

VAERS 2609038

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7148b

gering

Staat: MI
Alter: 78,0
Geschlecht: M
Eingang: 04.04.2023
Impfdatum: 04.10.2022
Beginn: 25.03.2023
Tage bis Beginn: 172,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

covid vaccine breakthrough case all Moderna dose 1 2/26/21 010a21a dose 2 3/26/21 017b21a dose 3 10/23/21 039d21a dose 4 4/21/22 066k21a

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: covid+ 3/25/23
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2603368

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: FL
Alter: 68,0
Geschlecht: F
Eingang: 24.03.2023
Impfdatum: 10.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation Heart rate increased Laboratory test abnormal

Symptomtext

I did not have an adverse reaction to the vaccine. My heart started beating really fast when I would lay down which lasted several days. I was out-of-town but when I returned home, I went to the doctor. I went through some test and was diagnosed with AFIB and rapid heartbeat. I am taking medication to control both. As of today, I am feeling better and less frequent episodes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Atrial fibrillation
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2602320

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MN
Alter: 76,0
Geschlecht: F
Eingang: 23.03.2023
Impfdatum: 21.09.2022
Beginn: 28.02.2023
Tage bis Beginn: 160,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Vertigo positional

Symptomtext

In February 2023, I had my head down while moving a piece of furniture. The whole room tilted. It lasted for two weeks. I understood I was having vertigo symptoms. I saw a nurse practitioner on March 13th. I was diagnosed with positional vertigo. I was given some exercises. The final diagnosis was Benign Paroxysmal Positional Vertigo.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vertigo positional
Hospital-Tage: -
Labordaten: Physical exam
Aktuelle Erkrankungen: N/A
Vorgeschichte: Glaucoma; Sjogren's Syndrome; Osteopenia
Andere Medikamente: Dorzolamide; latanoprost; rosuvastatin; calcium with magnesium; coQ10; omega 3; aspirin; vitamin B12; vitamin K; bergamot
Allergien: Sulfa; Latex
Vorherige Impfungen: -

VAERS 2601770

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: OH
Alter: 71,0
Geschlecht: M
Eingang: 22.03.2023
Impfdatum: 20.09.2022
Beginn: 01.02.2023
Tage bis Beginn: 134,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Chest discomfort

Symptomtext

It's very hard to describe, but in late February, I began to have a strange sensation in the middle of my chest. It felt almost like and anxiety type feeling when you lose your keys or wallet. I was concerned it was heart related. I saw my doctor for an existing appointment and described my symptoms. He advised that I take one of three over the counter acid reducers. I went with a 14-day course of lansoprazole. Tomorrow is my last day. It seems to have helped, but the sensation is not entirely gone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anxiety
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: High Cholesterol
Andere Medikamente: Aspirin; atorvastatin; vitamin D3; vitamin B12; dutasteride; ezetimibe; ketoconazole prescription shampoo
Allergien: Environmental allergies; latex sensitivity; shellfish
Vorherige Impfungen: Shingles vaccine (Shingrix) 2018, unusual fatigue and uncomfortable sensation for 24 hours.

VAERS 2599628

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: TN
Alter: 80,0
Geschlecht: M
Eingang: 20.03.2023
Impfdatum: 17.09.2022
Beginn: 01.03.2023
Tage bis Beginn: 165,0
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Discomfort Exposure to SARS-CoV-2 Nasal congestion Respiratory symptom Rhinorrhoea SARS-CoV-2 test negative Taste disorder

Symptomtext

My wife already had COVID-19 and started PAXLOVID on Tuesday. Wednesday night, I had two degrees above my normal temperature and I had my usual upper respiratory like symptoms. I called the next day for a doctor and was given PAXLOVID. My rhinorrhea increased and I had a terrible taste in my mouth. Everything resolved over time. I never had significant symptoms. I have been uncomfortable with nasal congestion and cough, but that's about it. No difficulties with oxygen, breathing, or cardiac issues. I had tested negative the day my wife tested positive for COVID-19. When symptoms began, I did not retest because I had been in close proximity to my wife, and we knew it was already COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cough
Hospital-Tage: -
Labordaten: 27FEB2023 at home COVID-19 test; negative
Aktuelle Erkrankungen: Iron deficiency anemia
Vorgeschichte: Obstructive Sleep Apnea; Pulmonary Hypertension; Hypercholesterolemia; Residual Urine; History of Kidney Stones; Frequent UTIs; Musculoskeletal pains; Basal Cell Skin Cancers; Elevated pulmonary pressures; Diastolic dysfunction
Andere Medikamente: Atorvastatin; coenzymeQ10; AREDS 2 formula PRESERVISION; fluticasone; losartan potassium hydrochlorothiazide combination; multivitamin; resveratrol; BYSTOLIC; tadalafil; COLACE; FLOMAX; loratadine; iron
Allergien: Eggs; orange juice; cyproheptadine topical solution
Vorherige Impfungen: -

VAERS 2598688

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge as7148b

gering

Staat: PA
Alter: 65,0
Geschlecht: F
Eingang: 17.03.2023
Impfdatum: 09.09.2022
Beginn: 18.12.2022
Tage bis Beginn: 100,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 SARS-CoV-2 test positive

Symptomtext

Contracted Covid 19 from a close family contact. Took Paxlovid, prescribed by the nurse. Medicine worked well enabling me to successfully recover from the virus at home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: At home test confirmed that I was positive for Covid on Sunday, December 18, 2022. My husband contracted Covid the week before - his diagnosis was confirmed by a test at the doctor's office. I tested daily negative for 4 days but eventually contracted the virus on the 5th day.
Aktuelle Erkrankungen: none
Vorgeschichte: Graves Disease
Andere Medikamente: Synthroid daily (alternating between 50 and 75 mcg; estradiol 0.05 mg/24 hr patch twice weekly; calcium=vitamin D3 500-200mg once daily; cholecalciferol, vitamin D3, 25 mcg (1000) once daily; Moisturizing eye drops 4 times daily
Allergien: Bactrim, Levocetirizine, Sulfa
Vorherige Impfungen: -

VAERS 2596927

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 13.09.2022
Beginn: 14.11.2022
Tage bis Beginn: 62,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Escherichia infection Escherichia test positive Incontinence Micturition urgency Urinary tract discomfort Urine analysis

Symptomtext

11/14/2022 I had some urgency for urination and discomfort after I voided. It moved into borderline incontinence. I had an appointment on 11/16/2022 with the doctor. I had a urine check; my lungs and heart were checked. It was likely an infection which was later diagnosed with E. coli. I was prescribed cephalexin. I began taking the medication that day. It was a 5 day supply and my symptoms were resolved after 2 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Escherichia infection
Hospital-Tage: -
Labordaten: Urine check, E Coli
Aktuelle Erkrankungen: No
Vorgeschichte: None
Andere Medikamente: CENTRUM SILVER; zinc; glucosamine; calcium; vitamin D
Allergien: No
Vorherige Impfungen: -

VAERS 2594629

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 82,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 04.10.2022
Beginn: 09.03.2023
Tage bis Beginn: 156,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

covid vaccine breakthrough case dose 1 Moderna 3/9/21 044A21A dose 2 Moderna 4/6/21 040B21A dose 3 Moderna 11/4/21 076C21A

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: covid+ test on 3/9/23
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2591857

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MN
Alter: 75,0
Geschlecht: M
Eingang: 06.03.2023
Impfdatum: 16.09.2022
Beginn: 13.12.2022
Tage bis Beginn: 88,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

12/13/2022 tested positive even though I had no symptoms. I went to the ER locally. Due to my ongoing medications I was not a candidate for PAXLOVID so I received 3 days of IV remdesivir. I tested positive for 19 days after onset.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Sleep Apnea; Diabetes; High Cholesterol; Pre Existing Cardiac issues
Andere Medikamente: PRALUENT; pantoprazole; metropole ER; diltiazem XT; levothyroxine; metformin; TRULICITY; lisinopril; ELIQUIS; PLAVIX; hydrochlorothiazide; CRESTOR; tizanidine DR; coQ10; vitamin D3; vitamin B12; ferrous sulfate; baby aspirin; EQUATE probiot
Allergien: Statin drugs
Vorherige Impfungen: -

VAERS 2588087

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 22,0
Geschlecht: M
Eingang: 27.02.2023
Impfdatum: 22.02.2023
Beginn: 22.02.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

no adverse event; She states that a patient was supposed to receive 0.5 ml, but only got 0.25 ml.; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (She states that a patient was supposed to receive 0.5 ml, but only got 0.25 ml.) and NO ADVERSE EVENT (no adverse event) in a 22-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 22-Feb-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced ACCIDENTAL UNDERDOSE (She states that a patient was supposed to receive 0.5 ml, but only got 0.25 ml.). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (She states that a patient was supposed to receive 0.5 ml, but only got 0.25 ml.) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (She states that a patient was supposed to receive 0.5 ml, but only got 0.25 ml.). No concomitant medications were reported. The reporter stated that a patient was supposed to receive 0.5 ml as initial booster, but only got 0.25 ml. HCP asked if the recommendation was considered 24 hours or on the same day because the patient got the half dose yesterday 22-Feb2-023. HCP asked if she should give a full dose today 23-Feb-2023. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2586271

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 22,0
Geschlecht: M
Eingang: 23.02.2023
Impfdatum: 22.02.2023
Beginn: 22.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient should have received 0.5 ml but instead received 0.25 ml of the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2584763

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 67,0
Geschlecht: F
Eingang: 21.02.2023
Impfdatum: 23.09.2022
Beginn: 30.10.2022
Tage bis Beginn: 37,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 5 vaccines Moderna 2/17/21 Lot# 038K20A; Moderna 3/17/21 Lot# 030A21A; Moderna 8/16/21 Lot# 088D; Moderna 4/12/22 Lot# 005M21A; Moderna 9/23/22 Lot# AS7148B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2582371

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 63,0
Geschlecht: F
Eingang: 15.02.2023
Impfdatum: 07.01.2023
Beginn: 07.01.2023
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Underdose

Symptomtext

No adverse event, Wrong dose given. Given Moderna Bi-valent .25

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578334

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 73,0
Geschlecht: F
Eingang: 08.02.2023
Impfdatum: 05.12.2022
Beginn: 05.12.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Underdose

Symptomtext

No adverse event. Wrong dose given. Given Moderna Bi-valent .25

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2572098

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: KY
Alter: 49,0
Geschlecht: F
Eingang: 31.01.2023
Impfdatum: 19.01.2023
Beginn: 19.01.2023
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong product administered

Symptomtext

Patient given wrong vaccination. She needed the second dose of the primary series and was given Bivalent booster instead. The patient had no complications or issues with the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: HTN
Andere Medikamente: amlodipine, losartan, xyzal
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2570171

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: -
Alter: 79,0
Geschlecht: F
Eingang: 30.01.2023
Impfdatum: 05.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Circumstance or information capable of leading to medication error No adverse event Wrong product administered

Symptomtext

has it listed as a monovalent not a bivalent dose; Circumstance or information capable of leading to medication error; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (has it listed as a monovalent not a bivalent dose), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (No adverse event) in a 79-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (has it listed as a monovalent not a bivalent dose), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (has it listed as a monovalent not a bivalent dose), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (has it listed as a monovalent not a bivalent dose) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Circumstance or information capable of leading to medication error). No concomitant and treatment medications were reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Circumstance or information capable of leading to medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568267

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: KY
Alter: 49,0
Geschlecht: F
Eingang: 26.01.2023
Impfdatum: 12.12.2022
Beginn: 19.01.2023
Tage bis Beginn: 38,0
Dosis: 2
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration No adverse event Wrong product administered

Symptomtext

No Adverse Event; A bivalent vaccine was given to the patient instead of a monovalent as the patient needed primary series; Also the time between the two doses is outside of the two month recommendation; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (A bivalent vaccine was given to the patient instead of a monovalent as the patient needed primary series), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Also the time between the two doses is outside of the two month recommendation) and NO ADVERSE EVENT (No Adverse Event) in a 49-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. Co-suspect product included mRNA-1273 (Spikevax) (batch no. 057A22A) for COVID-19 prophylaxis. No Medical History information was reported. On 12-Dec-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Jan-2023, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Jan-2023, the patient experienced WRONG PRODUCT ADMINISTERED (A bivalent vaccine was given to the patient instead of a monovalent as the patient needed primary series) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Also the time between the two doses is outside of the two month recommendation). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, WRONG PRODUCT ADMINISTERED (A bivalent vaccine was given to the patient instead of a monovalent as the patient needed primary series), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Also the time between the two doses is outside of the two month recommendation) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (A bivalent vaccine was given to the patient instead of a monovalent as the patient needed primary series) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Also the time between the two doses is outside of the two month recommendation). For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (A bivalent vaccine was given to the patient instead of a monovalent as the patient needed primary series) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Also the time between the two doses is outside of the two month recommendation). Concomitant and treatment medications were not reported. Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that, bivalent vaccine was given to the patient instead of a monovalent as the patient needed primary series. Patient received primary series of Moderna vaccine on 12-Dec-2022 and a Moderna bivalent booster on 19-Jan-2023, so didn't received full primary series. The time between the two doses is outside of the two-month recommendation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2565731

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 65,0
Geschlecht: F
Eingang: 23.01.2023
Impfdatum: 15.09.2022
Beginn: 22.01.2023
Tage bis Beginn: 129,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrougn case admission after 4 vaccines Moderna 3/19/21 Lot# 0044A21A; Moderna 4/16/21 Lot# 025B21A; Moderna 11/17/21 Lot# 077C21B; Moderna 9/15/22 Lot# AS7148B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2558647

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 50,0
Geschlecht: F
Eingang: 12.01.2023
Impfdatum: 13.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 18,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Tinnitus

Symptomtext

A few weeks after receiving the Covid bivalent booster I developed severe tinnitus. It has slowly decreased since that time but is consistently what I would call mild to moderate tinnitus in both ears, left greater than right.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tinnitus
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: zyrtec prilosec singulair trintellix spironolactone methylated B complex
Allergien: IV contrast amoxicillin sesame seed grass
Vorherige Impfungen: -

VAERS 2556071

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: NJ
Alter: 68,0
Geschlecht: F
Eingang: 10.01.2023
Impfdatum: 06.10.2022
Beginn: 01.11.2022
Tage bis Beginn: 26,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Loss of personal independence in daily activities Magnetic resonance imaging Neuralgia

Symptomtext

I am having severe nerve pain affecting my legs. I had an MRI and was prescribed LYRICA. This is still ongoing, and it is affecting my everyday life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of personal independence in daily activities
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; Osteoporosis; High Cholesterol
Andere Medikamente: Flecainide; metoprolol; atorvastatin; aspirin; calcium; vitamin D
Allergien: Naproxen; TYLENOL cold
Vorherige Impfungen: -

VAERS 2548833

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: MN
Alter: 85,0
Geschlecht: F
Eingang: 03.01.2023
Impfdatum: 03.11.2022
Beginn: 30.12.2022
Tage bis Beginn: 57,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient vaccinated against then tested positive for COVID-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2548316

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: IL
Alter: 65,0
Geschlecht: M
Eingang: 02.01.2023
Impfdatum: 28.12.2022
Beginn: 28.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM); No adverse event; Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)), PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and NO ADVERSE EVENT (No adverse event) in a 65-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Pneumococcal 20 vaccine (Had received a pneumococcal 20 vaccine. Expiration date of vaccine was 13-Jan-2023) on 06-Dec-2022. Past adverse reactions to the above products included No adverse event with Pneumococcal 20 vaccine. On 28-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 28-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)), PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)). Concomitant medications were not reported. It was reported that a vial of the Moderna COVID-19 vaccine bivalent was initially punctured on 27-Dec-2022 at 10:00 AM, where 3 doses were administered. Yesterday on 28-Dec-2022, 2 doses were given more than 24 hours after the initial vial puncture (9:57 AM and 4:11 PM). No reported symptoms. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-692952 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-692952:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2548249

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: NJ
Alter: 77,0
Geschlecht: M
Eingang: 02.01.2023
Impfdatum: 24.10.2022
Beginn: 24.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Patient was vaccinated beyond use date of 10/8/2022. No symptoms reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None Reported
Vorgeschichte: None Reported
Andere Medikamente: None Reported
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2548245

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: NJ
Alter: 74,0
Geschlecht: F
Eingang: 02.01.2023
Impfdatum: 24.10.2022
Beginn: 24.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Patient was vaccinated beyond use date of 10/8/2022. No symptoms reported by patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None Reported
Vorgeschichte: None Reported
Andere Medikamente: None Reported
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2547982

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: IL
Alter: 64,0
Geschlecht: M
Eingang: 02.01.2023
Impfdatum: 28.12.2022
Beginn: 28.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM); No adverse event; Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)), PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and NO ADVERSE EVENT (No adverse event) in a 64-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 28-Dec-2022, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)), PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)) and PRODUCT STORAGE ERROR (Moderna COVID-19 vaccine bivalent was initially punctured on DEC 27, 2022 at 10:00 AM and on DEC 28, 2022 2 doses were given more than 24 hours after the initial vial puncture (9:57AM and 4:11PM)). Concomitant medications were not reported. It was reported that a vial of the Moderna COVID-19 vaccine bivalent was initially punctured on 27-Dec-2022 at 10:00 AM, where 3 doses were administered. Yesterday on 28-Dec-2022, 2 doses were given more than 24 hours after the initial vial puncture (9:57 AM and 4:11 PM). No reported symptoms. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-692977 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-692977:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545923

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545922

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 62,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545919

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 48,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 01.12.2022
Beginn: 01.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545917

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 48,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 01.12.2022
Beginn: 01.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545916

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 62,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 01.12.2022
Beginn: 01.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545914

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 43,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545913

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 29,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545910

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 44,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545909

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 47,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545905

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 53,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545904

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 47,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545898

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 30,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product use issue

Symptomtext

Given past 30 day use by date in fridge

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product use issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545896

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 50,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545892

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 43,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545891

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 42,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545887

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 59,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545885

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 59,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545883

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 53,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545881

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 46,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545880

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 33,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545879

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 36,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545878

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 58,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545876

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 48,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545875

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 60,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Given past 30 day use by date in fridge

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545873

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 42,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545599

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 42,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 15.12.2022
Beginn: 15.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545598

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 38,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 14.12.2022
Beginn: 14.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545596

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 30,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 13.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545591

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 60,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 13.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545589

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 47,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 13.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545583

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 78,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545575

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 78,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product use issue

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545572

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 48,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545569

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 61,0
Geschlecht: F
Eingang: 29.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545566

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 57,0
Geschlecht: M
Eingang: 29.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545019

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 58,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545018

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 36,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545015

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 47,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545014

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 47,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545012

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 29,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545010

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 43,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545008

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 36,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545007

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 44,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545006

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 26,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545005

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 60,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2545000

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 26,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544993

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 54,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544990

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 30,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544987

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 34,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544984

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 56,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544983

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 45,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544982

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 49,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544979

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 46,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544976

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 49,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544972

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: -
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544964

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 56,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544957

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 48,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544865

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544861

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 54,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544852

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 40,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544848

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 48,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544840

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 54,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered No adverse event

Symptomtext

Inadvertent administration past the 30-day Use by Date of the Moderna vaccine. No Symptoms to report as no adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544158

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 53,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 53-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). 60 doses was received to several patient from Lot AS7148B. Concomitant medications were not reported. No treatment information was provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544157

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 56,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 56-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 27-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up. 60 doses was received to several patient from Lot AS7148B. Concomitant medications were not reported. No treatment information was provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544156

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 30,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 30-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 27-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). Concomitant medications details were not reported by the reporter. Patient ID was reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, In this report the patient was not Eligible. Breakdown of doses were reported as 51 doses from batch number AS7140C and 60 doses from Batch number AS7148B. Treatment details were not reported by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-689946 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-689946:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544154

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 66,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 66-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). No concomitant medication was reported. No treatment medication was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544153

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 40,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 40-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 20-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). Concomitant medications details were not reported by the reporter. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, In this report the patient was not Eligible. Breakdown of doses were reported as 51 doses from batch number AS7140C and 60 doses from Batch number AS7148B. Treatment details were not reported by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-689946 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-689946:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544152

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: -
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 20-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). Concomitant medications details were not reported by the reporter. It was reported that 60 doses received to several patient from Lot AS7148B. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment details were not reported by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544151

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 50,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 50-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). Patient ID was reported. Concomitant medications details were not reported by the reporter. It was reported that 60 doses received to several patient from Lot AS7148B. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment details were not reported by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544144

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 42,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 15.12.2022
Beginn: 15.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 42-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). No concomitant medication was reported. 60 doses were received with Lot AS7148B. No treatment medication was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544142

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 30,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 13.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 30-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 13-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). Patient ID was reported as Unknown. Concomitant medications details were not reported by the reporter. It was reported that 60 doses received to several patient from Lot AS7148B. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment details were not reported by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544140

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 47,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 13.12.2022
Beginn: 13.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 47-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 13-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 13-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). Concomitant medications were not reported. 113 Bivalent doses administered after the BUD to patients 12 and up. Breakdown of doses were as 51 doses from Lot AS7140C and 60 doses from Lot AS7148B. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-689946 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-689946: Case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544139

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CO
Alter: 78,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 78-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 08-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). Concomitant medications were not reported. 113 Bivalent doses administered after the BUD to patients 12 and up. Breakdown of doses were as 51 doses from Lot AS7140C and 60 doses from Lot AS7148B. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-689946 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-689946:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544138

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 61,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 61-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 08-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). Patient ID was reported. Concomitant medications details were not reported by the reporter. It was reported that 60 doses received to several patient from Lot AS7148B. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment details were not reported by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544091

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 53,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 53-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). No concomitant medications were provided. It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was repored that administered 113 Bivalent doses administered after the BUD to patients 12 and up. 60 doses from Lot AS7148B. No treatment medication was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544089

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 50,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 50-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). No concomitant medication information was provided. Total 113 Bivalent doses administered after the BUD to patients 12 and up. 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B. It was unknown patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No treatment medication was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544087

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 43,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 43-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). No concomitant medications was provided. No treatment medications was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544085

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 42,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 42-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients). No concomitant drug was reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No treatment drug was reported. This case was linked to MOD-2022-690931 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544083

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CO
Alter: 59,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 59-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up). Patient ID was reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant drug was reported. Reportedly, the patient was eligible for COVID-19 vaccine. No treatment drug was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544078

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CO
Alter: 53,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 53-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 16-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 16-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.). No concomitant medications were reported. 113 Bivalent doses administered after the BUD to patients 12 and up. 51 doses from Lot AS7140C and 60 doses from Lot AS7148B. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544074

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CO
Alter: 46,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 46-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 16-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 16-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). No concomitant medications were provided. It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that 113 Bivalent doses administered after the BUD to patients 12 and up. 60 doses from Lot AS7148B. No treatment medication was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544066

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CO
Alter: 48,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 16.11.2022
Beginn: 16.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 48-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 16-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 16-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.). No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2022-690819 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544063

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CO
Alter: 47,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 47-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.). No relevant concomitant medications were reported. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544060

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 58,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event: Bivalent doses administered after the BUD to patients 12 and up. This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 58-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients 12 and up.). No relevant concomitant medications were reported. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544054

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CO
Alter: 36,0
Geschlecht: M
Eingang: 28.12.2022
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD) and NO ADVERSE EVENT (No adverse event) in a 36-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 15-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD). No concomitant medications were reported. It was reported that, the patient received bivalent doses after the beyond use-by date. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543577

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MN
Alter: 85,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 03.11.2022
Beginn: 26.12.2022
Tage bis Beginn: 53,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient vaccinated against then tested positive for COVID-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543567

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge AS7148B

gering

Staat: MN
Alter: 59,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 22.09.2022
Beginn: 26.12.2022
Tage bis Beginn: 95,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient vaccinated against then tested positive for COVID-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543353

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 60,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 60-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). 60 doses was received to several patient from Lot AS7148B. Concomitant medications were not reported. No treatment information was provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543352

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 54,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 27-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). Concomitant medication was not reported. Patient ID was reported as 4688127. It was unknown if patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, in this report the patient was not Eligible. Breakdown of doses were reported as 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B. Treatment drug was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543351

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 57,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 57-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 08-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). Concomitant medication was not provided. Treatment medication information was not provided by the reporter. It was reported that breakdown of doses is as follows- 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543350

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 62-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 08-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). No concomitant medication was reported. 60 doses were received with Lot AS7148B. No treatment medication was reported. This case was linked to MOD-2022-690899 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543326

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CO
Alter: 48,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event: 113 Bivalent doses administered after the BUD to patients 12 and up. This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 48-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 20-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). 60 doses was received to several patient from Lot AS7148B. Concomitant medications were not reported. No treatment information was provided This case was linked (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543323

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 48,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 08.12.2022
Beginn: 08.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

113 Bivalent doses administered after the BUD to patients 12 and up; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 48-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 08-Dec-2022, the patient experienced NO ADVERSE EVENT (No adverse event). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). 60 doses was received to several patient from Lot AS7148B. Concomitant medications were not reported. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543321

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 62,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 01.12.2022
Beginn: 01.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up. This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 62-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 01-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). 60 doses was received to several patient from Lot AS7148B. Concomitant medications were not reported. No treatment information was provided This case was linked (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543320

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 48,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 01.12.2022
Beginn: 01.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 48-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 01-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 01-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). 60 doses were received to several patient from Lot AS7148B. Concomitant medications were not reported. No treatment information was provided This case was linked (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543318

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 29,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

113 Bivalent doses administered after the BUD to patients 12 and up; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 29-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 17-Nov-2022, the patient experienced NO ADVERSE EVENT (No adverse event). On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). Concomitant medications details were not reported by the reporter. Patient ID was reported as 8850855. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, In this report the patient was not Eligible for VFC. Breakdown of doses were reported as 51 doses from batch number AS7140C and 60 doses from Batch number AS7148B. Treatment details were not reported by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-689946 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-689946:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543317

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 44,0
Geschlecht: F
Eingang: 27.12.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 44-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). Concomitant medication was not reported. Patient ID was reported. It was unknown if patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, in this report the patient was not Eligible. Breakdown of doses were reported as 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B. Treatment drug was not reported. This case was linked to (E2B Linked Report). Sender's Comments:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543259

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 30,0
Geschlecht: M
Eingang: 27.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 30-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Nov-2022 at 3:05 PM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 03-Nov-2022 at 3:05 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). No concomitant drug information was provided. It was reported that 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B were administered. No treatment drug information was provided. This case was linked (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543209

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 55,0
Geschlecht: M
Eingang: 26.12.2022
Impfdatum: 11.10.2022
Beginn: 11.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 55-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 11-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 11-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). Concomitant medications details were not reported by the reporter. Patient ID was reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, In this report the patient was not Eligible. Breakdown of doses were reported as 51 doses from batch numberAS7140C and 60 doses from Batch number AS7148B. Treatment details were not reported by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543204

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 47,0
Geschlecht: F
Eingang: 26.12.2022
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 47-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 15-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant product use was not provided by the reporter. It was reported that 113 Bivalent doses administered after the BUD to patients 12 and up. Breakdown of doses was as follows 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543203

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 47,0
Geschlecht: M
Eingang: 26.12.2022
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to o patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to o patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 47-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 15-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to o patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to o patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to o patients 12 and up). It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant product use was not provided by the reporter. It was reported that 113 Bivalent doses administered after the BUD to patients 12 and up. Breakdown of doses was as follows 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543202

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 29,0
Geschlecht: M
Eingang: 26.12.2022
Impfdatum: 15.11.2022
Beginn: 15.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD to patient 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 29-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 15-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 15-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient 12 and up.). Patient ID was reported. No concomitant medication was reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, in this report the patient was not Eligible. Breakdown of doses were reported as 51 doses from batch numberAS7140C and 60 doses from Batch number AS7148B. No treatment medication was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543201

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 43,0
Geschlecht: M
Eingang: 26.12.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD to the patient 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to the patient 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 43-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 10-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to the patient 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to the patient 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to the patient 12 and up.). Concomitant medication was not reported. Patient ID was reported. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, in this report the patient was not Eligible. Breakdown of doses were reported as 51 doses from batch numberAS7140C and 60 doses from Batch number AS7148B. Treatment medication was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543200

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: -
Geschlecht: M
Eingang: 26.12.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 36-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 10-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). It was reported that it was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant product use was not provided by the reporter. Patient received empower health and wellness center. It was reported that 113 Bivalent doses administered after the BUD to patients 12 and up. Breakdown of doses is as follows- 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543198

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 44,0
Geschlecht: F
Eingang: 26.12.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 44-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 10-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 10-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). Concomitant medications details were not reported by the reporter. Patient ID was reported as 7223173. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, In this report the patient was not eligible for vaccine. Breakdown of doses were reported as 51 doses from batch numberAS7140C and 60 doses from Batch number AS7148B. Treatment details were not reported by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543197

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 60,0
Geschlecht: F
Eingang: 26.12.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) in a 60-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 10-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 10-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up). Concomitant medications details were not reported by the reporter. Patient ID was reported as 7656467. It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Reportedly, In this report the patient was not Eligible for vaccine. Breakdown of doses were reported as 51 doses from batch numberAS7140C and 60 doses from Batch number AS7148B. Treatment details were not reported by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543196

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 26,0
Geschlecht: M
Eingang: 26.12.2022
Impfdatum: 04.11.2022
Beginn: 04.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) in a 26-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 04-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient). Concomitant product use was not provided by the reporter. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543195

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 54,0
Geschlecht: F
Eingang: 26.12.2022
Impfdatum: 04.11.2022
Beginn: 04.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) in a 54-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 04-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patient). Concomitant product use was not provided by the reporter. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543194

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 34,0
Geschlecht: M
Eingang: 26.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 34-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Nov-2022 at 2:46 PM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 03-Nov-2022 at 2:46 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). No concomitant drug information was provided. It was reported that 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B were administered. No treatment drug information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543192

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 45,0
Geschlecht: M
Eingang: 26.12.2022
Impfdatum: 03.11.2022
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

113 Bivalent doses administered after the BUD to patients 12 and up.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). No concomitant medications were reported. It was unknown if the patent had received any other vaccines in the 4 weeks prior to COVID-19 vaccine. No treatment drugs were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543188

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: -
Geschlecht: F
Eingang: 26.12.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

113 Bivalent doses administered after the BUD to patients 12 and up.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event). At the time of the report, NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). No concomitant medications were reported. It was reported that 113 Bivalent doses were administered after the BUD to patients 12 and up. 51 doses were administered from Lot AS7140C, and 60 doses from Lot AS7148B. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2543187

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 46,0
Geschlecht: F
Eingang: 26.12.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Bivalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 46-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 03-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients). Concomitant medication was not reported. Treatment medication was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2542206

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: NJ
Alter: 73,0
Geschlecht: M
Eingang: 23.12.2022
Impfdatum: 21.09.2022
Beginn: 18.12.2022
Tage bis Beginn: 88,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Nasopharyngitis SARS-CoV-2 test

Symptomtext

Cold symptoms starting 12/18/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nasopharyngitis
Hospital-Tage: -
Labordaten: Home COVID test on 12/20/2022 and test at urgent care clinic same day
Aktuelle Erkrankungen: none
Vorgeschichte: high cholesterol, cardiac scarring, Afib
Andere Medikamente: Hydrochlorothiazide,Tamsulosin, Metropolol, aspirin 81mg,
Allergien: none
Vorherige Impfungen: -

VAERS 2542005

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 44,0
Geschlecht: M
Eingang: 23.12.2022
Impfdatum: 21.09.2022
Beginn: 19.12.2022
Tage bis Beginn: 89,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

General symptom

Symptomtext

Called for telehealth visit after receiving 4th dose, prescribed Paxlovid symptoms subsided after a day or two.

Weitere VAERSDATA-Felder

Praegender Schweregrund: General symptom
Hospital-Tage: -
Labordaten: no
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: METSORSIN; LEXATRO; BUPROPION; GLIPIZIDE; LOSARTAN; ATORVASTATIN
Allergien: POLLEN
Vorherige Impfungen: -

VAERS 2536539

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: OH
Alter: 75,0
Geschlecht: F
Eingang: 19.12.2022
Impfdatum: 14.09.2022
Beginn: 20.11.2022
Tage bis Beginn: 67,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Nasopharyngitis SARS-CoV-2 test positive Sinus congestion

Symptomtext

I woke up with a head cold and did not think a thing about it because I have sinus issues. The next day I woke up feeling better but over the next few days sinus and congestion issues continued so on Tuesday November 22 2022 I tested for COVID-19 the result was positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID-19 test positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Kidney and Lung disease
Andere Medikamente: Amlodipine; BASAGLAR; enalapril; hydrochlorothiazide; JARDIANCE; montelukast; NOVOLIN; JUICE PLUS; vegetable fruit fish oil; DOTERRA; turmeric ONGAURD; DDR prime; copaiba; vitamin D; vitamin B1; aspirin
Allergien: Sulfa; peppers
Vorherige Impfungen: -

VAERS 2528989

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 87,0
Geschlecht: M
Eingang: 12.12.2022
Impfdatum: 15.09.2022
Beginn: 06.12.2022
Tage bis Beginn: 82,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Vaccine breakthrough infection

Symptomtext

Fully Vaccinated. COVID infection breakthrough

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2523214

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MA
Alter: 56,0
Geschlecht: F
Eingang: 05.12.2022
Impfdatum: 03.11.2022
Beginn: 01.11.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Diplopia Laboratory test

Symptomtext

Double vision both eyes

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diplopia
Hospital-Tage: -
Labordaten: Eye Doctor visit Labs by pcp Labs by Neurologist
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: Flovent inhaler
Allergien: Shellfish Novocain with epinephrine
Vorherige Impfungen: -

VAERS 2484844

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: NY
Alter: 83,0
Geschlecht: F
Eingang: 30.11.2022
Impfdatum: 28.09.2022
Beginn: 13.10.2022
Tage bis Beginn: 15,0
Dosis: 5
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dysgraphia Hypoaesthesia Peripheral swelling Loss of personal independence in daily activities Muscular weakness SARS-CoV-2 test Vaccination site reaction

Symptomtext

Two weeks and one day after the vaccine, I experienced numbness in three fingers in my dominant hand, the three fingers are the thumb, and the pointer and the middle finger. It's basically the first section of the finger, from the thumb down in the joint. And then there are swelling on those fingers. I can bend the hand, there are no pain anywhere else in any joints in my hand, or the palm or the wrist. It's just 24 hours of numbness every single day. It feels like the nervous system was attacked by the virus. As a result of this, I have the inability to write, because I cant hold any writing device in my left hand. I cant form the letters. I have to print, I cant do script anymore. Unable to fully form each letter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypoaesthesia
Hospital-Tage: -
Labordaten: I have not had any testing done yet
Aktuelle Erkrankungen: Nothing
Vorgeschichte: None
Andere Medikamente: Losartan Potassium 50mg, Hydrochlorothiazide, Estradiol 0.1mg patch, Antacid pill named-Cimetidine 400mg
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2514221

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: -
Alter: 25,0
Geschlecht: F
Eingang: 22.11.2022
Impfdatum: 21.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Incorrect product formulation administered

Symptomtext

Patient inadvertently administered the 6-11 year formulation of Moderna rather than the bivalent booster.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2514220

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: -
Alter: 61,0
Geschlecht: F
Eingang: 22.11.2022
Impfdatum: 21.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered Product administered to patient of inappropriate age

Symptomtext

Patient inadvertently given the Moderna 6-11 year formulation instead of the bivalent booster.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2507172

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: VA
Alter: 66,0
Geschlecht: F
Eingang: 22.11.2022
Impfdatum: 07.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthma Cough Loss of personal independence in daily activities Pulmonary function challenge test abnormal

Symptomtext

Asthma/ cough got worse after she got the Moderna bivalent booster dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ASTHMA (Asthma/ cough got worse after she got the Moderna bivalent booster dose) in a 66-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. The patient's past medical history included TIA. Previously administered products included for Product used for unknown indication: Pfizer (Dose 1,Lot number EL9267) on 13-Feb-2021, Pfizer (Dose 2,Lot number EN6202) on 05-Mar-2021, Pfizer (1st booster dose,Lot number FF8839) on 05-Oct-2021, Pfizer (2nd booster dose and Lot number FK9729) on 27-Apr-2022. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Cough, Hypertension, Hypercholesteraemia, Sulfonamide allergy (Sulfa), Allergy to antibiotic (Quinolone) and Adhesive tape allergy (adhesive of bandages). Concomitant products included IRBESARTAN (AVAPRO), HYDRALAZINE, ATORVASTATIN CALCIUM (LIPITOR) and CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication. On 07-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHMA (Asthma/ cough got worse after she got the Moderna bivalent booster dose). At the time of the report, ASTHMA (Asthma/ cough got worse after she got the Moderna bivalent booster dose) had not resolved. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Other relevant medical history information included breast and stomach ca that was taken cared last year. The patient received flu vaccine on 18-OCT 2022. On Unknown date, Laboratory test included Metacholine test with result reported as Positive. Patient was told that a positive test would mean that she had asthma so she was going to follow up with her pulmonologist. Patient was scheduled to have an endoscopy to see if it was GERD (Gastroesophageal reflux disease) or EOE (eosinophilic esophagitis). Treatment medications included Trelegy inhaler, Fluticasone inhaler which was not started on yet and patient planned to start with them after her endoscopy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Asthma
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Adhesive tape allergy (adhesive of bandages); Allergy to antibiotic (Quinolone); Cough; Hypercholesteraemia; Hypertension; Sulfonamide allergy (Sulfa)
Vorgeschichte: Medical History/Concurrent Conditions: TIA
Andere Medikamente: AVAPRO; HYDRALAZINE; LIPITOR; PLAVIX
Allergien: -
Vorherige Impfungen: -

VAERS 2507172

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge AS7148B

gering

Staat: VA
Alter: 66,0
Geschlecht: F
Eingang: 22.11.2022
Impfdatum: 07.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthma Cough Loss of personal independence in daily activities Pulmonary function challenge test abnormal

Symptomtext

Asthma/ cough got worse after she got the Moderna bivalent booster dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ASTHMA (Asthma/ cough got worse after she got the Moderna bivalent booster dose) in a 66-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. The patient's past medical history included TIA. Previously administered products included for Product used for unknown indication: Pfizer (Dose 1,Lot number EL9267) on 13-Feb-2021, Pfizer (Dose 2,Lot number EN6202) on 05-Mar-2021, Pfizer (1st booster dose,Lot number FF8839) on 05-Oct-2021, Pfizer (2nd booster dose and Lot number FK9729) on 27-Apr-2022. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Cough, Hypertension, Hypercholesteraemia, Sulfonamide allergy (Sulfa), Allergy to antibiotic (Quinolone) and Adhesive tape allergy (adhesive of bandages). Concomitant products included IRBESARTAN (AVAPRO), HYDRALAZINE, ATORVASTATIN CALCIUM (LIPITOR) and CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication. On 07-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHMA (Asthma/ cough got worse after she got the Moderna bivalent booster dose). At the time of the report, ASTHMA (Asthma/ cough got worse after she got the Moderna bivalent booster dose) had not resolved. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Other relevant medical history information included breast and stomach ca that was taken cared last year. The patient received flu vaccine on 18-OCT 2022. On Unknown date, Laboratory test included Metacholine test with result reported as Positive. Patient was told that a positive test would mean that she had asthma so she was going to follow up with her pulmonologist. Patient was scheduled to have an endoscopy to see if it was GERD (Gastroesophageal reflux disease) or EOE (eosinophilic esophagitis). Treatment medications included Trelegy inhaler, Fluticasone inhaler which was not started on yet and patient planned to start with them after her endoscopy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Asthma
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Adhesive tape allergy (adhesive of bandages); Allergy to antibiotic (Quinolone); Cough; Hypercholesteraemia; Hypertension; Sulfonamide allergy (Sulfa)
Vorgeschichte: Medical History/Concurrent Conditions: TIA
Andere Medikamente: AVAPRO; HYDRALAZINE; LIPITOR; PLAVIX
Allergien: -
Vorherige Impfungen: -

VAERS 2513064

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 72,0
Geschlecht: U
Eingang: 21.11.2022
Impfdatum: 18.11.2022
Beginn: 21.11.2022
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered Interchange of vaccine products

Symptomtext

Covid-19 Bivalent booster given instead of Moderna Covid-19 Vaccine for first dose in primary series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2513060

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 57,0
Geschlecht: U
Eingang: 21.11.2022
Impfdatum: 18.11.2022
Beginn: 21.11.2022
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered Interchange of vaccine products

Symptomtext

Covid-19 Bivalent booster given instead of Moderna Covid-19 Vaccine for second dose in primary series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2513054

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 23,0
Geschlecht: M
Eingang: 21.11.2022
Impfdatum: 18.11.2022
Beginn: 21.11.2022
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered Interchange of vaccine products

Symptomtext

Covid-19 Bivalent booster given instead of Moderna Covid-19 Vaccine for second dose in primary series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2513051

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 30,0
Geschlecht: U
Eingang: 21.11.2022
Impfdatum: 18.11.2022
Beginn: 21.11.2022
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

Covid-19 Bivalent booster given instead of Moderna Covid-19 for second dose of primary series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2513043

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 71,0
Geschlecht: F
Eingang: 21.11.2022
Impfdatum: 18.11.2022
Beginn: 21.11.2022
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

Covid-19 Bivalent booster given instead of second Moderna dose for primary series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2512126

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 26,0
Geschlecht: M
Eingang: 18.11.2022
Impfdatum: 26.10.2022
Beginn: 22.10.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

No adverse event; Inadvertently administered 3 doses of the bivalent vaccine which was beyond the 30 day use by date today; the vial was initially stored in the refrigerator on 22Sep2022 administered on 26Oct2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Inadvertently administered 3 doses of the bivalent vaccine which was beyond the 30 day use by date today), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 22Sep2022 administered on 26Oct2022) and NO ADVERSE EVENT (No adverse event) in a 26-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. Concurrent medical conditions included Drug allergy (Abilify, Haldol, Risperdol). On 26-Oct-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 22-Oct-2022, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 22Sep2022 administered on 26Oct2022). On 26-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Inadvertently administered 3 doses of the bivalent vaccine which was beyond the 30 day use by date today). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Inadvertently administered 3 doses of the bivalent vaccine which was beyond the 30 day use by date today), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 22Sep2022 administered on 26Oct2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Inadvertently administered 3 doses of the bivalent vaccine which was beyond the 30 day use by date today) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 22Sep2022 administered on 26Oct2022). No concomitant medication information was reported. The patient took previously first dose on 18-May-2021, route of administration as unknown, second dose on 07-June-2021, route of administration as unknown. No treatment medication information was reported. This case was linked to US-MODERNATX, INC.-MOD-2022-673501 (Linked Report). This case was linked to MOD-2022-673510 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-673501:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy (Abilify, Haldol, Risperdol)
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2512125

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: 66,0
Geschlecht: M
Eingang: 18.11.2022
Impfdatum: 26.10.2022
Beginn: 26.10.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Date the vial was initially stored in the refrigerator on 22Sep2022 and administered on 26Oct2022; No adverse event; given bivalent dose which was beyond the 30 use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given bivalent dose which was beyond the 30 use by date), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 22Sep2022 and administered on 26Oct2022) and NO ADVERSE EVENT (No adverse event) in a 66-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. The patient had ever been diagnosed with/ tested positive for COVID-19 was unknown. Acute illnesses at the time of vaccination and up to one month before was unknown. Concurrent medical conditions included Drug allergy. On 26-Oct-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 26-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (given bivalent dose which was beyond the 30 use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 22Sep2022 and administered on 26Oct2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (given bivalent dose which was beyond the 30 use by date), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 22Sep2022 and administered on 26Oct2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (given bivalent dose which was beyond the 30 use by date) and NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 22Sep2022 and administered on 26Oct2022). Concomitant medications were not reported. Patient received dose 1 on 30Jun2022 and dose 2 on 12Aug2022. The vial was initially stored in refrigerator on 22Sep2022 12pm. The vial size was 2.5 ml and vial did not undergo any temperature excursion. They inadvertently administered 3 doses of the bivalent vaccine which was beyond the 30 days use by date today on 260ct2022. There was no other potential causes and unknown whether any similar experience happened in the past. No treatment medications were required. This case was linked to US-MODERNATX, INC.-MOD-2022-673503, US-MODERNATX, INC.-MOD-2022-664543 (Linked Report). This case was linked to MOD-2022-673509 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-673503:Same reporter US-MODERNATX, INC.-MOD-2022-664543:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drug allergy
Vorgeschichte: Comments: The patient had ever been diagnosed with/ tested positive for COVID-19 was unknown. Acute illnesses at the time of vaccination and up to one month before was unknown.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2510934

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: VA
Alter: 61,0
Geschlecht: M
Eingang: 17.11.2022
Impfdatum: 17.11.2022
Beginn: 17.11.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

Only a partial dose of the vaccine was administered due to the sweater slipping upward on arm and hitting the safety needle which immediately retracted. CDC guidelines were followed and the client agreed to receive a full dose of the vaccine, immediately, as per guideline indications. The vaccine was administered successfully on the R deltoid, approximately 1 inch below the initial injection site. The Client was asymptomatic, and able to ambulate to the waiting area where he waited for 15 minutes after the administration of the complete dose. There appeared to be no negative effect as a result of this adverse event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: NONE PER CLIENT
Vorherige Impfungen: -

VAERS 2510917

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: NJ
Alter: 35,0
Geschlecht: F
Eingang: 17.11.2022
Impfdatum: 02.11.2022
Beginn: 02.11.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

Patient received 1st dose of Pfizer primary series on 9/8/22. She returned to have her second dose of primary series on 11/2/22. She received the bivalent booster instead of the second dose of her primary series. They were advised to be revaccinated to complete the primary series. They were also asked to get the

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2510314

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CA
Alter: 24,0
Geschlecht: U
Eingang: 17.11.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

It was given to 2 people beyond the 12 hr mark.; No adverse event; There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster.), PRODUCT STORAGE ERROR (It was given to 2 people beyond the 12 hr mark.) and NO ADVERSE EVENT (No adverse event) in a 24-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 10-Nov-2022 at 3:05 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (It was given to 2 people beyond the 12 hr mark.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster.), PRODUCT STORAGE ERROR (It was given to 2 people beyond the 12 hr mark.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster.) and PRODUCT STORAGE ERROR (It was given to 2 people beyond the 12 hr mark.). No concomitant medications were reported. It was reported that total 2 patients received the Bivalent booster vaccines post 12 hours of punctured. 1 Vial and 2 doses were given with vial size of 2.5 ml. Vial was initially stored in the refrigerator on 04-Nov-2022. The vial was first punctured on 08-Nov-2022. The vial was stored in the Refrigerator post punctured. The vial did not undergo any temperature excursions. Vial remained Refrigerated within range. No treatment medication details were reported. This case was linked to MOD-2022-672831 (Linked Report).; Sender's Comments: MOD-2022-672831: Patient case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2510307

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CA
Alter: 27,0
Geschlecht: U
Eingang: 17.11.2022
Impfdatum: 09.11.2022
Beginn: 09.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

It was given to 2 people beyond the 12 hr mark.; No adverse event; There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster.), PRODUCT STORAGE ERROR (It was given to 2 people beyond the 12 hr mark.) and NO ADVERSE EVENT (No adverse event) in a 27-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 09-Nov-2022 at 10:15 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 09-Nov-2022 at 10:15 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (It was given to 2 people beyond the 12 hr mark.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster.), PRODUCT STORAGE ERROR (It was given to 2 people beyond the 12 hr mark.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster.) and PRODUCT STORAGE ERROR (It was given to 2 people beyond the 12 hr mark.). No concomitant medications were reported. There was an administration error with Moderna Covid-19 Vaccine, Bivalent booster. It was given to 2 people beyond the 12 hr mark. Vial size was reported as 2.5 mL On 04-Nov-2022, the vial was initially stored in the refrigerator. On 08Nov2022, Vial was first punctured. The vial stored post puncture in Refrigerator. The vial did not undergo any temperature excursions. Vial was remained refrigerated within range. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2022-672851 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-672851:MOD-2022-672851 (IB patient)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2506436

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 82,0
Geschlecht: U
Eingang: 12.11.2022
Impfdatum: 08.11.2022
Beginn: 08.11.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; One of the patients got 0.5ml of a 2-day expired booster on 8Nov2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (One of the patients got 0.5ml of a 2-day expired booster on 8Nov2022) and NO ADVERSE EVENT (No adverse event) in an 82-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 08-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 08-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (One of the patients got 0.5ml of a 2-day expired booster on 8Nov2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (One of the patients got 0.5ml of a 2-day expired booster on 8Nov2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (One of the patients got 0.5ml of a 2-day expired booster on 8Nov2022). No concomitant drug was reported. The vial was initially stored in the refrigerator on 11-Oct-2022. Size of vial was reported as 2.5 ml. It was reported that vial did not undergo any temperature excursions. No treatment drug was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2506448

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 24,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 10.11.2022
Beginn: 11.11.2022
Tage bis Beginn: 1,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Poor quality product administered Product storage error

Symptomtext

Vaccine was withdrawn from a vial that was punctured 12 hours before then administered to the patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Poor quality product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2506445

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 27,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 09.11.2022
Beginn: 09.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

Vaccine was withdrawn from a vial that was punctured 12 hours before then administered to the patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2504445

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CT
Alter: 3,0
Geschlecht: F
Eingang: 10.11.2022
Impfdatum: 25.10.2022
Beginn: 25.10.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered Product administered to patient of inappropriate age

Symptomtext

Patient received an adult dose of Moderna Covid 19 vaccine. Parents were notified and informed of incident.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: N/A
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2504433

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CT
Alter: 3,0
Geschlecht: F
Eingang: 10.11.2022
Impfdatum: 25.10.2022
Beginn: 25.10.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered Product administered to patient of inappropriate age

Symptomtext

The patient received an adult dose of Moderna COVID vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: Not applicable.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2503290

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: IL
Alter: 72,0
Geschlecht: F
Eingang: 09.11.2022
Impfdatum: 04.10.2022
Beginn: 05.11.2022
Tage bis Beginn: 32,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

I though I was having bad allergic reaction to seasonal allergies, I took a covid home test and results came back positive had telehealth visit I was instructed to quarantine 11/3 to 11/10. And wear mask for week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: No
Vorgeschichte: Lung condition from scare tissue.
Andere Medikamente: I take Allegra and Claritin. I also take an eye health vitamin called ARED.
Allergien: I have known allergies to codeine and diary intolerance.
Vorherige Impfungen: -

VAERS 2502571

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 64,0
Geschlecht: F
Eingang: 08.11.2022
Impfdatum: 08.11.2022
Beginn: 08.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Extra dose administered

Symptomtext

Patient was scheduled to receive flu vaccine at clinic, arrived to appointment with registered nurse and admitted to needing flu vaccine, completed flu pre-vaccination checklist. RN later checked System which revealed that patient had already received flu vaccine on 9/20/22 at Health Center. RN informed patient of situation, explained risks (higher likelihood of experiencing side effects. RN informed patient that she can take Tylenol PRN for fever/pain. RN answered all of patient's questions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: No tests conducted/performed
Aktuelle Erkrankungen: Chronic prescription opiate use (NORCO 10) for bilateral knee pain and shoulders
Vorgeschichte: Chronic pain of bilateral knees; rotator cuff injury of bilateral shoulders; adenocarcinoma of endometrium; tobacco dependence; essential hypertension; obesity (BMI 30-39.9); mixed hyperlipidemia
Andere Medikamente: Hydrocodone-acetaminophen (NORCO 10) (1 tab 3-4 times daily as needed for pain); Senna 8.6 mg tab (1 tab once daily as needed for constipation); simethicone 125 mg chewable tab (1 tab every 6 hours as needed for flatulence / gastric acidity
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2501295

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CA
Alter: 59,0
Geschlecht: F
Eingang: 08.11.2022
Impfdatum: 31.10.2022
Beginn: 31.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Received expired Bivalent booster after 30-day Use By Date; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired Bivalent booster after 30-day Use By Date) and NO ADVERSE EVENT (No adverse event) in a 59-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. No Medical History information was reported. On 31-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 31-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired Bivalent booster after 30-day Use By Date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired Bivalent booster after 30-day Use By Date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Received expired Bivalent booster after 30-day Use By Date). Concomitant product use was not provided by the reporter. It was reported that vial was received as liquid with note use by date was 30-Oct-2022. On 31-Oct-2022, the patient received bivalent booster after 30-day Use By Date. Vial did not undergone any temperature excursions. Treatment information was not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2498682

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: NY
Alter: 88,0
Geschlecht: F
Eingang: 04.11.2022
Impfdatum: 28.10.2022
Beginn: 28.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 25SEP2022 and administered on 28OCT2022; No adverse event; Moderna bivalent administered after 30 day beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25SEP2022 and administered on 28OCT2022) and NO ADVERSE EVENT (No adverse event) in an 88-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 28-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25SEP2022 and administered on 28OCT2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25SEP2022 and administered on 28OCT2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 25SEP2022 and administered on 28OCT2022). No concomitant medication were reported. The Moderna COVID-19 bivalent booster dose were administered after a beyond use date of 25-OCT-2022. Unbroken carton with unknown vial size. The vial was initially stored in the refrigerator on 25-SEP-2022. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-667362 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-667362:male patient

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2498270

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: NY
Alter: 87,0
Geschlecht: F
Eingang: 03.11.2022
Impfdatum: 28.10.2022
Beginn: 28.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered

Symptomtext

Vaccine was administered 3 days post Beyond use date. Moderna was contacted with no further actions needed. Per Moderna, the lot number AS7148B maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2498267

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: NY
Alter: 77,0
Geschlecht: M
Eingang: 03.11.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product use issue

Symptomtext

The vaccine was used 2 days post beyond use date. The manufacturer Moderna was contacted, their analysis states that the lot number AS7148B maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration therefore no further actions needed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product use issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 2497142

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: NY
Alter: 77,0
Geschlecht: M
Eingang: 03.11.2022
Impfdatum: 27.10.2022
Beginn: 27.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Moderna bivalent administered after 30 day beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 77-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 27-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna bivalent administered after 30 day beyond use date). The vial was initially stored in the refrigerator on 25-Sep-2022. The vials were from unbroken cartons. The doses were administered after a beyond use date of 25-Oct-2022. The vial had undergone no temperature excursions. The concomitant and treatment medication was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2496665

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: IL
Alter: 67,0
Geschlecht: F
Eingang: 02.11.2022
Impfdatum: 30.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Underdose

Symptomtext

This is not an adverse event. This is an administration error. Patient was under dosed in error and received 0.25mL instead of the recommended 0.50mL. Patient did not have any AEs and has been asked to return to the clinic and receive a full dose of the Moderna bivalent booster (0.50mL).

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2496644

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: IL
Alter: 37,0
Geschlecht: M
Eingang: 02.11.2022
Impfdatum: 21.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product administration error Underdose

Symptomtext

This is not an adverse event. This is an administration error. Patient was under dosed in error and received 0.25mL instead of the recommended 0.50mL. Patient did not have any AEs and has been asked to return to the clinic and receive a full dose of the Moderna bivalent booster (0.50mL).

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2491452

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: TX
Alter: 48,0
Geschlecht: M
Eingang: 27.10.2022
Impfdatum: 21.10.2022
Beginn: 22.10.2022
Tage bis Beginn: 1,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ear discomfort Fluid retention Hypoaesthesia

Symptomtext

Moderna COVID Bivalent administered on 10/21/22. On 10/22/22 Employee reports the day after vaccination that he developed right-sided facial numbness and his ear feels clogged and full of fluid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ear discomfort
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2489450

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: MI
Alter: -
Geschlecht: U
Eingang: 26.10.2022
Impfdatum: 21.10.2022
Beginn: 21.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; given bivalent booster from a vial punctured >12 hours; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given bivalent booster from a vial punctured >12 hours) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. No Medical History information was reported. On 21-Oct-2022 at 10:00 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 21-Oct-2022 at 10:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (given bivalent booster from a vial punctured >12 hours). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (given bivalent booster from a vial punctured >12 hours) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (given bivalent booster from a vial punctured >12 hours). No concomitant medications were reported. Nurse reported that they inadvertently administered the bivalent vaccine from a vial punctured for more than 12 hours. The vial was a 2.5mL vial. It was initially stored in the refrigerator on19-Oct-2022. The vial was first punctured on 20-Oct-2022 between 9-12 noon. The vial was stored in fridge post puncture and it did not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2485614

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 54,0
Geschlecht: F
Eingang: 21.10.2022
Impfdatum: 21.10.2022
Beginn: 21.10.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

Refrigerated Bivalent was opened and punctured between 9am -12 on 10/20/22. On 10/21/22 a dose was given from that same vial between 9 and 10 am. The vial was stored in the fridge the whole time. The vial may have been left out of the fridge for a total of 40 minutes as a total of 3 doses were given on 10/20/22. Theses were in office doses so the vial was only taken out of the fridge to draw up the doses and then placed back in the fridge until a provider ordered another administration. Spoke with Moderna per CDC guidelines and they determined no excursion occurred. The Bivalent maintained its efficacy. Determined no repeat booster necessary.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2485257

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge As7148b

gering

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 21.10.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Moderna bivalent dose .25 given, should have been .5

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2485253

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge As7148b

gering

Staat: MI
Alter: 82,0
Geschlecht: M
Eingang: 21.10.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Moderna bivalent dose .25 given and should have been .50

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2485237

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge As7148b

gering

Staat: MI
Alter: 78,0
Geschlecht: F
Eingang: 21.10.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Underdose

Symptomtext

Moderna bivalent .25 given, should have been .5

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2485225

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge As7148b

gering

Staat: MI
Alter: 76,0
Geschlecht: F
Eingang: 21.10.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

.25 booster given and should have been .5

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2485219

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge As7148b

gering

Staat: MI
Alter: 78,0
Geschlecht: M
Eingang: 21.10.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

.25 booster dose given instead of .5

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2485187

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge As7148b

gering

Staat: MI
Alter: 69,0
Geschlecht: M
Eingang: 21.10.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Bivalent booster given- dose given was .25 instead of .5

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2485178

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge As7148b

gering

Staat: MI
Alter: 70,0
Geschlecht: F
Eingang: 21.10.2022
Impfdatum: 20.10.2022
Beginn: 20.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered Underdose

Symptomtext

Booster dose .25 inadvertently given instead of .5.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2483662

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: NY
Alter: 45,0
Geschlecht: M
Eingang: 20.10.2022
Impfdatum: 18.10.2022
Beginn: 18.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; inadvertently administered an expired (30 day use by date - 13-Oct-2022); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (inadvertently administered an expired (30 day use by date - 13-Oct-2022)) and NO ADVERSE EVENT (No adverse event) in a 45-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. No Medical History information was reported. On 18-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (inadvertently administered an expired (30 day use by date - 13-Oct-2022)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (inadvertently administered an expired (30 day use by date - 13-Oct-2022)) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (inadvertently administered an expired (30 day use by date - 13-Oct-2022)). No concomitant medications was reported. It was reported that the vaccine was administered on 18-oct-2022 around noon time. No treatment drug details was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2483660

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: NY
Alter: -
Geschlecht: U
Eingang: 20.10.2022
Impfdatum: 14.10.2022
Beginn: 14.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Patient was administered bivalent vaccine beyond the 30 day use; No adverse event; Patient was administered bivalent vaccine beyond the 30 day use; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered bivalent vaccine beyond the 30 day use), PRODUCT STORAGE ERROR (Patient was administered bivalent vaccine beyond the 30 day use) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. No Medical History information was reported. On 14-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered bivalent vaccine beyond the 30 day use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient was administered bivalent vaccine beyond the 30 day use) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered bivalent vaccine beyond the 30 day use), PRODUCT STORAGE ERROR (Patient was administered bivalent vaccine beyond the 30 day use) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered bivalent vaccine beyond the 30 day use) and PRODUCT STORAGE ERROR (Patient was administered bivalent vaccine beyond the 30 day use). No concomitant medications were reported. Vial size was reported as 2.5 ml. The vial was initially stored in the refrigerator on 13-Sep-2022 at 2:20pm. Use by date was reported as 13-Oct-2022. The vial did not undergo any temperature excursions. The patient was administered the vaccine before noon time. No treatment medications were reported. This case contains information for the 1st of 2 patients described by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2482850

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: NY
Alter: 25,0
Geschlecht: F
Eingang: 19.10.2022
Impfdatum: 03.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 1,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cellulitis

Symptomtext

cellulitis; "reaction" started 1 day post-vaccination, "progressed rapidly", diagnosed as cellulitis by HCP 2 days post-vaccination

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cellulitis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2478513

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: HI
Alter: 55,0
Geschlecht: M
Eingang: 14.10.2022
Impfdatum: 08.09.2022
Beginn: 28.09.2022
Tage bis Beginn: 20,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

On 9/28/2022, I tested positive for COVID-19 via a Binax hometest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Binax Covid home test on 9/28/2022
Aktuelle Erkrankungen: none
Vorgeschichte: diabetes hypertension
Andere Medikamente: Metformin, Lisinopril, Atorvastatin, aspirin
Allergien: Dilantin
Vorherige Impfungen: -

VAERS 2476518

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: TX
Alter: 64,0
Geschlecht: F
Eingang: 12.10.2022
Impfdatum: 07.10.2022
Beginn: 07.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Aphasia Laryngospasm Stridor

Symptomtext

About an hour after receiving the Moderna bivalent vaccine (right deltoid) and a Flublok flu vaccine (lotUJ893AA) (left deltoid), she began having laryngospasm (stridor and could not talk). She called our office to report it and we referred her to the local ED where she received racemic epinephrine and Solu-Medrol. She was observed for approximately 6-7 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Aphasia
Hospital-Tage: -
Labordaten: Unknown - performed at the local ED
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Chronic asthma, atrial fibrillation, Ig4 deficiency
Andere Medikamente: Unknown
Allergien: ambien, doxycycline, duramorph, latex, levaquin, lyrica, norco, sulfa
Vorherige Impfungen: -

VAERS 2476352

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: NJ
Alter: 65,0
Geschlecht: M
Eingang: 12.10.2022
Impfdatum: 27.09.2022
Beginn: 27.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

This was a vaccination error, not a adverse event. This patient was previously vaccinated with 3 primary series doses of covid-19 vaccine, then had undergone an autologous stem cell transplantation (ASCT) for treatment of Multiple Myeloma in April 2022. The patient then was to be revaccinated with new primary vaccine series and was to get dose 1 of primary series vaccine on 9/27/22. However a booster dose of bivalent moderna vaccine was given instead. Patient is aware. A revaccination is planned and a correct action plan is finalized and will be implemented

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Multiple Myeloma patients who had undergone a autologous stem cell transplantation (ASCT) April 2022
Vorgeschichte: Multiple Myeloma
Andere Medikamente: acyclovir; bactrim DS, Calcium + Viatmin D, Cymblata, Digoxin; diltiazem, lenalidomide; lyrica; metformin, Multivitamin; pantoprazole; sildenaafil, simvastatin, zolpidem
Allergien: Bacitracin
Vorherige Impfungen: -

VAERS 2476204

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: FL
Alter: 74,0
Geschlecht: F
Eingang: 12.10.2022
Impfdatum: 14.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiogram cerebral normal Antiacetylcholine receptor antibody positive Eyelid ptosis

Symptomtext

Pt has had a total of 5 Moderna covid vaccinations: 2/15/2021, 3/15/2021, 8/20/2021, 4/18/2022 9/5/2022 first noted mild ptosis of left eye. 9/14/22 in am had 5th covid vaccination, Moderna Bivalent. 9/14 in pm severe left eye ptosis, went to eye doc who sent her to ED. BMP NL, exam Ptosis, GREATLY IMPROVED W ICE PACK TEST, Acetylcholine Receptor Binding Antibody sent, later returned POSITIVE 3.49 (see attached) 9/15 CTA no aneurysms

Weitere VAERSDATA-Felder

Praegender Schweregrund: Angiogram cerebral normal
Hospital-Tage: -
Labordaten: 9/14/22 Acetylcholine Receptor Binding Antibody sent, later returned POSITIVE 3.49 9/1522 CTA Head No aneurysms
Aktuelle Erkrankungen: None
Vorgeschichte: Hyperlipidemia, osteopenia
Andere Medikamente: alendronate, atorvastatin, KCL, Lasix
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2475901

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: TX
Alter: 55,0
Geschlecht: M
Eingang: 12.10.2022
Impfdatum: 12.10.2022
Beginn: 01.10.2022
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered

Symptomtext

I inquired if he had received his Moderna Bivalent vaccine and he stated no. Only the previous Moderna series with the two boosters. Offered the Moderna Bivalent vaccine and he accepted. After Vaccine was administered, I gave him his vaccine card and he pulled out another card showing he had already received the bivalent vaccine in September. The doctor on site was notified.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: Diabetes
Andere Medikamente: N/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2475650

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 58,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475649

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 49,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475645

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 63,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475643

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 46,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475641

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 64,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475640

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 36,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475638

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 55,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475636

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 50,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475632

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 58,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475628

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 43,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475626

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 69,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475624

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 39,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475622

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 52,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475621

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 69,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475618

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 63,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475616

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 51,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475614

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 32,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475610

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 69,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475609

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 47,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475607

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 62,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475604

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 38,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475602

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 64,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475587

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 68,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475584

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 70,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475581

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 35,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475579

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 27,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475578

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 53,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475576

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 33,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475571

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 57,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475501

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 67,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475497

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 23,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475496

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 56,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475493

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 38,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475492

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 36,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475491

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 60,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475490

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 41,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475488

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 56,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475486

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 60,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 04.10.2022
Beginn: 04.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient only received 0.25mL booster dose instead of 0.5mL. Patient was contacted and informed of the error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2475285

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 88,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 15.09.2022
Beginn: 07.10.2022
Tage bis Beginn: 22,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case after 4 vaccines Pfizer 1/26/21 Lot# EL9264; Pfizer 2/17/21 Lot# EN6201; Pfizer 11/24/21 Lot# 30145BA; Moderna 9/15/22 Lot# AS7148B

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2473889

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 43,0
Geschlecht: M
Eingang: 10.10.2022
Impfdatum: 06.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration No adverse event

Symptomtext

Patient received Bivalent booster too early. No symptoms or treatments.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Non-ischemic Priapism related to previous medication.
Vorgeschichte: Hypertension, Diabetes Mellitus, Gerd, Dyslipidemia, Allergic rhinitis, Vitamin D deficiency
Andere Medikamente: Benztropine, Escitalopram, Haloperidol, Acetaminophen, Insulin Glargine, Sitagliptin, Cholecalciferol, Fluticasone, Atorvastatin, Loratadine, Lisinopril metformin, ferrous Sulfate, Omeprazole, Diphenhydramine,
Allergien: aspirin and ibuprofen
Vorherige Impfungen: -

VAERS 2470921

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: OH
Alter: 86,0
Geschlecht: F
Eingang: 06.10.2022
Impfdatum: 06.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Inappropriate schedule of product administration

Symptomtext

PATIENT RECEIVED THE 5TH DOSE BEFORE THE TWO MONTH INTERVAL. PREVIOUS MODERNA MONOVALENT DOSE WAS GIVEN ON 8/25/22. LOT 082B22A.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2469894

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 46,0
Geschlecht: M
Eingang: 05.10.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

Pt received Moderna Bivalent instead of requested Pfizer Bivalent. Pt notified. No adverse event noted. Further details not provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: None Known
Andere Medikamente: None Known
Allergien: NKA
Vorherige Impfungen: -

VAERS 2469886

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 38,0
Geschlecht: M
Eingang: 05.10.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

Pt received Moderna Bivalent instead of requested Pfizer Bivalent. Pt notified. No adverse event noted. Further details not provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: None
Andere Medikamente: NOne
Allergien: None
Vorherige Impfungen: -

VAERS 2469880

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 59,0
Geschlecht: F
Eingang: 05.10.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Wrong product administered

Symptomtext

Pt received Moderna Bivalent instead of requested Pfizer Bivalent. Pt notified. No adverse event noted. Further details not provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: PMH: major depressive disorder, PTSD, asthma, HTN, atypical chest pain, bilateral sacroilitis, GERD, Goiter, HLD, TMJ,kidney stones,osa,prediabetes
Andere Medikamente: Medications: Allopurinol 300mg Dexamethasone 1mg Diltiazem CD 240mg cap hydroxychloroquine 200mg hydroxyzine 100mg Lamotrigine 150mg montelukast 10mg pravastatin 10mg zaleplon 10mg
Allergien: Allergies: Gabapentin (anxiety, tachypnea arrhythmia), levofloxacin (muscle pain), prednisone (unknown), divalprovex, shellfish, trazodone
Vorherige Impfungen: -

VAERS 2469862

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 63,0
Geschlecht: F
Eingang: 05.10.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Wrong product administered

Symptomtext

Pt received Moderna Bivalent instead of requested Pfizer Bivalent. Pt notified. No adverse event noted. Further details not provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: PMH: Endometrial cancer s/p hysterectomy and bilateral oophorectomy
Andere Medikamente: None
Allergien: NOne
Vorherige Impfungen: -

VAERS 2469849

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 71,0
Geschlecht: F
Eingang: 05.10.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered

Symptomtext

Pt received Moderna Bivalent instead of requested Pfizer Bivalent. Pt notified. No adverse event noted

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: PMH: hyperlipidemia, hypothyroidism, HTN, IBS
Andere Medikamente: Medications: atenolol 25mg atorvastatin 10mg HCTZ 25mg Levothyroxine 50mcg
Allergien: Allergies: Cephalexin, griseofulvin (rash), Lisinopril (cough), Nitrofurantoin (rash)
Vorherige Impfungen: -

VAERS 2468461

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: HI
Alter: 58,0
Geschlecht: M
Eingang: 04.10.2022
Impfdatum: 14.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syringe issue

Symptomtext

Error: Leaking from Syringe-

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syringe issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2468377

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CO
Alter: 63,0
Geschlecht: M
Eingang: 04.10.2022
Impfdatum: 19.09.2022
Beginn: 26.09.2022
Tage bis Beginn: 7,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

Covid-19 infection

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Antigen tests 9/29/2022, 10/3/2022
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma, hypertension
Andere Medikamente: Losar?an, methylphenidate, Advair, Niacinamide, fluticasone,
Allergien: None
Vorherige Impfungen: -

VAERS 2468266

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: -
Alter: 75,0
Geschlecht: M
Eingang: 04.10.2022
Impfdatum: 28.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Eye irritation Ocular hyperaemia

Symptomtext

The patient reports that when he looked in the mirror he noticed that his right eye was red. He stated that it feels mildly scratchy and "gamey", but his vision is unaffected. He denies discharge and pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Eye irritation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2628820

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: TN
Alter: 46,0
Geschlecht: F
Eingang: 03.10.2022
Impfdatum: 30.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event

Symptomtext

There are no adverse events (symptoms, signs, time course) and treatments that I am aware of.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: SULFA (SULFONAMIDE ANTIBIOTICS
Andere Medikamente: CETIRIZINE MEFORMIN HCL LISINOPRIL BUPROPION HCL SR ROSUVASTATIN CALCIUM DEXCOM G6 TRANSMITTER DEXCOM G6 SENSOR DEXCOM G6 REVEIVER VITAMIN B-12 MONTELUKAST SODIUM SERTRALINE HCL VITAMIN D3 NASACORT CO Q-10 MAGNESIUM FREESTYLE LIBRE 14 DAY S
Allergien: -
Vorherige Impfungen: Given COVID Mon~COVID19 (COVID19 (Moderna))~4~46.00~Patient

VAERS 2466643

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: VA
Alter: 24,0
Geschlecht: F
Eingang: 01.10.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong product administered

Symptomtext

I went to the lab and obtained the influenza vaccine, placed the needle on the syringe and expressed the gas. I administered the Pfizer vaccine without complications. I then mistook a Moderna bivalent booster for the iinfluenza vaccine and admnistered it in the opposite arm. I recognized the influenza vaccine and told the patient about my mistake. I reported the event to clinic chief. Jointly, she, I and the patient decided to give the influenza vaccine, again without complications. I observed the patient for fifteen minutes. She reported no untoward effects, and returned to work, where she was to be close to a number of people. The day after the event, the patient reported she was all right.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong product administered
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: -
Allergien: none known
Vorherige Impfungen: -

VAERS 2465945

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 17,0
Geschlecht: M
Eingang: 30.09.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event

Symptomtext

Moderna's COVID-19 Bivalent Booster was given to a patient younger than 18 years of age (patient is 17 years and 6 months old). No adverse symptoms or signs have been reported from the patient as of 9/30/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2465454

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: WI
Alter: 23,0
Geschlecht: F
Eingang: 30.09.2022
Impfdatum: 20.09.2022
Beginn: 20.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product administered to patient of inappropriate age

Symptomtext

Pt has never received a covid vaccine. She needs a covid vaccine today. If she does not receive the vaccine, she cannot start her new CNA job tomorrow. Per PCP, she should get the Moderna. Today is Tuesday and the covid injection schedule is open for patients to receive their covid vaccines. Vaccine Information Statement(s) or the Emergency Use Authorization was given today. This has been reviewed, questions answered, and verbal consent given by Patient for injection(s) and administration of COVID-19 Immunization Moderna COVID-19. Pt waited 15 mins and tolerated Covid Moderna vaccine well with no issues. Patient tolerated without incident. See immunization grid for documentation. Discussed with PCP about pt receiving Moderna Bivalent vaccine instead of Moderna Monovalent. Per PCP, this is fine since the dose is the same (0.5mL). Told this to pt as well. We will be contacting pt in the next few weeks to update her on her on the due date of her booster. Pt voiced understanding. A copy of her immunizations including the Covid Bivalent was handed to pt. Pt needed this to provide to her new job today.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: Not applicable
Aktuelle Erkrankungen: Not applicable
Vorgeschichte: Not applicable
Andere Medikamente: Valacyclovir HCl 1000 MG Tab Take 1 tablet by mouth daily. ferrous sulfate 325 (65 FE) MG tablet Take 325 mg by mouth daily. acetaminophen (TYLENOL) 325 MG tablet Take 2 tablets by mouth every 6 hours. ibuprofen (MOTRIN) 600 MG tablet Take
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2464484

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: VT
Alter: 80,0
Geschlecht: F
Eingang: 29.09.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Underdose

Symptomtext

incorrect dose given. Given 0.25 instead of 0.5 mL. No adverse symptoms or signs

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2463805

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7148b

gering

Staat: -
Alter: 48,0
Geschlecht: M
Eingang: 28.09.2022
Impfdatum: 28.09.2022
Beginn: 28.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Unevaluable event

Symptomtext

Bilateral PE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Unevaluable event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: ALCOHOLISM
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2461806

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: MI
Alter: 60,0
Geschlecht: F
Eingang: 27.09.2022
Impfdatum: 26.09.2022
Beginn: 26.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered Product administered to patient of inappropriate age

Symptomtext

High dose influenza vaccine given to a patient at age 60 years

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2461801

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge AS7148B

gering

Staat: MN
Alter: 55,0
Geschlecht: F
Eingang: 27.09.2022
Impfdatum: 22.09.2022
Beginn: 24.09.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient vaccinated against then tested positive for COVID19

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2460647

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: VA
Alter: 15,0
Geschlecht: F
Eingang: 26.09.2022
Impfdatum: 25.09.2022
Beginn: 25.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered Product administered to patient of inappropriate age

Symptomtext

15 year old given Moderna bivalent booster. Moderna authorized for 18+ only. Mother notified by vaccinator on site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2459754

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7148b

gering

Staat: CA
Alter: 66,0
Geschlecht: M
Eingang: 24.09.2022
Impfdatum: 23.09.2022
Beginn: 23.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Peripheral swelling

Symptomtext

outer palm swollen

Weitere VAERSDATA-Felder

Praegender Schweregrund: Peripheral swelling
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2459571

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CA
Alter: 58,0
Geschlecht: M
Eingang: 24.09.2022
Impfdatum: 22.09.2022
Beginn: 22.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Vaccine administered to the patient after more than 12 hour post puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered to the patient after more than 12 hour post puncture) and NO ADVERSE EVENT (No adverse event) in a 58-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. No Medical History information was reported. On 22-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered to the patient after more than 12 hour post puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered to the patient after more than 12 hour post puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered to the patient after more than 12 hour post puncture). No concomitant medications were reported. No treatment medications were reported. Reporter stated that they received the bivalent Moderna vaccine, and they had been administering them. Reporter stated that they stored the vaccines in a fridge. On 19-Sep-2022, the vial (of size 2.5 ml) was initially stored in the refrigerator. On 21-Sep-2022, the staff pulled a bivalent vial from the fridge and pierced it around 8:29 AM and the vial was returned to the refrigerator. On 22-Sep-2022, the opened vial was pulled and administered to the patient around 8:30 AM. The vial did not undergone any temperature excursions. The total amount of time the vial was exposed to room temperature was only to draw up syringes. The patient had already received 4 doses of Moderna and the last dose was on 15-Jun-2022. The reporter wants to know whether the patient needs to be re-vaccinated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2456188

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7148b

gering

Staat: OH
Alter: 51,0
Geschlecht: M
Eingang: 23.09.2022
Impfdatum: 23.09.2022
Beginn: 23.09.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered

Symptomtext

Patient was given the Moderna Bivalent instead of the Moderna monovalent by our nurse. Should have been the monovalent since it was the second dose of the primary series.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2456036

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7148b

gering

Staat: PA
Alter: 68,0
Geschlecht: M
Eingang: 23.09.2022
Impfdatum: 21.09.2022
Beginn: 22.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient tested positive for Covid the day after receiving vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2454323

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CA
Alter: 65,0
Geschlecht: U
Eingang: 22.09.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event Product label issue

Symptomtext

Health Care Provider becoming confused by the labeling on the Moderna Covid-19 vaccine; No adverse event; Patient received 0.25ml instead of 0,5ml for a booster dose of the Moderna Bivalent Vaccine; This spontaneous case was reported by a physician assistant and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received 0.25ml instead of 0,5ml for a booster dose of the Moderna Bivalent Vaccine), PRODUCT LABEL ISSUE (Health Care Provider becoming confused by the labeling on the Moderna Covid-19 vaccine) and NO ADVERSE EVENT (No adverse event) in a 65-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 19-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 19-Sep-2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient received 0.25ml instead of 0,5ml for a booster dose of the Moderna Bivalent Vaccine). On an unknown date, the patient experienced PRODUCT LABEL ISSUE (Health Care Provider becoming confused by the labeling on the Moderna Covid-19 vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received 0.25ml instead of 0,5ml for a booster dose of the Moderna Bivalent Vaccine), PRODUCT LABEL ISSUE (Health Care Provider becoming confused by the labeling on the Moderna Covid-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for ACCIDENTAL UNDERDOSE (Patient received 0.25ml instead of 0,5ml for a booster dose of the Moderna Bivalent Vaccine) and PRODUCT LABEL ISSUE (Health Care Provider becoming confused by the labeling on the Moderna Covid-19 vaccine). No concomitant medication was reported. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 19-Sep-2022: Live follow up information received: Event (product quality issue) and QE ID no. added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2454311

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: FL
Alter: 65,0
Geschlecht: F
Eingang: 22.09.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; Punctured initially at 6:15 PM last night and then was administered at 11:00 AM this morning; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Punctured initially at 6:15 PM last night and then was administered at 11:00 AM this morning) and NO ADVERSE EVENT (No adverse event) in a 65-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis. No Medical History information was reported. On 19-Sep-2022 at 11:00 AM, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 19-Sep-2022 at 11:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Punctured initially at 6:15 PM last night and then was administered at 11:00 AM this morning). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Punctured initially at 6:15 PM last night and then was administered at 11:00 AM this morning) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Punctured initially at 6:15 PM last night and then was administered at 11:00 AM this morning). No concomitant medications were reported. On 06-Mar-2021 (lot number 048A21A, expiration date unknown), patient received first dose intramuscularly. On 03-Apr-2021 (lot number 006B21A, expiration date unknown) patient received second dose intramuscularly. On 23-Oct-2021 (lot number 017F21A, expiration date unknown) patient received third dose intramuscularly. On 06-Apr-2022 (lot number 002M21A, expiration date unknown), patient received fourth dose intramuscularly. On 18-Sep-2022, a dose of vaccine was taken out at 5:00 PM, punctured initially at 6:15 PM and then was administered at 11:00 AM next morning. Vial did not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2453442

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: WI
Alter: 68,0
Geschlecht: M
Eingang: 21.09.2022
Impfdatum: 14.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Underdose

Symptomtext

Patient was inadvertently administered 0.25 ml of the required 0.5 ml dose of Moderna Bivalent Booster vaccine. There were no adverse effects to the patient. In accordance to the regulatory authority guidelines: Lower-than-authorized dose administered (e.g., leaked out of the syringe, equipment failure, recipient pulled away, incorrect product resulting in lower-than-authorized dose) Repeat dose immediately (no minimum interval).?? However, if a half-volume dose of vaccine is administered to a patient recommended for the full volume, another half-volume dose can be administered on the same clinic day, and the 2 doses can count as 1 full dose. Patient was called (VM left) to return to the clinic to receive a full dose 0.5 Moderna Bivalent Booster

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2451820

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CA
Alter: 68,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 12.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No adverse event; patient was administer half the dosage of the bivalent vaccine; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (patient was administer half the dosage of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 68-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for an unknown indication. The patient's past medical history included Dental cavity. Previously administered products included for Product used for unknown indication: Flu shot in December 2020. Past adverse reactions to the above products included No adverse event with Flu shot. Concurrent medical conditions included Drug allergy, Drug allergy, Drug allergy, Heart disease, unspecified, Atrial fibrillation, Type 2 diabetes mellitus, High cholesterol and Blood pressure high. Concomitant products included WARFARIN SODIUM (COUMADIN), METFORMIN HYDROCHLORIDE (METFORMIN HCL), METOPROLOL and GABAPENTIN for an unknown indication. On 12-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 12-Sep-2022, the patient experienced ACCIDENTAL UNDERDOSE (patient was administer half the dosage of the bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (patient was administer half the dosage of the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (patient was administer half the dosage of the bivalent vaccine). Patient only received half the dose 0.25ml and patient wanted to know when the patient should receive the other 0.25 ml shot to complete the shot. Patient was taking other medication. On 05Feb2021, patient received first dose of Moderna vaccine 0.5 milliliters, batch lot no 015N20A on Left Deltoid. On 05Mar2021, patient received second dose of Moderna vaccine 0.5 milliliters, batch lot no 032M20A on Left Deltoid. On 23Aug2021, patient received first booster dose of Moderna vaccine batch lot no 091D on Left Deltoid. Treatment medications were not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Atrial fibrillation; Blood pressure high; Drug allergy; Heart disease, unspecified; High cholesterol; Type 2 diabetes mellitus
Vorgeschichte: Medical History/Concurrent Conditions: Dental cavity
Andere Medikamente: COUMADIN; METFORMIN HCL; METOPROLOL; GABAPENTIN
Allergien: -
Vorherige Impfungen: -

VAERS 2443950

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CA
Alter: 75,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Device connection issue No adverse event Underdose Incorrect dose administered Syringe issue

Symptomtext

No Adverse Event; A lot of Bivalent liquid leaked out of her arm during vaccination; A lot of Bivalent liquid leaked out of her arm during vaccination; This spontaneous case was reported by a patient and describes the occurrence of UNDERDOSE (A lot of Bivalent liquid leaked out of her arm during vaccination), DEVICE CONNECTION ISSUE (A lot of Bivalent liquid leaked out of her arm during vaccination) and NO ADVERSE EVENT (No Adverse Event) in a 75-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. No Medical History information was reported. On 13-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Sep-2022, the patient experienced UNDERDOSE (A lot of Bivalent liquid leaked out of her arm during vaccination) and DEVICE CONNECTION ISSUE (A lot of Bivalent liquid leaked out of her arm during vaccination). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, UNDERDOSE (A lot of Bivalent liquid leaked out of her arm during vaccination), DEVICE CONNECTION ISSUE (A lot of Bivalent liquid leaked out of her arm during vaccination) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. No concomitant product use was reported. The patient received 4 Monovalent doses (first dose, second dose, first and 2nd monovalent boosters) of COVID-19 vaccine. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2443950

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 75,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Device connection issue No adverse event Underdose Incorrect dose administered Syringe issue

Symptomtext

No Adverse Event; A lot of Bivalent liquid leaked out of her arm during vaccination; A lot of Bivalent liquid leaked out of her arm during vaccination; This spontaneous case was reported by a patient and describes the occurrence of UNDERDOSE (A lot of Bivalent liquid leaked out of her arm during vaccination), DEVICE CONNECTION ISSUE (A lot of Bivalent liquid leaked out of her arm during vaccination) and NO ADVERSE EVENT (No Adverse Event) in a 75-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. No Medical History information was reported. On 13-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Sep-2022, the patient experienced UNDERDOSE (A lot of Bivalent liquid leaked out of her arm during vaccination) and DEVICE CONNECTION ISSUE (A lot of Bivalent liquid leaked out of her arm during vaccination). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, UNDERDOSE (A lot of Bivalent liquid leaked out of her arm during vaccination), DEVICE CONNECTION ISSUE (A lot of Bivalent liquid leaked out of her arm during vaccination) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. No concomitant product use was reported. The patient received 4 Monovalent doses (first dose, second dose, first and 2nd monovalent boosters) of COVID-19 vaccine. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2451221

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: OH
Alter: 61,0
Geschlecht: F
Eingang: 19.09.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient was given the high dose flu shot instead of Fluarix flu shot in the left Deltoid. Also given the Moderna Bivalent Booster in the left Deltoid. NO adverse side affects noted .

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: albuterol inhaler
Allergien: N/A
Vorherige Impfungen: -

VAERS 2451035

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 59,0
Geschlecht: F
Eingang: 19.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Underdose

Symptomtext

On Thursday, September 16th, 2022, at Healthcare, we administered the new bivalent Modena Booster Vaccines to the following patients (listed below). Our Nurse Practitioner on duty was used to the 0.25mg per dose' booster vaccines which yields 20 doses per vial. She was aware of a difference between the previous monovalent and the new bivalent but wasn't aware of a vast difference. The bivalent vaccines appear to give 5 doses per vial (0.5mg per dose) versus the monovalent which yielded 20 doses per vial. Our provider was under the impression that it yielded 10 doses per vial. Since 10 doses per vial were administered each patient received 0.25mg instead of 0.5mg. Each patient did not receive the recommended amount. The POC at the facility is aware of this. There were no adverse reactions noted and everyone seemed to be in good health status prior to our departure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450996

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: FL
Alter: 65,0
Geschlecht: F
Eingang: 19.09.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

When preparing my vaccines, my technician, was gathering the processed paperwork and vaccines together while I was finishing another task. The patient was getting a flu shot and her Moderna BIV Booster. She pulled the flu vaccine from the fridge and pulled the Moderna vaccine from the drawer where they keep the open vials. I am a floater pharmacist and did not know that is where they keep their current open COVID vaccines. I had just opened a new vial of Moderna for the person ahead of this one and gave one shot from the new vial I opened. I had the vial still on the countertop where I had prepared the last vaccine. Our order had come in just previous to this second shot and some bottles had been set on the countertop. The technician did not see the vial I was using and assumed I had put it in the drawer, so she pulled out the vial in the drawer (from the previous evening) and set it with the flu shot she had just pulled from the refrigerator. When I walked over to prepare the vaccines, I thought she had pulled the vial I had just opened. I did not know about the vial from the previous day that was in the drawer and I did not know that was what was on the counter for me to use. I prepared the vaccines and gave both vaccines to the patient. After the patient had left the pharmacy, I went back to my station and was putting up the bottles that were on the countertop and when I picked them up, that is when I saw my vial sitting on the countertop. Then I looked over and saw the vial she had pulled and that is when I realized there were 2 vials and began investigating where the other vial had come from. I called Moderna to see what was advised to do for the patient. I am still waiting for their reply. The case number is MOD22-023938. The vial from the previous day in the drawer was pulled out of the fridge at 5pm on 9/18/22 and the vial was punctured at aprox. 6:15pm. The vaccine from this vial that was mistakenly given was given aprox. 18 hours after being brought to room temp and aprox. 17hrs after vial puncture.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2450928

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 73,0
Geschlecht: F
Eingang: 19.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

On Thursday, September 16th, 2022, at Healthcare, we administered the new bivalent Modena Booster Vaccines to the following patients (listed below). Our Nurse Practitioner on duty was used to the ?0.25mg per dose' booster vaccines which yields 20 doses per vial. She was aware of a difference between the previous monovalent and the new bivalent but wasn?t aware of a vast difference. The bivalent vaccines appear to give 5 doses per vial (0.5mg per dose) versus the monovalent which yielded 20 doses per vial. Our provider was under the impression that it yielded 10 doses per vial. Since 10 doses per vial were administered each patient received 0.25mg instead of 0.5mg. Each patient did not receive the recommended amount. The POC at the facility is aware of this. There were no adverse reactions noted and everyone seemed to be in good health status prior to our departure. ?

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450686

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: AL
Alter: 43,0
Geschlecht: F
Eingang: 18.09.2022
Impfdatum: 17.09.2022
Beginn: 18.09.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Swelling face

Symptomtext

facial swelling day after vaccine, patient stated she will take benadryl and follow up with primary care md or urgent care if needed

Weitere VAERSDATA-Felder

Praegender Schweregrund: Swelling face
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450605

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7148b

gering

Staat: PA
Alter: 75,0
Geschlecht: M
Eingang: 18.09.2022
Impfdatum: 16.09.2022
Beginn: 17.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Blood pressure increased Heart rate increased

Symptomtext

The patient's son called to let us know that his father was sent to the ER due to a spike in blood pressure and heart rate. He believes one of the vaccination is the cause of this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood pressure increased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450546

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 61,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Underdose

Symptomtext

On Thursday, September 16th, 2022, at Healthcare, we administered the new bivalent Modena Booster Vaccines to the following patients (listed below). Our Nurse Practitioner on duty was used to the ?0.25mg per dose' booster vaccines which yields 20 doses per vial. She was aware of a difference between the previous monovalent and the new bivalent but wasn?t aware of a vast difference. The bivalent vaccines appear to give 5 doses per vial (0.5mg per dose) versus the monovalent which yielded 20 doses per vial. Our provider was under the impression that it yielded 10 doses per vial. Since 10 doses per vial were administered each patient received 0.25mg instead of 0.5mg. Each patient did not receive the recommended amount. The POC at the facility is aware of this. There were no adverse reactions noted and everyone seemed to be in good health status prior to our departure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450545

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 75,0
Geschlecht: F
Eingang: 17.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered No adverse event Underdose

Symptomtext

On Thursday, September 16th, 2022, at a HCF, we administered the new bivalent Modena Booster Vaccines to the following patients (listed below). Our Nurse Practitioner on duty was used to the ?0.25mg per dose' booster vaccines which yields 20 doses per vial. She was aware of a difference between the previous monovalent and the new bivalent but wasn?t aware of a vast difference. The bivalent vaccines appear to give 5 doses per vial (0.5mg per dose) versus the monovalent which yielded 20 doses per vial. Our provider was under the impression that it yielded 10 doses per vial. Since 10 doses per vial were administered each patient received 0.25mg instead of 0.5mg. Each patient did not receive the recommended amount. The POC at the facility is aware of this. There were no adverse reactions noted and everyone seemed to be in good health status prior to our departure. ??

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450542

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 67,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 15.09.2022
Beginn: 17.09.2022
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect product formulation administered No adverse event

Symptomtext

On Thursday, September 16th, 2022, at Healthcare, we administered the new bivalent Modena Booster Vaccines to the following patients (listed below). Our Nurse Practitioner on duty was used to the ?0.25mg per dose' booster vaccines which yields 20 doses per vial. She was aware of a difference between the previous monovalent and the new bivalent but wasn?t aware of a vast difference. The bivalent vaccines appear to give 5 doses per vial (0.5mg per dose) versus the monovalent which yielded 20 doses per vial. Our provider was under the impression that it yielded 10 doses per vial. Since 10 doses per vial were administered each patient received 0.25mg instead of 0.5mg. Each patient did not receive the recommended amount. The POC at the facility is aware of this. There were no adverse reactions noted and everyone seemed to be in good health status prior to our departure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450541

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: CA
Alter: 69,0
Geschlecht: F
Eingang: 17.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

On Thursday, September 16th, 2022 we administered the new bivalent Modena Booster Vaccines to the following patients (listed below). Our Nurse Practitioner on duty was used to the ?0.25mg per dose' booster vaccines which yields 20 doses per vial. She was aware of a difference between the previous monovalent and the new bivalent but wasn?t aware of a vast difference. The bivalent vaccines appear to give 5 doses per vial (0.5mg per dose) versus the monovalent which yielded 20 doses per vial. Our provider was under the impression that it yielded 10 doses per vial. Since 10 doses per vial were administered each patient received 0.25mg instead of 0.5mg. Each patient did not receive the recommended amount. The POC at the facility is aware of this. There were no adverse reactions noted and everyone seemed to be in good health status prior to our departure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2450512

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: ME
Alter: 15,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 17.09.2022
Beginn: 17.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product administered to patient of inappropriate age

Symptomtext

patient given bivalent Moderna, patient is under 18 years of age

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450230

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: ME
Alter: 16,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 17.09.2022
Beginn: 17.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered Product administered to patient of inappropriate age

Symptomtext

Patient was given Moderna bivalent, patient is under 18 years of age.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449753

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: -
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

Patient was administered 0.25 ml of the bivalent dose instead of 0.50 ml; No Adverse event; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient was administered 0.25 ml of the bivalent dose instead of 0.50 ml) and NO ADVERSE EVENT (No Adverse event) in an elderly male patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Patient was administered 0.25 ml of the bivalent dose instead of 0.50 ml) and NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient was administered 0.25 ml of the bivalent dose instead of 0.50 ml) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient was administered 0.25 ml of the bivalent dose instead of 0.50 ml). No concomitant medications were provided by the reporter. The patient was administered 0.25 ml instead of 0.50 ml of the bivalent vaccine. No treatment medications were provided by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-642993 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-642993:1st patient case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449752

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CO
Alter: -
Geschlecht: F
Eingang: 17.09.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

administered 0.25 ml of the bivalent dose instead of 0.50 ml; No Adverse event; This spontaneous case was reported by a physician and describes the occurrence of ACCIDENTAL UNDERDOSE (administered 0.25 ml of the bivalent dose instead of 0.50 ml) and NO ADVERSE EVENT (No Adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (administered 0.25 ml of the bivalent dose instead of 0.50 ml) and NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (administered 0.25 ml of the bivalent dose instead of 0.50 ml) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (administered 0.25 ml of the bivalent dose instead of 0.50 ml). No Concomitant medications were provided. No treatment medications were provided. This case was linked to US-MODERNATX, INC.-MOD-2022-643040 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-643040:1st patient case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2448827

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: IN
Alter: 17,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient asked to receive the Moderna Bivalent booster (all 3 previous shots were for pfizer). It wasn't noted until after the fact that he was 17-1/2 years old instead of the current recommended 18 years of age for this vaccine. No adverse events noted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2447850

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: PA
Alter: 56,0
Geschlecht: F
Eingang: 16.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest discomfort Speech disorder Wheezing

Symptomtext

chest tightness, wheezy feeling, trouble talking. treated with epi and benadryl and symptoms improved. pt monitored for 3 hours and departed. .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest discomfort
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: none
Vorgeschichte: dm, asthma, allergies
Andere Medikamente: 04/2022 Advair HFA 230-21 MCG/ACT Aerosol 2 PUFFS INHALATION TWICE A DAY (AT THE ONSET OF URIS) 30 DAYS 204/2022 Albuterol Sulfate HFA 108 (90 Base) MCG/ACT Aerosol Solution INHALE 2 PUFFS INTO THE LUNGS EVERY 4 HOURS AS NEEDED FOR 30 DAYS
Allergien: Seafood = Anaphylaxis Pork = Anaphylaxis Pistachio Nut (Diagnostic) = Anaphylaxis peanuts = Anaphylaxis Orange = Anaphylaxis mushrooms = Rash; Pruitis Nickel = Hives; Swollen Eyelids peaches = Rash; Pruitis Wheat Dextrin = Rash; Pruitis Latex Moderna COVID-19 Vaccine = Anaphylaxis
Vorherige Impfungen: Dose 1 and 2 of covid vaccine

VAERS 2447762

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: NC
Alter: 55,0
Geschlecht: F
Eingang: 16.09.2022
Impfdatum: 08.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

patient came in to receive Moderna bivalent booster dose of 0.50 ml: the patient actually received 0.25 ml dise

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: Chronic obstructive pulmonary disease,Chronic renal insufficiency, stage III (moderate),Asymptomatic HIV infection, Moderate episode of recurrent major depressive disorder,PVD (peripheral vascular disease),Hypercholesteremia,Neuropathy, Primary osteoarthritis of both knees,Stress incontinence, female,Vitamin D deficiency, Gout,Primary osteoarthritis,
Andere Medikamente: n/a
Allergien: codeine, codeine sulfate, latex, sulfate ion
Vorherige Impfungen: -

VAERS 2447758

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: NC
Alter: 57,0
Geschlecht: F
Eingang: 16.09.2022
Impfdatum: 08.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 0,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

patient came in to receive Moderna bivalent booster: booster dose to be given was 0.50 ml and the patient actually received 0.25 ml

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: n/a
Vorgeschichte: HIV infection, HTN, hypothyroidism, hypercholesterolemia
Andere Medikamente: n/a
Allergien: nka
Vorherige Impfungen: -

VAERS 2446397

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: PA
Alter: 61,0
Geschlecht: M
Eingang: 15.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered Syringe issue

Symptomtext

The syringe leaked between needle and plunger when giving injection to the patient. They did not get a full dose. Re-injected the patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2444975

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: OR
Alter: 13,0
Geschlecht: M
Eingang: 14.09.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered No adverse event Product administered to patient of inappropriate age

Symptomtext

Given to a 13 year old. No adverse reaction, parents present no concerns all questions answered

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Moderna COVID - 19 Vaccine Bivalent given IM 0.5mL Left Deltoid Lot # AS7148B Exp 10/07/2022 (NO adverse reaction / parents advised)
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2444961

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: TX
Alter: 23,0
Geschlecht: M
Eingang: 14.09.2022
Impfdatum: 14.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Amnesia Blood glucose normal Fall Head injury Hyperhidrosis Pallor Pulse abnormal

Symptomtext

Was given Vaccine by RN BSN. Client states he does not like needles. He went to sit in a chair. One of the workers states he made contact with the chair and was sitting but client does not remember, He fell to the side and his head hit the ground. He was diaphoretic and pale when I got to him. Thready pulse 62 O2Sat 96% BP 98/42 Blood sugar checked by EMT was 83 at 3:05. At 3:18 pulse was 67 BP 112/68 O2sat 100% Resp 16. He was given an icepack and put in recovery position at beginning. After a couple of minutes he was no longer diaphoretic. Color was back to normal. Talkative. Alert and oriented. Mother informed of signs of head injury and instructed to seek care if he exhibits any signs. Given cell number to call for any questions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Amnesia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: -
Andere Medikamente: Patient passed out and hit head after vaccination from seated position
Allergien: None
Vorherige Impfungen: -

VAERS 2443264

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7148B

gering

Staat: CA
Alter: 68,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 12.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered

Symptomtext

Patient received 0.25 mL of the COVID-19 Moderna Bivalent vaccine instead of 0.5 mL as prescribed. Pt refused to come back to clinic to receive other half of dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Atrial fibrillation Hypertension Hyperlipidemia Diabetes Endocarditis
Andere Medikamente: Warfarin Metoprolol Lisinopril Inovokana Crestor Metformin Coumadin
Allergien: Norco Amioradrone Tylenol
Vorherige Impfungen: -

VAERS 2442743

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: OH
Alter: 75,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 12.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Inappropriate schedule of product administration

Symptomtext

Vaccine given before 2 month interval between last the booster dose. Last booster dose was given 7/22/2022 and the bivalent Moderna vaccine was given on 9/12/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2441078

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: VA
Alter: 54,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered No adverse event

Symptomtext

Patient was given 0.25ml dose instead of 0.5ml dose. There were no reported adverse symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2441077

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: VA
Alter: 79,0
Geschlecht: M
Eingang: 12.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

0.25ml dose of the Moderna Bivalent vaccine was administered instead of 0.5ml dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2441072

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: VA
Alter: 73,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 08.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

Patient was given a (0.25ml) dose instead of (0.5ml) dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2441071

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: VA
Alter: 79,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered

Symptomtext

She received 0.25ml dose of bivalent Moderna vaccine, instead of 0.5ml dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2441069

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7148B

gering

Staat: VA
Alter: 68,0
Geschlecht: M
Eingang: 12.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Underdose

Symptomtext

Patient received 0.25ml dose instead of 0.5ml dose, no adverse symptoms reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -